日本臨牀　62/増刊1　痴呆症学2

出版社： 日本臨牀社
発行日： 2004-01-28
分野： 臨床医学：一般  >  雑誌
雑誌名：
特集： 痴呆症学2 高齢社会と脳科学の進歩
電子書籍版： 2004-01-28 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

13,420 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

13,420 円(税込)

購入する

目次

  • 日本臨牀　62/増刊1　痴呆症学2

    ―目次―

    特集　痴呆症学2 高齢社会と脳科学の進歩

    臨床編―各論― 　 　
    ?　脳血管性痴呆 　 　
    　 1． 脳血管性痴呆：概念と診断基準
    　 2． 疫学的事項
    　 3． 症候と検査成績
    　 4． 診断と類似疾患の鑑別
    　 5． 分類と病理像
    　 6． 治療法
    ?　神経変性疾患による痴呆(変性性痴呆) 　 　
    　 1． Alzheimer病 　 　
    　　 1) 孤発性Alzheimer病 　 　
    　　　　a． 概念と診断基準
    　　　　b． 危険因子 　 　
    　　　　c． 病態
    　　　　d． 診断と類似疾患の鑑別
    　　　　e． 治療法 　 　
    　　　　f． 予後
    　　 2) 家族性Alzheimer病 　 　
    　　　　a． アミロイド前駆体蛋白遺伝子変異によるAlzheimer病
    　　　　b． プレセニリン遺伝子変異によるAlzheimer病
    　 2． Parkinson病，家族性Parkinson病
    　 3． Huntington病
    　 4． 進行性核上性麻痺
    　 5． 大脳皮質基底核変性症
    　 6． グアム・パーキンソン痴呆症候群
    　 7． レビー小体型痴呆
    　 8． 多系統萎縮症
    　 9． 歯状核赤核・淡蒼球ルイ体萎縮症
    　10． 痴呆を伴う運動ニューロン疾患 　 　
    　　 1) Guam島の筋萎縮性側索硬化症とパーキンソン痴呆複合
    　　 2) 紀伊半島のALSとパーキンソン痴呆複合
    　11． 前頭側頭葉変性症とPick複合 　 　
    　　 1) 前頭側頭葉変性症 　 　
    　　　　a． 前頭側頭葉型痴呆 　 　
    　　　　b． Progressive non-fluent aphasia
    　　　　c． Semantic dementia
    　　　　d． 進行性右側頭葉萎縮症
    　　 2) Pick complex
    　12． その他の変性性痴呆 　 　
    　　 1) 石灰沈着を伴うびまん性神経原線維変化病
    　　 2) 辺縁系神経原線維変化痴呆
    　　 3) 嗜銀性グレイン型痴呆
    　　 4) 進行性皮質下膠症
    　　 5) 視床変性症
    ?　脳血管性痴呆とAlzheimer病との合併型
    ?　 一般身体疾患による痴呆 　 　
    　 1． 概論
    　 2． 各論 　 　
    　　 1) 脳・髄膜感染症 　 　
    　　　　a． 中枢神経系ウイルス感染症
    　　　　b． HIV感染症，AIDS
    　　　　c． 細菌性，真菌性，原虫性感染症
    　　　　d． 神経梅毒
    　　　　e． Lyme病
    　　　　f． Whipple病
    　　　　g． プリオン病 　 　
    　　　　　a) 孤発性プリオン病 　 　
    　　　　　b) 遺伝性プリオン病 　 　
    　　 2) 頭部外傷 　 　
    　　　　a． 慢性硬膜下血腫
    　　　　b． 急性硬膜外血腫
    　　　　c． 外傷後痴呆
    　　 3) 特発性正常圧水頭症―診療ガイドラインに関連して―
    　　 4) 脳腫瘍
    　　 5) 中枢性脱髄性疾患 　 　
    　　　　a． 多発性硬化症と認知機能障害
    　　　　b． 同心円硬化症
    　　　　c． 進行性多巣性白質脳症
    　　　　d． 散在性壊死性白質脳症
    　　　　e． 放射線誘発性痴呆
    　　　　f． 急性散在性脳脊髄炎
    　　　　g． 橋中心髄鞘崩壊症
    　　　　h． Binswanger病
    　　　　i． 若年性遺伝性Binswanger型脳血管性痴呆
    　　 6) 傍腫瘍性辺縁系脳炎
    　　 7) 内分泌疾患 　 　
    　　　　a． 下垂体機能低下症
    　　　　b． 甲状腺機能低下症
    　　　　c． 副甲状腺疾患
    　　　　d． 副腎皮質機能低下症
    　　　　e． インスリノーマ
    　　 8) 栄養障害・代謝異常 　 　
    　　　　a． ビタミン欠乏症 　 　
    　　　　b． 糖代謝障害(糖尿病，低血糖，高血糖，ｲﾝｽﾘﾝ抵抗性)
    　　　　c． 低酸素(性)脳症
    　　　　d． 先天代謝異常 　 　
    　　 9) 電解質異常による痴呆様症状
    　　10) 肝 疾 患 　 　
    　　　　a． 肝性脳症
    　　　　b． Chronic portal-systemic encephalopathy
    　　　　c． Chronic acquired hepatocerebral degeneration
    　　11) 尿毒症性脳症，透析脳症
    　　12) リウマチ性疾患(膠原病・血管炎症候群) 　 　
    　　　　a． Systemic lupus erythematosus
    　　　　b． Cerebral vasculitis
    　　　　c． サルコイドーシス
    　　　　d． Behcet病
    　　　　e． セリアック病
    　　13) 薬物，化学物質による痴呆症 　 　
    　　　　a． 薬物による痴呆 　 　
    　　　　b． 非薬物性化学物質による痴呆 　 　

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

臨床編 - 各論 -

P.12 掲載の参考文献
1) Fisher CM : Lacunes : small deep cerebral infarcts. Neurology 15 : 774-784, 1965.
PubMed
2) Fisher CM : Lacunar strokes and infarcts : A review. Neurology 32 : 871 -876, 1982.
 
3) Tomlinson BE, et al : Observations on the brains of demented old people. J Neurol Sci 11 : 205-242, 1970.
 
4) Hachinski VC, et al : Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2 : 207-209, 1974.
PubMed
5) World Health Organization : ICD-10 精神および行動の障害-臨床記述と診断ガイドライン, p 4262-4264, 医学書院, 1993.
 
6) American Psychiatric Association : Diagnostic and statistical manual of mental disorders, 4th ed, DSM-IV Washington, American Psychiatric Association, 1994. (表2は日本語訳DSM-IV精神疾患の診断・統計マニュアル (高橋三郎ほか訳), 医学書院, 1996より引用)
 
7) Chui HC, et al : Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 : 473-480, 1992.
PubMed
8) Roman GC, et al : Vascular dementia : diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 : 250-260, 1993.
 
9) 山之内博, 朝長正徳 : 脳血管性痴呆の分類と多発梗塞性痴呆の位置づけ. 医学のあゆみ 139 : 1003-1004, 1986.
Medical*Online
10) Yamanouchi H, et al : Subtypes and proportions of cerebrovascular disease in an autopsy series in a Japanese geriatric hospital. Klin Wochenschr 68 : 1173-1177, 1990.
 
11) Mckhann GC, et al : Clinical diagnosis of Alzheimer's disease-report of the NINCDS-ADRDA Work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease-. Neurology 34 : 939-944, 1984.
 
12) Hachinski VC, et al : Cerebral blood flow in dementia. Arch Neurol 32 : 632-637, 1975.
PubMed
13) Gold G, et al : Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 49 : 690-694, 1997.
PubMed
P.16 掲載の参考文献
1) Rocca WA, et al : The prevalence of vascular dementia in Europe : Facts and fragments from 1980-1990 Studies. Ann Neurol 30 : 817-824, 1991.
PubMed
2) Rocca WA, et al : Frequency and distribution of Alzheimer's disease in Europe : a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol 30 : 381-390, 1991.
 
3) Andersen K, et al : Gender differences in the incidence of AD and vascular dementia. The EURO DEM Studies. Neurology 53 : 1992-1997, 1999.
 
4) Yamada M, et al : Prevalence and risks of dementia in the Japanese population : RERF's adult health study Hiroshima subjects. Radiation Efiiects Research Foundation. J Am Geriatr Soc 47 : 189-195, 1999.
 
5) Kiyohara Y, et al : Changing Patterns in the prevalence of dementia in a Japanese community : The Hisayama Study. Gerontology 40 : 29-35, 1994.
 
6) Fukunishi I, et al : Epidemiological surveys of senile dementia in Japan. Int J Soc Psychiatry 37 : 51-56, 1991.
PubMed
7) Shiba M, et al : Prevalence of dementia in the rural village of Hanazono-mura, Japan. Neuroepidemiology 18 : 32-36, 1999.
PubMed
8) Komahashi T, et al : Epidemiological survey of dementia and depression among the aged living in the community in Japan. Jpn J psychiatry Neurol 48 : 517-526, 1994.
PubMed
9) Yoshitake T, et al : Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population : The Hisayama Study. Neurology 45 : 1161-1168, 1995.
 
10) Knopman DS, et al : Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol 60 : 85-90, 2003.
PubMed
11) Sauvaget C, et al : Dementia-free life expectancy among elderly Japanese. Gerontology 43 : 168-175, 1997.
PubMed
12) 三山吉夫 : 血管性痴呆. 新老年学 (折茂肇編), p 1016-1020, 東京大学出版会, 1999.
 
13) Ruitenberg A, et al : Alcohol consumption and risk of dementia : the Rotterdam Study. Lancet 359 : 281-286, 2002.
PubMed
14) Mukamal KJ, et al : Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 289 : 1405-1413, 2003.
PubMed
P.21 掲載の参考文献
1) World Health Organization : International statistical classhication of disease and related health problems, 10th ed (ICD-10), Vol 11, 1992.
 
2) American Psychiatric Association : Diagnostic and manual of mental disorders, 4th ed (DSM-IIIR), American Psychiatric Association, Washington DC, 1987.
 
3) Chui HC, et al : Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 : 473-480, 1992.
PubMed
4) Roman GC, et al : Vascular dementia : diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 : 250-260, 1993.
 
5) Caplan LR, Schoene WC : Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurology 28 : 1206-1215, 1978.
PubMed
6) Howard R, et al : Clinical features of ischemia in cerebral arterial border zone after periods of reduce cerebral blood flow. Arch Neurol 44 : 934-940, 1987.
 
7) 天野隆弘 : 新しい高次機能検査 (JSS-H) は痴呆の評価に使えるか. Clin Neurosci 20 : 671-674, 2002.
 
8) Joutel A, et al : Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 : 707-710, 1996.
PubMed
P.27 掲載の参考文献
1) 中村重信 : 痴呆疾患の治療ガイドライン, ワールドプランニング, 2003.
 
2) American Psychiatric Association : Diagnostic and Stantistical Manuual of Mental Disorders, 4th ed, Washington DC, ADA, 1994. (高橋三郎ほか訳 : DSM-IV-精神疾患の分類と手引き, 医学書院, 1995. )
 
3) Roman GC, et al : Vascular dementia ; Diagnostic criteria for reseach studies-Report of the NINDS-AIREN International Workshop. Neurology 43 : 250-260, 1993.
 
4) Tomlinson BE, et al : Observations on the brains of demented old people. J Neurol Sci 11 : 205-242, 1970.
 
5) Wilkinson D, et al : Donepezil in vascular dementia : A randomized, placebo-controlled study. Neurology 61 : 479-486, 2003.
PubMed
6) Morishima S, et al : Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease. Ann Neurol 42 : 85-94, 1997.
 
7) Feldman H, et al : A 24 week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57 : 613-620, 2001.
 
8) Mohs RC, et al : A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 57 : 481-488, 2001.
PubMed
9) Querfurth HW, et al : Acetylcholinesterase inhibition in dementia with Lewy bodies : results of a prospective pilot trial. Dement Geriatr Cogn Disord 11 : 314-321 2000.
PubMed
10) Ishii K, et al : Regional cerebral blood flow difference between dementia With Lewy bodies and AD. Neurology 53 : 413-416, 1999.
 
11) Rosen HJ, et al : Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58 : 198-208, 2002.
PubMed
12) 池田学 : 前方型痴呆 (ピック病を含む) の薬物療法の戦略. 臨床精神医学 31 : 1195-1201, 2002.
 
13) 水野美邦 : 神経内科ハンドブック, 医学書院, 2003.
 
P.33 掲載の参考文献
1) 松下正明 : 病変部位による脳血管性痴呆の分類. 日本臨牀 51 (増刊 : CT, MRI時代の脳卒中学-新しい診断治療体系- (下)) : 435-438, 1993.
 
2) Marshall J : Vascular dementia. In : Dementia (ed by Whitehouse PJ), P215-236, FA Davis, Philadelphia, 1993.
 
3) Markesbery WR (ed) : Vascular dementia. In : Neuropathology of Dementing Disorders, p 293-311, Arnold, London, 1998.
 
4) 葛原茂樹 : 脳血管性痴呆の概念と臨床病型分類. 日本臨牀 51 (増刊 : CT, MRI時代の脳卒中学-新しい診断治療体系- (下)) : 439-442, 1993.
 
5) Roman GC, et al : Vascular dementia : diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 : 250-260, 1993.
 
6) Hachinski VC, et al : Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2 : 207-210, 1974.
PubMed
7) Tomlinson BE, et al : 0bservations on the brains of non-demented old people. J Neurol Sci 7 : 331-356, 1968.
 
8) Tomlinson BE, et al : Observations on the brains of demented old people. J Neurol Sci 11 : 205-242, 1970.
 
9) Fisher CM : Lacunes : small, deep cerebral infarcts. Neurology 15 : 774-784, 1965.
PubMed
10) 亀山正邦 : 痴呆の臨床と鑑別 : 内科の立場から-前頭葉連合野の血管障害と痴呆-. 精神医学 15 : 357-366, 1973.
 
11) Binswanger O : Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 39 : 1103-1105, 1137-1139, 1180-1186, 1984.
 
12) Fisher CM : Binswanger's encephalopathy : a review. J Neurol 236 : 65-79, 1989.
 
13) 葛原茂樹ほか : CTによる脳血管性痴呆へのアプローチ (1) 多発梗塞性痴呆とcritical lesion. 文部省特定研究. 神経難病の発症機構 (1) (研究代表者・豊倉康夫), 昭和59年度研究業績集, p57-59, 1985.
 
14) Benson DF, et al : Angular gyrus syndrome simulating Alzheimer's disease. Arch Neurol 39 : 616-620, 1982.
PubMed
15) Yamada M, et al : Cerebral amyloid angiopathy in the aged. J Neurol 234 : 371-376, 1987.
PubMed
16) Jutel A, et al : Notch 3 mutations in CADASIL, an hereditary adult-onset condition causing stroke and dementia. Nature 383 : 707-710, 1996.
 
17) 柳下章ほか : 若年に発症し, 高血圧を欠き, 禿頭と腰痛を伴う白質脳症. 病理と臨床 13 : 393-398, 1995.
 
18) Ghiso J, et al : Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of γ-trace basic protein (cystatin C). Proc Natl Acad Sci USA 83 : 2974-2978, 1986.
 
19) Levy E, et al : Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248 : 1124-1126, 1990.
PubMed
20) Vidal R, et al : A stop codon mutation in the BRI gene associated with familial British dementia. Nature 399 (6738) : 776-781, 1999.
 
P.39 掲載の参考文献
1) Brauner DJ, et al : Treating nondementia illnesses in patients with dementia. JAMA 283 : 3230-3235, 2000.
PubMed
2) Isaacs B : The evaluation of drugs in Alzheimer's disease. Age Ageing 8 : 1-7, 1979.
 
3) Eto F : Activities of daily living and mental status in elderly patients with organic brain disorders. In : Carers, Professionals and Alzheimer's Disease (ed by O'Neill D), p 323-327, John Libbey & Company, London, 1991.
 
4) 江藤文夫ほか : 痴呆の増悪における老年内科的因子の検討. 日老医誌 22 : 385, 1985 (会).
 
5) 吉川政己, 江藤文夫 : 痴呆 I, II, III. 臨床脳波 19 : 268-275, 338-344, 408-415, 1977.
 
6) Erkinjuntti T, et al : Ethcacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : a randomized trial. Lancet 359 : 1283-1290, 2002.
PubMed
7) Weyer G, et al : Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia : experience from a placebo controlled multicenter study. Pharmacopsychiatry 33 (3) : 89-97, 2000.
PubMed
8) 柳澤勝彦 : コレステロールとアルツハイマー病. Dementia Japan 16 : 11-17, 2002.
 
9) 江藤文夫, 坂田卓志 : 脳血管障害後遺症患者の健康関連Quality of Lifeに影響を及ぼす要因の研究. 日老医誌 37 : 554-560, 2000.
 
10) 江藤文夫 : 脳血管性痴呆とその他の精神症状. 総合リハビリテーション 10 : 173-180, 1982.
 
11) 江藤文夫 : 痴呆に対して作業療法の果たす役割. OTジャーナル 34 : 358-359, 2000.
 
12) 江藤文夫 : 痴呆に対する理学療法の意義. PTジャーナル 25 : 601-605, 1991.
 
P.45 掲載の参考文献
1) McKhann G, et al : Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 : 939-944, 1984.
 
2) WHO : The ICD-10 Classhication of Mental and Behavioral Disorders, 1992. (ICD-10 精神および行動の障害, 臨床記述と診断ガイドライン (融, 中根, 小見山監訳), 医学書院, 1993.)
 
3) American Psychiatric Association : Quick Reference to the Diagnostic Criteria from DSM-rV. Washington, DC, 1994. (DSM-IV 精神疾患の分類と診断の手引 (高橋, 大野, 染矢訳), 医学書院, 1995.)
 
4) American Psychiatric Association : Quick Reference to the Diagnostic Criteria from DSM-IV-TR. Washington, DC, 2000. (DSM-IV-TR 精神疾患の分類と診断の手引 (高橋, 大野, 染矢訳), 医学書院, 2002.)
 
5) Knopman DS, et al : Practice parameter. Diagnosis of dementia (an evidence-based review). Report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 56 : 1143-1153, 2001.
 
6) American Psychiatric Association : Quick Reference to the Diagnostic Criteria from DSM-III-R. Washington, DC, 1987. (DSM-III-R 精神障害の分類と診断の手引 (高橋, 花田, 藤縄訳), 医学書院, 1988. )
 
7) 三好功峰 : 老年期の痴呆性疾患, 医学書院, 1997.
 
8) Khachaturian ZS : Diagnosis of Alzheimer's disease. Arch Neurol 42 : 1097-1106, 1985.
 
9) Mirra SS, et al : The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479-486, 1991.
 
P.50 掲載の参考文献
1) Finckh U : The future of genetic association studies in Alzheimer disease. J Neural Transm 110 (3) : 253-266, 2003.
PubMed
2) Saunders AM, et al : Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1) : 1467-1472, 1993.
 
3) Rocchi A, et al : Causative and susceptibility genes for Alzheimer's disease ; a review. Brain Res Bull 61 (1) : 1-24, 2003.
PubMed
4) Breitner JC, et al : Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 52 (8) : 763-771, 1995.
PubMed
5) Bergem AL, et al : The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry 54 (12) : 264-270, 1997.
PubMed
6) Nee LE, Lippa CF : Alzheimer's disease in 22 twin pairs-13-year follow up : hormonal, infectious and traumatic factors. Dement Geriatr Cogn Disord 10 (6) : 148-151, 1999.
 
7) Breitner JC : Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med 115 (8) : 601-606, 1991.
PubMed
8) Liddell MB, et al : Genetic risk of Alzheimer's disease : advising relatives. Br J Psychiatry 178 (1) : 7-11, 2001.
PubMed
9) Kehoe P, et al : A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8 (2) : 237-245, 1999.
PubMed
10) Corder EH, et al : Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (5123) : 921-923, 1993.
PubMed
11) Ueki A, et al : A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 163 (2) : 166-168, 1993.
PubMed
12) Farrer LA, et al : Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis and Alzheimer disease meta analysis consortium. JAMA 278 : 1349-1356, 1997.
PubMed
13) Namba Y, et al : Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541 : 163-166, 1991.
PubMed
14) Puglielli L, et al : Alzheimer's disease : the cholesterol connection. Nat Neurosci 6 : 345-355, 2003.
PubMed
15) Tooyama I : Interaction of α2-macroglobulin and amyloid β peptide. In : Neuroinflammatory Mechanisms in Alzheimer's Disease. Basic and Clinical Research (ed by Rogers J), p 145-154, Birkhauser Verlag, Basel, 2001.
 
16) Blacker D, et al : Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. Nat Genet 19 : 357-360, 1998.
 
17) Kang DE, et al : Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49 (1) : 56-61, 1997.
PubMed
18) Okuizumi K, et al : Genetic association of very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet 11 : 207-209, 1995.
PubMed
19) 太田成男 : アルツハイマー病の危険因子としてのアルデヒド脱水素酵素2遺伝子. 日本痴呆学会誌 15 : 40-55, 2001.
 
20) Ertekin-Taner N, et al : Linkage of plasma A β42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290 : 2303-2304, 2000.
 
P.55 掲載の参考文献
1) Katzman R : Education and the prevalence of dementia and Alzheimer's disease. Neurology 43 : 13-20, 1993.
PubMed
2) Launer IJ, et al : Rates and risk factors for dementia and Alzheimer's disease : Results from EURO-DEM pooled analyses. Neurology 52 : 78-84, 1999.
 
3) Kalmijn S, et al : Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42 : 776-782, 1997.
PubMed
4) Morris MC, et al : Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60 : 194-200, 2003.
PubMed
5) Goodwin JS, et al : Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249 : 2917-2921, 1983.
 
6) Jama JW, et al : Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol 144 : 275-280, 1996.
 
7) Ortega RM, et al : Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 66 : 803-809, 1997.
 
8) Jick H, et al : Statins and the risk of dementia. Lancet 356 : 1627-1631, 2000.
PubMed
9) Rockwood K, et al : Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 59 : 223-227, 2002.
PubMed
10) Laurin D, et al : Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58 : 498-504, 2001.
PubMed
11) Brenner DE, et al : Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43 : 293-300, 1993.
 
12) Wang HX, et al : Smoking and the occurrence of Alzheimer's disease : cross-sectional and longitudinal data in a population-based study. Am J Epidemiol 149 : 640-644, 1999.
 
13) Orgogozo JM, et al : Wine consumption and dementia in the elderly : aprospective community study in the Bordeaux area. Rev Neurol (Paris) 153 : 185-192, 1997.
 
14) Ruitenberg A, et al : Alcohol consumption and risk of dementia : the Rotterdam Study. Lancet 359 : 281-286, 2002.
PubMed
15) Roberts GW : Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease : evidence for common genesis. Lancet ii : 1456-1458, 1989.
 
16) Tokuda T, et al : Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol (Berl) 82 : 280-285, 1992.
 
17) Alfey AC, et al : The dialysis encephalopathy syndrome : Possible aluminum intoxication. N Engl J Med 294 : 184-188, 1976.
 
18) Neri LC, Hewitt D : Aluminium, Alzheimer's disease, and drinking water. Lancet 338 : 390, 1991.
 
19) Candy JM, et al : Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet i : 354-357, 1986.
 
20) Sobel E, et al : Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology 47 : 1477-1481, 1997.
 
P.59 掲載の参考文献
1) Hachinski VC, et al : Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet ii : 207-210, 1974.
 
2) Kalaria RN, Ballard C : Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13 (Suppl 3) : S115-123, 1999.
 
3) Skoog I, et al : Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13 (Suppl 3) : S106-114, 1999.
 
4) White L, et al : Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 977 : 9-23, 2002.
 
5) Breteler MM : Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann NY Acad Sci 903 : 457-465, 2000.
PubMed
6) Breteler MM : Vascular risk factors for Alzheimer's disease : an epidemiologic perspective. Neurobiol Aging 21 : 153-160, 2000.
 
7) Hofman A, et al : Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349 : 151-154, 1997.
PubMed
8) Ott A, et al : Association of diabetes mellitus and dementia : the Rotterdam Study. Diabetologia 39 : 1392-1397, 1996.
PubMed
9) Ott A, et al : Diabetes mellitus and the risk of dementia : The Rotterdam Study. Neurology 53 : 1937-1942, 1999.
PubMed
10) Ott A, et al : Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study : the Rotterdam Study. Lancet 351 : 1840-1843, 1998.
 
11) Bots ML, et al : Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study. Haemostasis 28 : 209-215, 1998.
PubMed
12) Bots ML, et al : Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study. Haemostasis 28 : 216-222, 1998.
PubMed
13) Kalmijn S, et al : Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42 : 776-782, 1997.
PubMed
14) Ott A, et al : Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 28 : 316-321, 1997.
 
15) Weller RO, et al : Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain : implications for therapy of Alzheimer's disease. Ann NY Acad Sci 977 : 162-168, 2002.
 
16) de la Torre JC : Vascular basis of Alzheimer's pathogenesis. Ann NY Acad Sci 977 : 196-215, 2002.
PubMed
P.65 掲載の参考文献
1) Braak H, Braak E : Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 : 239-259, 1991.
PubMed
2) American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV), p 135-155, American Psychiatric Association, Washington, DC, 1994.
 
3) Petersen RC, et al : Mild cognitive impairment ; clinical characterization and outcome. Arch Neurol 56 : 303-308, 1999.
PubMed
4) Petersen RC, et al : Practice Parameter ; Early detection of dementia ; Mild cognitive impairment (an evidence-based review). Neurology 56 : 1133-1142, 2001.
PubMed
5) Morris JC, et al : Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58 : 397-405, 2001.
PubMed
6) Minoshima S, et al : Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease. Ann Neurol 42 : 85-94, 1997.
 
7) Shinotoh H, et al : Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET. Neurology 56 : 408-410, 2001.
PubMed
8) Arai H, et al : Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memoryimpaired individuals. Alzheimer's Res 3 : 211-213, 1997.
 
9) Ishiguro K, et al : Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci Lett 270 : 91-94, 1999.
 
10) Shoji M, et al : Taps to Alzheimer's patients : a continuous Japanese study of cerebrospinal fluid biomarkers. Ann Neurol 48 : 402, 2000.
 
P.71 掲載の参考文献
1) MacKahann G, et al : Clinical diagnosis of Alzheimer's disease ; Report of the NINCDS-ADRDA work group under the auspices on department of health ad human services task fbrce on Alzheimer's disease. Neurology 34 : 939-944, 1984.
 
2) 高橋三郎ほか (訳) : American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV), American Psychiatric Association, Washington DC, DSM-IV 精神疾患の診断・統計マニュアル, 医学書院, 1996.
 
3) 融道夫ほか (監訳) : World Health Organization : The ICD-10 Classification of Mental and Behavioral Disorders ; Clinical descriptions and diagnostic guidelines. WHO, Geneva, ICD-10 精神および行動の障害-臨床記述と診断ガイドライン, p5-62, 医学書院, 1993.
 
4) Tierney MC, et al : The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38 : 359-364, 1988.
PubMed
5) Mirra SS, et al : The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479-486, 1991.
 
6) Braak H, Braak E : Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82 : 239-259, 1991.
 
7) Galasko D, et al : High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55 : 937-945, 1998.
PubMed
8) Andreasen N, et al : Evaluation CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58 : 373-379, 2001.
 
9) Clark CM, Karlawish JH : Alzheimer disease : Current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med 138 : 400-410, 2003.
PubMed
10) Kosaka K, Iseki E : Recent advances in dementia research in Japan ; Non-Alzheimer-type degenerative dementias. Psychiatry Clin Neurol 52 : 367-373, 1998.
 
P.75 掲載の参考文献
1) Kogar SM, et al : Is music therapy an effective intervention for dementia? J Music Ther 36 : 2-15, 1999.
 
2) Holden UP, Woods RT : Positive Approaches to Dementia Care, Churchill Livingstone, Edinburgh, 1995.
 
3) 黒川由紀子ほか : 老年期における精神療法の効果評価-回想法をめぐって. 老精医誌 6 : 315-329, 1995.
 
4) Ashton D : Therapeutic use of reminiscence with the elderly. Br J Nurs 12 : 894-898, 1993.
 
5) Lord TR, Gardner JE : Effects of music on Alzheimer patients. Percept Mot Skills 76 : 451-455, 1993.
 
6) Clark ME, et al : Use of music to decrease aggressive behaviors in people With dementia. J Gerontol Nurs 24 : 10-17, 1998.
PubMed
7) 松岡恵子ほか : 非薬物療法によるAlzheimer型痴呆患者の認知機能に及ぼす効果. 老精医誌 13 : 929-935, 2002.
 
8) Dick-Muehlke C, et al : Acquisition and long term retention of a gross motor skill in Alzheimer's disease patients under constant and varied practice conditions. J Gerontol (Psychol) 51B : 103-111, 1996.
 
9) Jacobs DH, et al : Apraxia and motor-skill acquisition in Alzheimer's disease are dissociable. Neuropsychologia 37 : 875-880, 1999.
PubMed
10) Nakano S, et al : Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med 42 : 1441-1445, 2001.
 
11) 川島隆太 : 高次機能のブレインイメージング, p196-203, 医学書院, 2002.
 
12) Backman L, et al : Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 52 : 1861-1870, 1999.
PubMed
P.80 掲載の参考文献
1) Thal LJ, et al : A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 47 (3) : 705-711, 1996.
PubMed
2) Thal LJ, et al : A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease. Neurology 52 (6) : 1146-1152, 1999.
PubMed
3) Summers WK, et al : Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer type. N Engl J Med 315 (20) : 1241 -1245, 1986.
 
4) Qizilbash N, et al : Cholinesterase inhibition for Alzheimer disease : a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration. JAMA 280 (20) : 1777-1782, 1998.
PubMed
5) Birks JS, et al : Donepezil for mild and moderate Alzheimer's disease (Cochrane Review). In : The Cochrane Library, Issue 1, Oxford, 2003.
 
6) Mori F, et al : Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neurol Rep 6 : 633-636, 1995.
 
P.85 掲載の参考文献
1) Green RC : 32 Alzheimer's disease and other dementing disorders in adults. In : Clinical Neurology 3 (ed by Joynt RJ, Griggs RC), p 1-84, Lippincott-Raven, Philadelphia, 1997.
 
2) Reisberg B, et al : Senile dementia of the Alzheimer type : Diagnostic and differential diagnostic features with special reference to functional assessment staging. In : Senile Dementia of the Alzheimer Type Early Diagnosis, Neuropathology and Animal Models (ed by Traber J, Gispen WH), p 18-37, Springer-Verlag, Berlin, 1985.
 
3) Lopez OL, et al : Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades : I. Neurology 55 : 1854-1862, 2000.
PubMed
4) Evans DA, et al : Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 134 : 403-412, 1991.
 
5) Bowen JD, et al : Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 47 : 433-439, 1996.
PubMed
6) Aguero-Torres H, et al : Mortality from dementia in advanced age : A 5-year follow up study of incident dementia cases. J Clin Epidemiol 58 : 737-743, 1999.
 
7) Wolfson C, et al : A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344 : 1111-1116, 2001.
PubMed
8) Walsh JS, et al : Survival of outpatients with Alzheimer-type dementia. Ann Intem Med 113 : 429-434, 1990.
 
9) Helmer C, et al : Mortality with dementia : results from a French prospective community-based cohort. Am J Epidemiol 154 : 642-648, 2001.
PubMed
10) Brookmeyer R, et al : Survival following a diagnosis of Alzheimer disease. Arch Neurol 59 : 1764-1767, 2002.
PubMed
11) Dodge HH, et al : Functional transitions and active life expectancy associated with Alzheimer's disease. Arch Neurol 60 : 253-259, 2003.
PubMed
12) Mohs RC, et al : A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 57 : 481-488, 2001.
PubMed
13) Winblad B, et al : A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57 : 489-495, 2001.
PubMed
14) Sano M, et al : A controlled trial of selegiline, alpha-tocopherol, both as treatment for Alzheimer's disease. N Engl J Med 336 : 1216-1222, 1997.
 
P.89 掲載の参考文献
1) St George-Hyslop PH : Molecular genetics of Alzheimer's disease. Biol Psychiatry 47 (3) : 183-199, 2000.
 
2) Alzheimer Disease Mutations Database http://molgen-www.uia.ac.be/ADMutations/
 
3) Selkoe DJ : Alzheimer's disease : genes, proteins, and therapy. Physiol Rev 81 (2) : 741-766, 2001.
 
4) Ghiso J, Frangione B : Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia. J Alzheimers Dis 3 (1) : 65-73, 2001.
PubMed
P.94 掲載の参考文献
1) Kamimura K, et al : Familial Alzheimer's disease genes in Japanese. J Neurol Sci 160 : 76-81, 1998.
PubMed
2) Cruts M : http://molgen-www.uia.ac.be/ADMutations/
 
3) Crook R, et al : A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 4 : 452-455, 1998.
 
4) Takao M, et al : A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family : presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol (Berl) 104 : 155-170, 2002.
 
5) Tabira T, et al : Alzheimer's disease with spastic paresis and cotton wool type plaques. J Neurosci Res 70 : 367-372, 2002.
PubMed
6) Araki W, et al : Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons. J Neurochem 79 : 1161-1168, 2001.
PubMed
7) Chui DH, et al : Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5 : 560-564, 1999.
PubMed
8) 田平武 : アルツハイマー病研究の進歩. 日老医誌 38 : 723-734, 2001.
 
9) Tabira T, et al : SignMcance of intracellular Abeta 42 accumulation in Alzheimer's disease. Front Biosci 7 : a44-49, 2002.
PubMed
10) Tabira T : Alzheimer's disease mechanism and development of therapeutic strategies. A review. Geriat Gerontol 2003. (in press)
 
P.101 掲載の参考文献
1) 柳澤信夫 パーキンソン病の診断基準と鑑別診断. 治療 76 : 1158-1166, 1994.
Medical*Online
2) Yamamura Y, et al : Clinical, pathological, and genetic studies on autosomal recessive early-onset parkinsonism with diurnal fluctuation. Parkinsonism Related Disord 4 : 64-72, 1998.
 
3) Golbe LI, et al : Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 43 : 2222-2227, 1993.
PubMed
4) Muenter MD, et al : Hereditary form of parkinsonism-dementia. Ann Neurol 43 (6) : 768-781, 1998.
PubMed
5) Leroy E, et al : The ubiquitin pathway in Parkinson's disease. Nature 395 (6701) : 451-452, 1998.
PubMed
6) Bentivoglio AR, et al : Phenotypic characterization of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord 16 : 999-1006, 2001.
 
7) Dekker M, et al : Clinical features and neuroimaging of PARK7-linked parkinsonism. Mov Disord 18 : 751-757, 2003.
PubMed
8) Funayama M, et al : A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11. 2-q13.1. Ann Neurol 51 (3) : 296-301, 2002.
PubMed
9) Druschky A, et al : Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 175 (1) : 3-12, 2000.
PubMed
10) 日本神経学会治療ガイドラインAd Hoc委員会 : パーキンソン病治療ガイドライン 2002. 臨床神経学 42 : 430-494, 2002.
 
P.106 掲載の参考文献
1) The Huntington's Disease Collaborative Research Group : A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (6) : 971-983, 1993.
 
2) Nance MA, Myers RH : Juvenile onset Huntington's disease-clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7 (3) : 153-157, 2001.
 
3) Andrew SE, et al : The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4 (4) : 398-403, 1993.
 
4) Folstein SE, et al : The diagnosis of Huntington's disease. Neurology 36 : 1279-1283, 1986.
 
5) 金澤一郎 : Huntington病. 神経内科学書 (豊倉康夫編), p 609-613, 朝倉書店, 1987.
 
6) Hayden MR : Huntington's disease. In : Neurogenetics (ed by Plust SM), p 265-280, Oxford University Press, New York, 2000.
 
7) Pillon B, et al : Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 41 : 634-643, 1991.
 
8) SuttonBrown M, Suchowersky O : Clinical and research advance in Huntington's disease. Can J Neurol Sci 30 (Suppl 1) : S45-52, 2003.
 
9) Vonsattel JP, DiFiglia M : Huntington disease. J Neuropathol Exp Neurol 57 : 369-384, 1998.
PubMed
10) Davies SW, et al : Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 : 537-548, 1997.
 
11) DiFiglia M, et al : Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuritis in brain. Science 277 : 1990-1993, 1997.
 
12) Tanaka M, et al : Intra-and intermolecular β-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases. J Biol Chem 276 : 45470-45475, 2001.
 
13) Sanchez I, et al : Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421 : 373-379, 2003.
PubMed
14) Katsuno M, et al : Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9 : 768-773, 2003.
 
P.112 掲載の参考文献
1) Steele JC, et al : Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10 : 333-359, 1964.
PubMed
2) Amano N, Takahashi T : Clinical aspects of progressive supranuclear palsy. Neuropathology 16 : 246-252, 1996.
 
3) Albert ML, et al : The 'subconical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37 : 121-130, 1974.
 
4) Litvan I, et al : Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) : report of the NINDS-SPSP international workshop. Neurology 47 : 1-9, 1996.
PubMed
5) Inoue M, et al : Neuropathology of progressive supranuclear palsy. Neuropathology 16 : 257-261, 1996.
 
6) Amano N, et al : Abnormal glial cytoskeleton in progressive supranuclear palsy. Neuropathology 16 : 139-144, 1996.
 
7) Komori T, et al : Astrocytic plaques and tufts of abnormal fibers do not coexist in conicobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 96 : 401-408, 1998.
PubMed
8) Spillantini MG, et al : Frontotemporal dementia and parkinsonism linked to chromosome 17 : a new group of tauopathies. Brain Pathol 8 : 387-402, 1998.
PubMed
9) Arai T, et al : Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 101 : 167-173, 2001.
PubMed
10) 高橋竜哉 : 大脳新皮質に変性を伴う進行性核上性麻痺. 横浜医学 52 : 149-157, 2001.
 
P.117 掲載の参考文献
1) Rebeiz JJ, et al : Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18 : 20-33, 1968.
PubMed
2) Gibb WR, et al : Corticobasal degeneration. Brain 112 : 1171-1192, 1989.
PubMed
3) Rinne JO, et al : Corticobasal degeneration. A clinical study of 36 cases. Brain 117 : 1183-1196, 1994.
PubMed
4) Spillantini MG, et al : Frontotemporal dementia and parkinsonism linked to chromosome 17 : a new group of tauopathies. Brain Pathol 8 : 387-402, 1998.
PubMed
5) Ikeda K : Basic pathology of corticobasal degeneration. Neuropathology 17 : 127-133, 1997.
 
6) Komori T, et al : Astrocytic plaques and tufts of abnormal fibers do not coexist in conicobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 96 : 401-408, 1998.
PubMed
7) Arai T, et al : Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 101 : 167-173, 2001.
PubMed
8) 高橋竜哉 : 大脳新皮質に変性を伴う進行性核上性麻痺. 横浜医学 52 : 149-157, 2001.
 
P.121 掲載の参考文献
1) Hirano A, et al : Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain 84 : 642-661, 1961.
PubMed
2) Hirano A, et al : Parkinsonism-dementia complex. II. Pathological features. Brain 84 : 662-679, 1961.
PubMed
3) 村上信之 : グアム・パーキンソン痴呆症候群. 別冊日本臨牀 神経症候群 II, p57-60, 日本臨牀社, 1999.
 
4) Mulder DW, et al : Neurologic disease on the island of Guam. US Armed Forced Med J 5 : 1724-1739, 1954.
 
5) Kurland LT, et al : Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to Mariana islands, including clinical and pathologic observation. Neurology 4 : 355-378, 1954.
 
6) Kuzuhara S, et al : Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninnsula of Japan : Clinical and neuropathological study and Tau analysis. Ann Neurol 49 : 501-511, 2001.
PubMed
7) Konagaya M, et al : Aclinical and pathological study of a Japanese case of amyotrophic lateral scler osis/Parkinsonism-dementia complex with family history. J Neurol 250 : 164-170, 2003.
 
8) Murakami N : Parkinsonism-dementia complex on Guam-overview of clinical aspects. J Neurol 246 : II16-18, 1999.
PubMed
9) Oyanagi K, et al : Distinct pathological features of the Gayllas and Tau-positive Glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. J Neuropathol Exp Neurol 56 : 308-316, 1997.
PubMed
P.125 掲載の参考文献
1) Kosaka K, et al : Presenile dementia with Alzheimer-, Pick-, and Lewy body changes. Acta Neuropathol 36 : 221-233, 1976.
PubMed
2) Perry RH, et al : Senile dementia of Lewy body type : a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95 : 119-139, 1990.
PubMed
3) Hansen L, et al : The Lewy body variant of Alzheimer's disease : a clinical and pathological entity. Neurology 40 : 1-8, 1990.
PubMed
4) McKeith IG, et al : Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) : report of the consortium on DLB intemational workshop. Neurology 47 : 1113-1124, 1996.
 
5) Shimomura T, et al : Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 55 : 1547-1552, 1998.
PubMed
6) Mori E, et al : Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 57 : 489-493, 2000.
PubMed
7) Hirono N, et al : Distinctive neurobehavioral features among neurodegenerative dementias. J Neuropsychiatry Clin Neurosci 11 : 498-503, 1999.
PubMed
8) Imamura T, et al : Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol 7 : 77-79, 2000.
 
9) Boeve BF, et al : REM sleep behavior disorder and degenerative dementia ; An association likely reflecting Lewy body disease. Neurology 51 : 363-370, 1998.
PubMed
10) Ferman TJ, et al : Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 8 : 907-914, 2002.
 
11) McKeith IG, et al : Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54 : 1050-1058, 2000.
 
12) Gnanalingham KK, et al : Motor and cognitive function in Lewy body dementia : comparison with Alzheimer's disease and Parkinson's disease. J Neurol Neurosurg Psychiatry 62 : 243-252, 1997.
 
13) Walker Z, et al : Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry 170 : 156-158, 1997.
 
14) Ala TA, et al : Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. J Neurol Neurosurg Psychiatry 70 : 483-488, 2001.
 
15) Hashimoto M, et al : Medial temporal and whole brain atrophy in dementia with Lewy bodies : A volumetric MRI study. Neurology 51 : 357-362, 1998.
PubMed
16) Barber R, et al : Medial temporal and whole-brain atrophy in dementia with Lewy bodies. Neurology 52 : 1153-1158, 1999.
 
17) Imamura T, et al : Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease : a comparative study using positron emission tomography. Neurosci Lett 235 : 49-52, 1997.
 
18) Albin RL, et al : Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47 : 462-466, 1996.
PubMed
19) Ishii K, et al : Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 53 : 413-416, 1999.
 
20) McShane R, et al : Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. J Neurol Neurosurg Psychiatry 59 : 185-188, 1995.
 
21) Imamura T, et al : Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 10 : 1903-1907, 1999.
PubMed
22) McKeith IG, et al : Efficacy of rivastigmine in dementia with Lewy bodies ; Arandomised, double-blind, placebo-controlled international study. Lancet 356 : 2031-2036, 2000.
 
23) Cummings JL, et al : Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies. Dement Geriatr Cogn Disord 13 : 67-73, 2002.
PubMed
P.130 掲載の参考文献
1) Gilman S, et al : Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163 : 94-98, 1999.
 
2) Watanabe H, et al : Progression and prognosis in multiple system atrophy : An analysis of 230 Japanese patients. Brain 125 : 1070-1083, 2002.
PubMed
3) Robbins TW, et al : Cognitive performance in multiple system atrophy. Brain 115 : 271-291, 1992.
PubMed
4) Robbins TW, et al : Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 57 : 79-88, 1994.
PubMed
5) Pillon B, et al : Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 58 : 174-179, 1995.
PubMed
6) Meco G, et al : Attentional functions in multiple system atrophy and Parkinson's disease. J Neurol Neurosurg Psychiatry 60 : 393-398, 1996.
PubMed
7) Soliveri P, et al : Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 69 : 313-318, 2000.
PubMed
8) Horimoto Y, et al : Cerebral atrophy in multiple system atrophy by MRI. J Neurol Sci 173 : 109-112, 2000.
PubMed
9) Konagaya M, et al : Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci 195 : 123-127, 2002.
PubMed
10) Mattay VS, et al : Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51 : 156-164, 2002.
PubMed
11) Konagaya M, et al : Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol 97 : 423-428, 1999.
PubMed
12) 山岡朗子ほか : 多系統萎縮症の高次脳機能障害. 臨床神経学 40 : 1407, 2000.
 
13) Pillon B, et al : Testing cognition may contribute to the diagnosis of movement disorders. Neurology 46 : 329-334, 1996.
 
14) Pirtosek Z, et al : Attention and cognition in bradykinetic-rigid syndromes : An event-related potential study. Ann Neurol 50 : 567-573, 2001.
PubMed
15) 渡辺宏久ほか : 多系統萎縮症. 神経・筋疾患の最新医療 (杉田秀夫ほか編), p161-168, 先端医療技術研究所, 2001.
 
P.135 掲載の参考文献
1) Smith JK, et al : Unusual form of cerebellar ataxia-combined dentato-rubral and pallido-Luysian degeneration. Neurology 8 : 205-209, 1958.
PubMed
2) 内藤明彦ほか : 優性遺伝型進行性ミオクローヌスてんかんの2家系. 精神経誌 74 : 871-897, 1972.
 
3) Naito N, Oyanagi-S : Familial myoclonus epilepsy and choreoathetosis : Hereditary dentatorubral-pallidoluysian atrophy. Neurology (NY) 32 : 798-807, 1982.
 
4) 内藤明彦 : DRPLA (歯状核赤核・淡蒼球ルイ体萎縮症 : dentaterubraLpallidoluysian atrophy) の臨床. 脳神経 47 : 931-938, 1995.
 
5) 湯浅龍彦 : 歯状核赤核・淡蒼球ルイ体萎縮症-45例の臨床的検討. 日本臨牀 51 : 220-227, 1993.
 
6) Koide R, et al : Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6 (1) : 9-13, 1994.
PubMed
7) 阿部康二 : 脊髄小脳変性症の臨床, 新興医学出版社, 1999.
 
8) Tsuchiya K, et al : Dentatorubropallidoluysian atrophy : clinicopathological study of dementia and involvement of the nucleus basalis of Meynert in seven autopsy cases. Acta Neuropathol (Berl) 96 (5) : 502-508, 1998.
PubMed
9) Schilling G, et al : Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 24 (1) : 275-286, 1999.
 
10) Shimohata T, et al : Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet 26 (1) : 29-36, 2000.
PubMed
P.139 掲載の参考文献
1) Kurland LT, Mulder DW : Epidemiologic investigation of ALS 1. Preliminary report on geographic distribution, with special reference to Mariana lslands, including clinical and pathologic observations. Neurology 4 : 355-378, 1954.
 
2) Spencer PS, et al : Guam ALS-PDC linked to a planet exchant neurotoxin. Science 237 : 517-522, 1987.
 
3) Yase Y : The pathogenesis of ALS. Lancet ii : 292-295, 1972.
 
4) Hirano A, et al : Parkinsonism-dementia complex, an endemic disease on the island of Guam I. Clinical features. Brain 84 : 642-661, 1961.
PubMed
5) Oyanagi K, et al : ALS of Guam : The nature of neuropathological findings. Acta Neuropathol 88 : 405-412, 1994.
PubMed
6) Gamlto RM, et al : Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 35 : 193-198, 1985.
 
7) Bailey -Wilson JE, et al : Potential role of an addictive genetic component in the cause of ALS and PDC in the Western Pacific. Am J Med Genet 45 : 68-76, 1993.
 
8) 奥村均ほか : Guam島における筋萎縮性側索硬化症 (ALS) およびパーキンソン症候群・痴呆コンプレックス (PDC) の最近の疫学的検討. 臨床環境 4 : 24-28, 1995.
 
9) Okumura H, et al : Recent epidemiological study of ALS and PDC in Guam island. In : Amyotrophic Lateral Sclerosis : Progress and Perspectives in Basic Research and Clinical Application (ed by Nakano I, Hirano A), p 154-157, Elsevier Science, BV, Amsterdam, 1996.
 
10) Okumura H : Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, USA and Hokkaido, Japan : A Comparative study. The Hokkaido Journal of Medical Science 78 : 187-195, 2003.
PubMed
11) Plato CC, et al : Amyotrophic lateral sclerosis and parkinsonism-dementia of Guam : Changing incidence rates during the past 60 years. Am J Epidemio1 157 : 149-157, 2003.
 
12) Garruto RM : Pacific paradigms of environmentally-induced neurological disorders : Clinical, epidemiological and molecular perspectives. NeuroToxicology 12 : 347-378, 1991.
PubMed
13) Rodegrs-Johnson P, et al : ALS and PDC on Guam : A 30-year evaluation of clinical and neuropathologic trends. Neurology 36 : 7-13, 1986.
 
14) Elizan TS, et al : Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation. Arch Neurol 14 : 356-368, 1966.
PubMed
15) 向井栄一郎ほか : 筋萎縮性側索硬化症の予後, グアム症例と本邦症例について. 臨床神経 22 : 139-144, 1982.
 
16) Chen KM : Motor neuron involvement in parkinsonism-dementia and its relationship to Guam amyotrophic lateral sclerosis. In : Amyotrophic Lateral Sclerosis (ed by Tsubaki T, Toyokura Y), p 319-344, University of Tokyo Press, Tokyo, 1979.
 
17) 平野朝雄 : Parkinsonism dementia complex. 神経病理を学ぶ人のために, 第2版, p 331, 医学書院, 1986.
 
18) Plato CC, et al : ALS and PDC of Guam, forty-year follow-up. Neurology 58 : 765-773, 2002.
PubMed
19) Garruto RM, et al : Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrant to Guam. Ann Neurol 10 : 341-350, 1981.
PubMed
20) Chen KM, et al : PDC in a Filipino migrant : A clinicopathologic report. Neurology 32 : 1221-1226, 1982.
 
P.146 掲載の参考文献
1) Kimura K, et al : Epidemiological and geomedical studies on ALS and allied diseases in Kii peninsula (Japan). Preliminary report. Proc Jpn Acad 37 : 417-420, 1961.
 
2) Shiraki H, Yase Y : Amyotrophic lateral sclerosis in Japan. In : Handbook of Clinical Neurology, Vol 22, System Disorders and Atrophies, Part II (ed by Vinken PJ, Bruyn GW), p 353-419, North Holland Publishing, Amsterdam, 1975.
 
3) Hirano A, et al : Parkinsonism-dementia complex, an endemic disease on the island of Guam. Clinical features. Brain 84 : 642-661, 1961,
PubMed
4) Hirano A, et al : Parkinsonism-dementia complex, an endemic disease on the island of Guam. Pathological features. Brain 84 : 662-679, 1961.
PubMed
5) Yase Y, et al : Amyotrophic lateral sclerosis. Association with schizophrenic symptoms and showing Alzheimer's tangles. Arch Neurol 27 : 118-128, 1972.
 
6) 葛原茂樹 : 紀伊半島のALS-parkinsonism-dementiaの家族性発症例. 神経内科 50 : 137-145, 1999.
 
7) Kuzuhara S, et al : Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula of Japan : clinical and neuropathological study and tau analysis. Ann Neurol 49 : 501-511, 2001.
PubMed
8) 小久保康昌, 葛原茂樹 : 紀伊半島多発地域の筋萎縮性側索硬化症とパーキンソン痴呆複合の臨床神経学的および神経病理学的検討. 臨床神経 41 : 769-774, 2001.
 
9) 葛原茂樹 : 紀伊半島のALSの疫学. 神経内科 54 : 13-19, 2001.
 
10) 葛原茂樹 : 紀伊半島のALS-その臨床面. 医学のあゆみ 191 : 825-828, 1999.
 
11) 葛原茂樹 : 紀伊半島のALS・パーキンソン・痴呆複合 (教育講演-III). 臨床神経 42 : 1073-1076, 2002.
 
12) Kokubo Y, Kuzuhara S : Neuroradiological study of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex on the Kii peninsula of Japan. Arch Neurol 60 : 1257-1261, 2003.
PubMed
P.152 掲載の参考文献
1) The Lund and Manchester Groups : Clinical and neuropathological criteria for frontotemporal dementia. JNNP 57 : 416-418, 1994.
 
2) Mitsuyama Y, Takamiya S : Presenile dementia with motor neuron disease in Japan. A new entity? Arch Neurol 36 : 592-593, 1979.
PubMed
3) Neary D, et al : Frontotemporal lobar degeneration, a consensus on clinical diagnostic criteria. Neurology 51 : 1546-1554, 1998.
 
4) Stevens M, et al : Familial aggregation in frontotemporal dementia. Neurology 50 : 1541-1545, 1998.
PubMed
5) 高松淳一 : 第17番染色体連鎖前頭側頭型痴呆・パーキンソニズム. 脳の科学 (2000年増刊号) : 349-356, 2000.
 
6) Yasuda M, et al : A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology 53 : 864-868, 1999.
 
7) Yasuda M, et al : A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation. Neurology 55 : 1224-1227, 2000.
 
8) Kitagaki H, et al : Alteration of white matter MR signal intensity in frontotemporal dementia. Am J Neuroradiol 18 : 367-378, 1997.
PubMed
9) Kitagaki H, et al : Frontotemporal dementia and Alzheimer disease : evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology 208 : 431-439, 1998.
PubMed
10) Ishii K, et al : Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39 : 1875-1878, 1998.
PubMed
11) Ikeda K : Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester group. Neuropathology 20 : 76-82, 2000.
PubMed
12) Hirono N, et al : Distinctive neurobehavioral features among neurodegenerative dementias. J Neuropsychiatry Clin Neurosci 11 : 498-503, 1999.
PubMed
13) 保田稔, 高松淳一 : Tauopathyの立場からみた前頭側頭型痴呆. 先端医療シリーズ 14 : 神経・筋疾患「神経・筋疾患の最新医療」, p204-211, 先端医療技術研究所, 2001.
 
P.157 掲載の参考文献
1) Pick A : Uber die beziehungen der senilen Hirnatropie zure aphasie. Prager Medizinishe Wochenscrift 17 : 165-167, 1892.
 
2) Alzheimer A : Uber eigenartige Krankheitsfalle des spateren Alters. Zeitscrift Fur die Gesamte Neurologie und Psychiatrie 4 : 356-385, 1911.
 
3) Altman E : Uber die umschriebene Gehimatrophie des sparteren Alters. Z Neurol Psychiatr 83 : 610-643, 1923.
 
4) Onari K, Spatz H : Anatomische Betrage zur Lehre von der Pickschen umschriebene-Grosshimriden-Atrphie ('Picksche Krankheit'). Zeitschrift fur die Gesamute Neurologie und Psychiatrie 101 : 470-511, 1926.
 
5) Constantinidis J, et al : Pick's disease. Histological and clinical correlations. Eur Neurol 11 : 208-217, 1974.
PubMed
6) Constantinidis J : Pick dementia. Anatomoclincal correlations and pathophysiological considerations. In : Modern approaches to the dementias. Part I : Etiology and Pathophysiology, Interdisciplinary Topics in Gerontology (ed by Rose FC), Vol 19, p 72-97, Karger, Basel, 1985.
 
7) Kertesz A, et al : The pathology and nosology of primary progressive aphasia. Neurology 44 : 2065-2072, 1994.
PubMed
8) Dickson DW : Pick's disease : A modern approach. Brain Pathol 8 : 339-354, 1998.
PubMed
9) Rosso SM, van Swieten JC : New developments in frontotemporal dementia and parkinsonism linked to chromosome 17. Curr Opin Neurol 15 : 423-428, 2002.
PubMed
10) Ratnavalli E, et al : The prevalence of frontotemporal dementia. Neurology 58 : 1615-1621, 2002.
PubMed
11) Hodges JR : Frontotemporal dementia (Pick's disease) : Clinical features and assessment. Neurology 56 (S4) : S6-S10, 2001.
 
12) Rahaman S, et al : Specific cognitive deficits in early frontal variant frontotemporal dementia. Brain 122 : 1469-1493, 1999.
 
13) Mesulam MM : Slowly progressive aphasia without generalized dementia. Ann Neurol 11 : 592-598, 1982.
PubMed
14) European Concerted Action on Picks's Disease (ECAPD) Consortium : Provisional clinical and neuroradiological criteria fbr the diagnosis of Pick's disease. Eur Neurol 5 : 519-520, 1998.
 
15) Rossor MN : Differential diagnosis of frontotemporal dementia : Pick's disease. Dement Geriatr Cogn Disord 10 (S1) : 43-45, 1999.
 
P.160 掲載の参考文献
1) 湯浅亮一 : 痴呆を伴う筋萎縮性側索硬化症について. 臨床神経学 4 : 529-534, 1964.
 
2) Mitsuyama Y, Takamiya S : Presenile dementia with motor neuron disease in Japan. A new entity? Arch Neurol 36 : 592, 1979.
PubMed
3) Meyer A : Uber eine der amyotrophieschen lateralsklerose nahestehende erkrankung mit psychiatrischen strorungen. Zugleich ein beitrag zur frage der spastischen pseudosklerose. Z Gesamte Neurol Psychiatr 121 : 107-128, 1929.
 
4) Bak TH, Hodges JR : Motor neuron disease, dementia and aphasia : coincidence, co-occurrence or continuum? J Neurol 248 : 260-270, 2001.
PubMed
5) 中野今治 : ALSと痴呆. 神経研究の進歩 40 : 63-74, 1996.
 
6) 湯浅亮一 : 湯浅・三山型運動ニューロン疾患. 別冊日本臨牀 神経症候群 II, p326-329, 日本臨牀社, 1999.
 
7) 吉田眞理ほか : 痴呆を伴う運動ニューロン疾患13例の臨床病理学的検討. 臨床神経 32 : 1193-1202, 1992.
 
8) 田中真, 平井俊策 : 痴呆の画像診断 : 痴呆を伴う運動ニューロン疾患. Dementia 8 : 475-481, 1994.
 
9) Okamoto K, et al : Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 239 : 426-430, 1992.
PubMed
10) Nakano I : Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 20 : 68-75, 2000.
PubMed
11) 伊東秀文ほか : 痴呆を伴う筋萎縮性側索硬化症におけるドパミン代謝異常. 臨床神経 27 : 1145-1149, 1987.
 
12) Jackson M, et al : Motor neuron disease-inclusion dementia. Neurodegeneration 5 : 339-350, 1996.
PubMed
13) Holton JL, et al : Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl) 103 : 221-227, 2002.
PubMed
14) Yaguchi M, et al : Frontotemporal dementia with cerebral intraneuronal ubiquitin-positive inclusions but lacking lower motor neuron involvement. Acta Neuropathol 105 : 81-85, 2003.
PubMed
15) Yamashita M, et al : Concurrence of amyotrophic lateral sclerosis with limbic degeneration and Alzheimer's disease. Neuropathology 17 : 334-339, 1997.
 
P.166 掲載の参考文献
1) Mesulam MM : Primary progressive aphasia-differentiation from Alzheimer's disease. Ann Neurol 22 : 533-534, 1987.
 
2) Neary D, et al : Frontotemporal lobar degeneration : a consensus on clinical diagnostic criteria. Neurology 51 : 1546-1554, 1998.
 
3) 武田克彦 : ベッドサイドの神経心理学, 中外医学社, 1998.
 
4) Mesulam MM : Slowly progressive aphasia without generalized dementia. Ann Neurol 11 : 592-598, 1982.
PubMed
5) Mesulam MM : Primary progressive aphasia. Ann Neurol 49 : 425-432, 2001.
PubMed
6) Weintraub S, et al : Primary progressive aphasia. Longitudinal course, neuropsychological profile, and language features. Arch Neurol 47 : 1329-1335, 1990.
PubMed
7) Grossman M : Progressive aphasic syndromes : clinical and theoretical advances. Curr Opin Neurol 15 : 1409-1413, 2002.
 
8) Abe K, et al : Imaging in primary progressive aphasia. Neuroradiology 39 : 556-559, 1997.
PubMed
P.170 掲載の参考文献
1) Tulving E : Episodic and semantic memory. In : Organization of Memory (ed by Tulving E, Donaldson W), p 381-403, Academic Press, New York, 1972.
 
2) Pick A : Zur Symptomatologie der linksseitigen Schafenlappenatrophie. Monatschrift fur Psychiatrie und Neurologie 16 : 378-388, 1904.
 
3) 井村恒郎 : 失語-日本語に於ける特性-. 精神神経学雑誌 47 : 196-218, 1943.
 
4) Warrington EK : The selective impairment of semantic memory. Q J Exp Psychol 27 : 635-657, 1975.
PubMed
5) Snowden JS, et al : Semantic dementia : a form of circumscribed cerebral atrophy. Behav Neurol 2 : 167-182, 1989.
 
6) Hodges JR, et al : Semantic dementia : progressive fluent aphasia with temporal lobe atrophy. Brain 115 : 1783-1806, 1992.
PubMed
7) Neary D, et al : Frontotemporal lobar degeneration : a consensus on clinical diagnostic criteria. Neurology 51 : 1546-1554, 1998.
 
8) 田邉敬貴ほか : 語義失語と意味記憶障害. 失語症研究 12 : 153-167, 1992.
 
9) 池田学ほか : 意味記憶とその障害. 精神医学 41 : 35-40, 1999.
 
10) Evans JJ, et al : Progressive prosopagnosia associated with selective right temporal lobe atrophy : A new syndrome? Brain 118 : 1-13, 1995.
PubMed
11) 田邉敬貴 : 語義失語症者・その人となり-器質性病変と性格の変容-. 神経心理学 8 : 34-42, 1992.
 
12) 田邉敬貴 : 痴呆の症候学-ハイブリッドCD-ROM付, 医学書院, 2000.
 
13) Snowden JS, et al : Progressive language disorder due to lobar atrophy. Ann Neurol 31 : 174-183, 1992.
PubMed
14) Schwarz M, et al : A case of primary progressive aphasia ; a 14-year follow-up study with neuropathological findings. Brain 121 : 115-126, 1998.
 
15) 倉知正佳, 松原三郎 : Pick病の臨床・病理と画像所見. 神経心理学 7 : 10-18, 1991.
 
16) Rossor MN, et al : Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 123 : 267-276, 2000.
PubMed
17) Odawara T, et al : Clinicopathological study of two subtypes of Pick's disease in Japan. Dement Geriatr Cogn Disord 15 : 19-25, 2003.
 
18) Okamoto K, et al : Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 239 : 426-430, 1992.
PubMed
19) 池田研二ほか : ピック病の再検討-ピック小体を伴わない葉性萎縮の位置づけ-. 神経進歩の研究 45 : 329-340, 2001.
 
20) Jackson M, et al : Motor neurone disease-inclusion dementia. Neurodegeneration 5 : 339-350, 1996.
PubMed
21) Wechsler AF, et al : Pick's disease ; A clinical, computed tomographic, and histologic study with Golgi impregnation observations. Arch Neurol 39 : 287-290, 1982.
PubMed
P.173 掲載の参考文献
1) Mesulam MM : Slowly progressive aphasia without generalized dementia. Ann Neurol 11 : 592-598, 1982.
PubMed
2) Brun A, et al : Consensus statement : clinical and neuropathological criteria for frontotemporal dementia ; the Lund and Manchester groups. J Neurosurg Neurol Psychiatry 57 : 416-418, 1994.
 
3) Snowden JS, et al : Semantic dementia : a form of circumscribed cerebral atrophy. Behav Neurol 2 : 167-182, 1989.
 
4) Gross C, Sergent J : Face recognition. Curr Opin Neurobiol 2 : 156-161, 1992.
PubMed
5) Allison T, et al : Face recognition in human extrastriate cortex. J Neurophysiol 71 : 821-825, 1994.
PubMed
6) Bruce V, Young A : Understanding face recognition. Br J Psychol Arch 77 : 305-327, 1986.
 
7) Geday J, et al : Emotional valance modulates actiVity in the posterior fusiforrri gyrus and inferior medial prefrontal cortex in social perception. NeuroImage 18 : 675-684, 2003.
 
8) Habib M : Visual hypoemotionality and prosopagnosia associated with right temporal lobe isolation. Neuropsychologia 24 : 577-582, 1986.
PubMed
9) McCarthy RA, et al : Topographic amnesia : spatial memory disorder, perceptual dysfunction, or category specific semantic memory impairment? J Neurol Neurosurg Psychiatry 60 : 318-325, 1996.
PubMed
10) Tyrrell PJ, et al : Progressive degeneration of the right temporal lobe studied with positron emission tomography. J Neurol Neurosurg Psychiatry 53 : 1046-1050, 1990.
PubMed
11) Evans JJ, et al : Progressive prosopagnosia associated with selective right temporal lobe atrophy. A new syndrome? Brain 118 : 1-13, 1995.
PubMed
12) Gentileschi V, et al : Progressive defective recognition of familiar people. Neurocase 5 : 407-424, 1999.
 
13) Gainotti G, et al : Slowly progressive defect in recognition of familiar people in a patient with right anterior temporal atrophy. Brain 126 : 792-803, 2003.
 
14) Bentin S, et al : Selective visual streaming in face recognition : evidence from developmental prosopagnosia. Neuroreport 10 : 823-827, 1999.
PubMed
15) Mishkin M, et al : Memories and habits : two neural systems. In : Neurobiology of Learning and Memory (ed by Lynch G, et al), p 65-77, Guildiford Press, 1984.
 
16) Brun A, Gustafson L : Frontal lobe degeneration of the non-Alzheimer type and dementia in motor neuron disease. In : Neuropathology of Dementing Disorders (ed by Markesbery WR), p 158-169, Arnold, 1998.
 
17) Knopman DS, et al : Dementia lacking distinctive histologic features : acommon non-Alzheimer degenerative dementia. Neurology 40 : 251-256, 1990.
 
18) Giannakopoulos P, et al : Dementia lacking distinctive histopathology : clinicopathological evaluation of 32 cases. Acta Neuropathol (Berl) 89 : 346-355, 1995.
PubMed
19) Hayashi M, et al : Non-Alzheimer dementia with status spongiosus and neuronal cell loss showing unusual perineuronal structures and point mutation at 129 codon of prion protein-a case report-. Dementia 8 : 55-59, 1997.
PubMed
20) Reed LA, et al : Phenotypic correlations in FTDP-17. Neurobiol Aging 22 : 89-107, 2001.
PubMed
21) Caselli RI : Visual syndromes as the presenting feature of degenerative brain disease. Semin Neurol 20 : 139-144, 2000.
 
P.177 掲載の参考文献
1) 小阪憲司 : 老化性痴呆の臨床, 金剛出版, 1988.
 
2) Onari K, Spatz H : Anatomische Beitrage zur Lehre Vbn Pickschen umschribenen Groβhirnrinden-Atrophie (Picksche Krankheit). Z Ges Neurol Psychiatr 101 : 470-511, 1926.
 
3) 土谷邦秋 : Pick病の歴史と概念の変遷. 神経内科 50 : 321-328, 1999.
 
4) Gustafson L : Frontal-Lobe degeneration of non-Alzheimer type. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 6 : 209-223, 1987.
PubMed
5) Neary D, et al : Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 53 : 929-931, 1990.
 
6) The Lund and Manchester Groups : Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57 : 416-418, 1994.
PubMed
7) Snowden JS, et al : Semantic dementia ; A form of circumscribed cerebral atrophy. Behav Neurol 2 : 167-182, 1989.
 
8) 田辺敬貴 : 前頭側頭型痴呆の臨床概念. 老精医誌 11. 1263-1265, 2000.
 
9) Snowden JS, et al : Fronto-Temporal Lobar Degeneration : Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia, Churchill Livingstone, New York, 1996.
 
10) 池田学, 田辺敬貴 : 痴呆の臨床的分類はどのようにすべきか. 神経心理 16 : 110-116, 2000.
 
11) Kertesz A, et al : The pathology and nosology of primary progressive aphasia. Neurology 44 : 2065-2072, 1994.
PubMed
12) Kertesz A, Munoz D : Pick's disease and Pick complex introductory nosology. In : Pick's Disease and Pick Complex (ed by Kertesz A, Munoz D), p 1-11, Wiley, New York, 1998.
 
13) 福井俊哉 : Pick complex (Kertesz) について. 老精医誌 11 : 1273-1280, 2000.
 
14) Kertesz A, Munoz D : Pick's disease, frontotemporal dementia, and Pick complex : emerging concepts. Arch Neurol 55 : 302-304, 1998.
PubMed
15) Constantinidis J, et al : Pick's disease : Histological and clinical correlations. Eur Neurol 418, 1994.
 
P.182 掲載の参考文献
1) 安藤烝ほか : Pick病の1剖検例. 神経研究の進歩 9 : 181-182, 1965.
 
2) Shibayama H, et al : Non-Alzheimer non-Pick dementia with Fahr's syndrome. Clin Neuropathol 11 : 237-250, 1992.
 
3) Kosaka K : Diffuse neurofibrillary tangles with calcification : a new presenile dementia. J Neurol Neurosurg Psychiatry 57 : 594-596, 1994.
PubMed
4) 田辺康之, 黒田重利 : 石灰沈着を伴うびまん性神経原線維変化病 (DNTC). Dementia Japan 15 : 8-15, 2001.
 
5) 池田学ほか : 特異な初老期痴呆症の1例-Alzheimer病・Pick病との比較検討-. 脳神経 46 : 175-181, 1994.
 
6) 小阪憲司 : 非アルツハイマー型変性性痴呆. 老年期痴呆 11 : 63-70, 1997.
 
7) 岩井清ほか : Fahr症状群を伴う非アルツハイマー非ピック痴呆症 (NANPDF) の臨床診断基準について. 老年精神医学雑誌 7 : 189-197, 1996.
Medical*Online
8) Tanabe Y, et al : Tau pathology in difiiuse neurofibrillary tangles with calcification (DNTC) : biochemical and immunohistochemical investigation. Neuroreport 11 : 2473-2477, 2000.
PubMed
9) Yokota O, et al : NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta Neuropathol 104 : 333-341, 2002.
PubMed
10) Haraguchi T, et al : Diffuse neurofibrillary tangles with calcification (a form of dementia) : X-ray spectrometric evidence of lead accumulation in calcified regions. Neuroreport 12 : 1257-1260, 2001.
PubMed
11) Haraguchi T, et al : Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC) : the possibility of lead neurotoxicity. Neuroreport 12 : 3887-3890, 2001.
PubMed
12) Imamura K, et al : Activation mechanism of brain microglia in patients with diffuse neurofibrillary tangles with calcification : a comparison with Alzheimer disease. Alzheimer Dis Assoc Disord 15 : 45-50, 2001.
PubMed
13) Terada S, et al : Plaque-like structures and arteriosclerotic changes in "diffuse neurofibrillary tangles with calcification" (DNTC). Acta Neuropathol 102 : 597-603, 2001.
PubMed
14) Fujita D, et al : Immunohistochemical examination on intracranial calcification in neurodegenerative diseases. Acta Neuropathol 105 : 259-264, 2003.
PubMed
15) Tsuchiya K, et al : Distribution of basal ganglia lesions in difuse neurofibrillary tangles with calcification : a clinicopathological study of five autopsy cases. Acta Neuropathol 103 : 555-564, 2002.
 
P.188 掲載の参考文献
1) 山田正仁 : 神経原線維変化型老年痴呆について. Geriatric Medcine 38 : 1163 -1167, 2000.
 
2) Bancher C, et al : Neurofibrillary tangle predominant form of senile dementia of Alzheimer type : a rare subtype in very old subjects. Acta Neuropathol 88 : 565-570, 1994.
PubMed
3) Yamada M, et al : Dementia of the Alzheimer type and related dementias in the aged : DAT subgroups and senile dementia of the neurofibrillary tangle type. Neuropathology 14 : 33-38, 2000.
 
4) Kosaka K, et al : Recent advances in dementia research in Japan : non-Alzheimer-type degenerative dementias. Psychiatry Clin Neurosci 52 : 36-37, 1998.
 
5) Ikeda K, et al : Clinical aspects of "senile dementia of the tangle type" : a subset of dementia in the senium separable from late onset Alzheimer's disease. Dement Geriatr Cogn Disord 10 : 6-11, 1999.
 
6) 島崎正夫ほか : 脳挫傷5年後に痴呆を呈し, 海馬体に限局した神経原線維変化を認めた1例. 精神医学 45 : 139-144, 2003.
 
7) 堀宏治ほか : 90歳以上で入院した痴呆患者の臨床的特徴. 精神医学 43 : 425-443, 2001.
 
8) Ikeda K, et al : A subset of senile dementia with high incidence of the apolipoprotein Eε2 allele. Ann Neurol 41 : 693-695, 1997.
 
9) Trzepacz PT : Is there a final common pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatr 5 : 132-148, 2000.
 
10) 堀宏治ほか : 塩酸ドネペジルの日常臨床における課題 : 周辺症状の観点から. 老精医学誌 13 (増刊号) : 44-48, 2002.
 
P.191 掲載の参考文献
1) Braak H, Braak E : Argyrophilic grains : characteHstic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 76 : 124-127, 1987.
PubMed
2) Braak H, Braak E : Argyrophilic grain disease : frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105 : 801-819, 1998.
PubMed
3) Tolnay M, et al : Argyrophilic grain disease : widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol 93 : 477-484, 1997.
PubMed
4) Martinez-Lage P, Munoz DG : Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol 56 : 157-164, 1997.
 
5) Togo T, et al : Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neu-rol 61 : 547-556, 2002.
 
6) Iseki E, et al : Dementia with Lewy bodies from the perspective of tauopathy. Acta Neuropathol (Berl) 105 : 265-270, 2003.
PubMed
7) Togo T, et al : Argyrophilic grain disease : neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12 : 45-52, 2002.
 
8) Ikeda K, et al : A study of dementia with argyrophilic grains. Possible cytoskeletal abnormality in dendrospinal portion of neurons and oligodendroglia. Acta Neuropathol (Berl) 89 : 409-414, 1995.
PubMed
9) Tolnay M, et al : Argyrophilic grains of Braak : occurrence in dendrites of neurons containing hyperphosphorylated tau protein. Neuropathol Appl Neurobiol 24 : 53-59, 1998.
PubMed
10) Braak H, Braak E : Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 15 : 13-26, 1989.
PubMed
11) Itagaki S, et al : A case of adult-onset dementia with argyrophilic grains. Ann Neurol 26 : 685-689, 1989.
PubMed
12) Ghebremedhin E, et al : Argyrophilic grain disease is associated with apolipoprotein E epsilon 2 allele. Acta Neuropathol (Berl) 96 : 222-224, 1998.
PubMed
13) Tolnay M, et al : Apolipoprotein E allele frequencies in argyrophilic grain disease. Acta Neuropathol (Berl) 96 : 225-227, 1998.
PubMed
14) Tolnay M, et al : Argyrophilic grain disease : distribution of grains in patients with and without dementia. Acta Neuropathol (Berl) 94 : 353-358, 1997.
PubMed
15) Ikeda K, et al : Clinical aspects of argyrophilic grain disease. Clin Neuropathol 19 : 278-284, 2000.
 
P.195 掲載の参考文献
1) Neumann M : Pick's disease. J Neuropathol Exp Neurol 8 : 255 -282, 1949.
 
2) Neumann M, Cohn R : Progressive subcortical gliosis, a rare form of presenile dementia. Brain 90 : 405-427, 1967.
PubMed
3) 皆川正男, 中里敬 : 初老期痴呆の1特殊型progressive subcortical gliosis (Neumann) の1例. 精神経誌 75 : 79-93, 1973.
 
4) Lanska DJ, et al : Late-onset sporadic progressive subcortical gliosis. J Neurological Sci 157 : 143-147, 1998.
 
5) Lanska DJ, et al : Familial progressive subcortical gliosis. Neurology 44 : 1633-1643, 1994.
PubMed
6) 茂呂和生ほか : Progressive subcortical gliosisの1例-Pick病の司法鑑定例から-. 脳神経 27 : 103-111, 1975.
 
7) 調輝雄ほか : Progressive subcortical gliosis (Neumann) と思われる初老期痴呆の1剖検例. 脳神経 24 : 1341-1347, 1972.
 
8) Hassin GB, Levitin D : Pick's disease. Clinicopathologic study and report of a case. Arch Neurol Psychiatry 45 : 814-833, 1941.
 
9) Will RG, et al : A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome. J Neurol Neurosurg Psychiatry 51 : 1224-1227, 1988.
PubMed
10) Foster NL, et al : Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. J Neurol Neurosurg Psychiatry 55 : 707-713, 1992.
PubMed
11) Petersen RB, et al : Familial progressive subcortical gliosis : Presence of prions and linkage to chromosome 17. Neurology 45 : 1062-1067, 1995.
PubMed
12) Goedert M, et al : Tau gene mutation in familial progressive subcortical gliosis. Nat Med 5 : 454-457, 1999.
PubMed
13) Revesz T, et al : A case of progressive subcortical gliosis associated with deposition of abnormal prion protein (PrP). J Neurol Neurosurg Psychiatry 58 : 759-760, 1995.
PubMed
14) Gambetti P : Prion in progressive subcortical gliosis revisited. Neurology 49 : 309-310, 1997.
PubMed
15) Auff E, Seitelberger F : Contribution to problem of presenile glial dystrophy. Neuropathology 1 : 113-118, 1980.
 
P.200 掲載の参考文献
1) 小田雅也 プリオン病 視床変性症と致死性家族性不眠症. 老年精神誌 9 : 280-287, 1998.
 
2) Lugaresi E, et al : Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315 : 997, 1986.
PubMed
3) Petersen RB, et al : Analysis of the prion protein gene in thalamic dementia. Neurology 42 : 1859, 1992.
PubMed
4) Stern K : Severe dementia associated with bilateral symmetrical degeneration of the thalamus. Brain 62 : 157, 1939.
 
5) Schulman S : Bilateral symmetrical degeneration of the thalamus. Clinico-pathological study. J Neuropathol Exp Neurol 16 : 446, 1957.
 
6) 小田雅也ほか : オリーブ核小脳萎縮を伴う両側視床系変性症の1剖検例. 精神神経誌 67 : 67, 1965.
 
7) Oda M : Thalamus degeneration in Japan. A review from clinical and pathological viewpoints. Appl Neurophysiol 39 : 178, 1976/77.
 
8) 若林允甫ほか : 視床変性症の1例. 臨床神経学 27 : 678 (抄), 1987.
 
9) McLean CA, et al : The D178N (cis-129M) "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology 49 : 552, 1997.
 
10) Budka H, et al : Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion disease). Brain Pathol 5 : 459, 1995.
PubMed
11) Janssen JC, et al : Thalamic degeneration with negative prion protein immunostaining. J Neurol 247 : 48, 2000.
PubMed
P.204 掲載の参考文献
1) Yanagihara T : Vascular dementia in Japan. Ann NY Acad Sci 977 : 24-28, 2002.
PubMed
2) Korczyn AD : Mixed dementia-the most common cause of dementia. Ann NY Acad Sci 977 : 129-134, 2002.
PubMed
3) Roman GC, et al : Vascular dementia : Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 : 250-260, 1993.
 
4) Barba R, et al : Poststroke dementia. Clinical features and risk factors. Stroke 31 : 1494-1501, 2000.
PubMed
5) Henon H, et al : Poststroke dementia : Incidence and relationship to prestroke cognitive decline. Neurology 57 : 1216-1222, 2001.
PubMed
6) Snowdon DA, et al : Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 277 : 813-817, 1997.
PubMed
7) Esiri MM, et al : Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354 : 919-920, 1999.
PubMed
8) Nolan KA, et al : Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 46 : 597-604, 1998.
 
9) Yoshitake T, et al : Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population : the Hisayama study. Neurology 45 : 1161-1168, 1995.
 
10) Zekry D, et al : The vascular lesions in vascular and mixed dementia : The weight of functional neuroanatomy. Neurobiol Aging 24 : 213-219, 2003.
PubMed
11) Kalaria RN : The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21 : 321-330, 2000.
PubMed
12) Skoong I, Gustafson D : Hypertension and related factors in the etiology of Alzheimer's disease. Ann NY Acad Sci 977 : 29-36, 2002.
PubMed
13) de la Torre JC : Alzheimer disease as vascular disorder. Nosological evidence. Stroke 33 : 1152-1162, 2002.
PubMed
14) Tanaka M, et al : Cerebral blood flow and oxygen metabolism in vascular dementia evaluated by positron emission tomography. Importance of frontal lobe hypoperfusion and hypometabolism. Ann NY Acad Sci 977 : 135-140, 2002.
PubMed
15) Okamoto K, et al : Treatment of vascular dementia. Ann NY Acad Sci 977 : 507-512, 2002.
PubMed
P.214 掲載の参考文献
1) Marsden CD, Harrison MJ : Out-come of investigation of patients with presenile dementia. BMJ 2 : 249 -252, 1972.
 
2) Freemon FR : Evaluation of patients with progressive intellectual deterioration. Arch Neurol 33 : 658-659, 1976.
PubMed
3) American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, 3rd ed (DSM-III).
 
4) Cummings J, et al : Reversible dementia. Illustrative cases, definition, and review. JAMA 243 : 2434, 1980.
PubMed
5) 黒岩義之, 東儀英夫 : 痴呆. Medicina 20 : 1282-1283, 1983.
 
6) 黒岩義之, 東儀英夫 : 痴呆の鑑別診断. Clinical Neuroscience 1 : 168-171, 1983.
 
7) 黒岩義之 : 痴呆-鑑別診断のポイントと治療指針. Medicament News 1130号 : 2-4, 1985.
 
8) 黒岩義之, 東儀英夫 : 痴呆の種類と鑑別のし方. Brain Nursing 2 : 434-440, 1986.
 
9) 黒岩義之 : 痴呆. 治療 69 : 239-244, 1987.
 
10) 東儀英夫 : Status lacunaris. その病理と臨床. 脳神経 35 : 209, 1983.
 
11) Adams RD, et al : Symptomatic occult hydrocephalus with normal cerebrospinal fluid pressure. A treatable syndrome. N Engl J Med 273 : 117, 1965.
PubMed
P.217 掲載の参考文献
1) 石原健児ほか : 単純ヘルペス脳炎における健忘の検討. 脳神経 52 : 979-983, 2000.
 
2) 古賀正哉 : 単純ヘルペス脳炎の臨床的研究. 久留米医学会誌 57 : 1061-1071, 1994.
 
3) Caparros-Lefebvre D, et al : Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways. J Neurol 243 : 248-256, 1996.
PubMed
4) Shoji H, et al : Partial Kluver-Bucy syndrome following probable herpes simplex encephalitis. J Neurol 221 : 163-167, 1979.
PubMed
5) Cinque P, et al : The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis. A consensus report. J Neurol Neurosurg Psychiatry 61 : 339-345, 1996.
PubMed
6) Baringer JR, Pisani P : Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 36 : 823-829, 1994.
PubMed
7) 楠原智彦ほか : 非ヘルペス性急性辺縁系脳炎の存在について. 臨床神経 34 : 1083-1088, 1994.
 
8) Nakajima H, et al : Herpes simplex virus myelitis ; Clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol 39 : 163-167, 1998.
PubMed
9) Kojima Y, et al : Recurrent herpes simplex virus type 2 meningitis. Jpn J Infect Dis 55 : 85-88, 2002.
PubMed
10) Levy RM, et al : Neurological manifestations of the acquired immunodeficiency syndrome (AIDS). Experience at UCSF and review of the literature. J Neurosurg 62 : 475-495, 1985.
PubMed
11) Yamada S, et al : Ipsilateral truncal sensory deficit in a patient with ophthalmic zoster sine herpete. Neurology 60 : 1049-1050, 2003.
 
12) De La Blanchardiere A, et al : Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency Virus infection. Scand J Infect Dis 32 : 263-269, 2000.
PubMed
13) Fujimoto H, et al : Epstein-Barr infections of the central nervous system. Intern Med 42 : 33-40, 2003.
PubMed
14) Roullet E, et al : Cytomegalovirus multifocal neuropathy in AIDS : Analysis of 15 consective cases. Neurology 44 : 2174-2182, 1994.
 
15) Wainwright MS, et al : Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50 : 612-619, 2001.
PubMed
16) Shoji H, et al : Japanese encephalitis in the Kumme regions of Japan. J Neurol 236 : 255-259, 1989.
 
17) Asnis DS, et al : The West Nile virus outbreak of 1999 in New York. Clin Infect Dis 30 : 413-418, 2000.
PubMed
P.223 掲載の参考文献
1) Price RW, et al : The brain in AIDS : Central nervous system HIV-1 infection and AIDS dementia complex. Science 239 : 586-592, 1988.
PubMed
2) Janssen RS, et al : Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41 : 778-785, 1991.
 
3) Budka H, et al : HIV-associated disease of the nervous system : review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1 : 143-152, 1991.
 
4) Glass JD, et al : Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43 : 2230-2237, 1993.
PubMed
5) Gray F, et al : Neuropathology of early HIV-1 infection. Brain Pathol 6 : 1-15, 1996.
PubMed
6) Masliah E, et al : Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42 : 963-972, 1997.
PubMed
7) Kaul M, et al : Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410 (6831) : 988-994, 2001.
PubMed
8) Langford D, Masliah E : Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol 11 : 306-312, 2001.
PubMed
9) Xing HQ, et al : Simian immunodeficiency virus encephalitis in the white matter and degeneration of the cerebral cortex occur independently in simian immunodeficiency Virus-infected monkey. J Neurovirol 9 : 508-518, 2003.
PubMed
10) Jellinger KA, et al : Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100 : 213-220, 2000.
PubMed
11) Masliah E, et al : Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14 : 69-74, 2000.
PubMed
12) 岸田修二ほか : Neuro-AIDSにおけるHAARTの影響-我が国の疫学調査から-. 厚生労働科学研究費補助金 (エイズ対策研究事業) HIV等のレトロウイルスによる痴呆や神経障害の病態と治療に関する研究, 平成14年度研究報告書, p16-22, 2003.
 
P.229 掲載の参考文献
1) 水谷智彦 : 感染症と痴呆. Clinical Neuroscience 13 : 695-697, 1995.
 
2) 廣瀬善清ほか : 細菌性髄膜炎. 日内会誌 85 : 699-704, 1996.
 
3) Kamei S, Takasu T : Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med 39 : 894-900, 2000.
PubMed
4) Durand ML, et al : Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328 : 21-28, 1993.
PubMed
5) Sigurdardottir B, et al : Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med 157 : 425-430, 1997.
PubMed
6) 春田恒和 : 髄膜炎菌髄膜炎. 別冊日本臨牀 感染症症候群 I, p286-288, 日本臨牀社, 1999.
 
7) 亀井聡 : 細菌性髄膜炎. 神経内科 55 : 428-433, 2001.
 
8) Roos KL, et al : Acute bacterial meningitis in children and adults. In : Infection of the Central Nervous System, 2nd ed (ed by Scheld M, et al), p 335-401, Lippincott-Raven, Philadelphia, 1997.
 
9) Bartt R : Listeria and atypical presentations of listeria in the central nerve system. Semin Neurol 20 : 361-373, 2000.
 
10) 亀井聡, 水谷智彦 : 忘れてはならない神経感染症. 臨床神経 41 : 1173-1177, 2001.
 
11) Pontrelli L, et al : Neurobehavioral manifestrations and sequelae of HIV and other infections. Child Adolesc Psychiatr Clin N Am 8 : 869-878, 1999.
 
12) 野崎博之 : 結核性髄膜炎. 神経内科 55 : 443-448, 2001.
 
13) Zuger A, Lowy FD : Tuberculosis. In : Infection of the Central Nervous System, 2nd ed (ed by Scheld WM, et al), p 417-443, Lippincott-Raven, Philadelphia, 1997.
 
14) 黒岩義之, 長友秀樹 : 結核性・真菌性髄膜炎. 日内会誌 85 : 705-710, 1996.
 
15) Thwaites G, et al : Tuberculous meningitis. J Neurol Neurosurg Psychiatry 68 : 289-299, 2000.
PubMed
16) Maedor KJ, et al : Dementia associated with dorsal midbrain lesion. J Int Neuropsychol Soc 2 : 359-367, 1996.
 
17) Ogawa SK, et al : Tuberculous meningitis in an urban medical center. Medicine 66 : 317-326, 1987.
 
18) Begg N, et al : Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 39 : 1-15, 1999.
 
19) Perfect JR, Durack DT : Fungal meningitis. In : Infection of the Central Nervous System, 2nd ed (ed by Scheld WM, et al), p 721-739, Lippincott-Raven, Philadelphia, 1997.
 
20) 藤木直人, 田代邦雄 : 真菌性髄膜炎. 神経内科 55 : 434-442, 2001.
 
21) Weenink HR, Bruyn GW : Cryptococcosis. In : Handbook of Clinical Neurology, Vol 8 (52) : Microbial Disease (ed by Harris AA), p 429-436, Elsevier Science, Amsterdam, 1988.
 
22) 水澤英洋 : 脳マラリアなどの脳原虫症. Clinical Neuroscience 15 : 62-64, 1995.
 
23) 狩野繁之 : トキソプラズマ症. 別冊日本臨牀 感染症症候群 I, p164-166, 日本臨牀社, 1999.
 
24) Couvreur J, Desmonts G. Acquired and congenital toxoplasmosis. In : Handbook of Clinical Neurology, Vol 8 (52) : Microbial Disease (ed by Harris AA), p351-363, Elsevier Science, Amsterdam, 1988.
 
25) Cegielski JP, Durack DT : Trypanosomiasis. In : Infection of the Central Nervous System, 2nd ed (ed by Scheld WM, et al), p 807-829, Lippincott-Raven, Philadelphia, 1997.
 
26) Durack DT : Amebic infections. In : Infection of the Central Nervous System, 2nd ed (ed by Scheld WM, et al), p 831-845, Lippincott-Raven, Philadelphia, 1997.
 
P.234 掲載の参考文献
1) Rowland LP, Stefanis L : Spirochete infections : neurosyphilis. In : Merrit'sNeurology (ed by Rowland LP), p 182-188, Lippincott Williams & Wilkins, Philadelphia, 2000.
 
2) Kohler CG, et al : Neurosyphilis presenting as schizophrenia-like psychosis. Neuropsychiatry Neuropsychol Behav Neurol 13 : 297-302, 2000.
 
3) Fujimoto H, et al : Neurosyphilis showing transient global amnesia-like attacks and magnetic resonance imaging abnormalities mainly in the limbic system. Intern Med 40 : 439-442, 2001.
PubMed
4) 亀子光明 : 梅毒の血清検査. 臨床検査法提要, 31版 (金井正光編), p891-898, 金原出版, 1998.
 
5) Marra CM, et al : A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 30 : 540-544, 2000.
PubMed
6) Kojan S, et al : Nonconvulsive status epilepticus resulting from Jarisch-Herxheimer reaction in a patient with neurosyphilis. Clin Electroencephalogr 31 : 138-140, 2000.
 
7) Morikawa M, et al : A case of general paresis showing marked treatment-associated improvement of cerebellar blood fiow by quantitative imaging analysis. Ann Nucl Med 16 : 71-74, 2002.
 
P.238 掲載の参考文献
1) Steere AC : Lyme disease. N Engl J Med 345 : 115-125, 2001.
PubMed
2) 川端寛樹 : Lyme病. 綜合臨牀 52 (Suppl) : 1183-1190, 2003.
 
3) Kaiser R : Neuroborreliosis. J Neurol 245 : 247-255, 1998.
PubMed
4) Logigian EL, et al : Chronic neurologic manifestation of Lyme disease. N Engl J Med 323 : 1438-1444, 1990.
PubMed
5) Oschmann P, et al : Stages and syndromes of neuroborreliosis. J Neurol 245 : 262 -272, 1998.
 
6) Kobayashi K, et al : Borrelia burgdorferi-seropositive chronic encephalomyelopathy : Lyme neuroborreliosis. Dement Geriatr Cognit Disorder 8 : 384-390, 1997.
 
7) 下山博身ほか : 血清Borrelia抗体価が陽性であった慢性脳症の1例-Lyme病による慢性脳症の可能性について-. 透析会誌 24 : 399-403, 1991.
 
8) Hauser U, et al : Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 35 : 1433-1444, 1997.
 
9) Halperin JJ : Nervous system Lyme disease. J Neurol Sci 153 : 182-191, 1998.
PubMed
10) Hengge UR, et al : Lyme borreliosis. Lancet Infect Dis 3 : 489-500, 2003.
PubMed
11) Krupp LB, et al : Cognitive functioning in late Lyme borreliosis. Arch Neurol 48 : 1125-1129, 1991.
PubMed
12) Kaplan RF, et al : Cognitive function in post-treatment Lyme disease. Neurology 60 : 1916-1922, 2003.
PubMed
13) Kohler J, et al : Borrelia encephalomyelitis. Lancet 2 : 35-36, 1986.
PubMed
14) MacDonald AB, Miranda JM : Concurrent neocortical Borreliosis and Alzheimer disease. Hum Pathol 18 : 759-761, 1987.
PubMed
15) Gutacker M, et al : Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Res Microbiol 149 : 31-37, 1998.
PubMed
16) Danek A, et al : Lyme neuroborreliosis disguised as normal pressure hydrocephalus. Neurology 46 : 1743-1745, 1996.
PubMed
17) Druschky K, et al : Secondary normal pressure hydrocephalus. A complication of chronic neuroborreliosis. Nervenarzt 70 : 556-559, 1999.
PubMed
18) Waniek C, et al : Rapidly progressive frontal-type dementia associated with Lyme disease. J Neuropsychiatry Clin Neurosci 7 : 345-347, 1995.
PubMed
19) Prasad A, Sankar D : Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable. Postgrad Med J 75 : 650-656, 1999.
PubMed
P.242 掲載の参考文献
1) Raoult D, et al : Cultivation of the bacillus of Whipple's disease. N Engl J Med 342 (9) : 620-625, 2000.
 
2) Marth T, Raoult D : Whipple's disease. Lancet 361 (9353) : 239-246, 2003.
 
3) Marth T, Strober W : Whipple's disease. Semin Gastrointest Dis 7 (1) : 41-48, 1996.
 
4) Eck M, et al : Invasion and destruction of mucosal plasma cells by Tropheryma whippelii. Hum Pathol 28 (12) : 1424-1428, 1997.
PubMed
5) Gerard A, et al : Neurologic presentation of Whipple disease : report of 12 cases and review of the literature. Medicine (Baltimore) 81 (6) : 443-457, 2002.
PubMed
6) Peters G, et al : Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology. J Neurol Neurosurg Psychiatry 73 (3) : 336-339, 2002.
 
7) Schnider P, et al : MR of cerebral Whipple disease. Am J Neuroradiol 16 (6) : 1328-1329, 1995.
PubMed
8) von Herbay A, et al : Whipple's disease : staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology 113 (2) : 434-441, 1997.
 
9) Ramzan NN, et al : Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 126 (7) : 520-527, 1997.
PubMed
10) Maibach RC, et al : Detection of Tropheryma whipplei DNA in feces by PCR using a target capture method. J Clin Microbiol 40 (7) : 2466-2471, 2002.
 
11) Coria F, et al : Whipple's disease with isolated central nervous system symptomatology diagnosed by molecular identification of Tropheryma whippelii in peripheral blood. Neurologia 15 (4) : 173-176, 2000.
 
12) Dumler JS, et al : Immunodetection of Tropheryma whipplei in intestinal tissues from Dr. Whipple's 1907 patient. N Engl J Med 348 (14) : 1411-1412, 2003.
 
13) Schneider T, et al : Treatment of refractory Whipple disease with interferon-gamma. Ann Intern Med 129 (11) : 875-877, 1998.
PubMed
P.247 掲載の参考文献
1) 立石潤 : プリオンとプリオン病, 共立出版, 1998.
 
2) 黒田康夫 : 疫学. 人と動物のプリオン病 (品川森一ほか監修), p41-50, 近代出版, 2003.
 
3) クロイツフェルト・ヤコブ病等に関する緊急全国調査研究班 (班長佐藤猛) : 研究報告書, 厚生省, 1997.
 
4) 疾病対策研究会 : クロイツフェルト・ヤコブ病診療マニュアル (改訂版), 太陽美術, 2002.
 
5) Sato J, et al : The 14-3-3 protein is detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases. Eur Neurol 41 : 216-225, 1999.
 
6) 厚生労働省プリオン病及び遅発性ウイルス感染に関する調査研究班 (班長水澤英洋) : 平成14年度研究報告書, 2003.
 
7) Saborio GP, et al : Sensitive detection of pathological prion protein by cyclic amplhication of protein misfolding. Nature 411 : 810-813, 2001.
PubMed
8) Korth C, et al : Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98 : 9836-9841, 2001.
PubMed
9) Farquhar C, et al : Prophylactic potential of pentosan polysulfate in transmissible spongiform encephalopathies. Lancet 353 : 117, 1999.
PubMed
10) Heppner FL, et al : Prevention of scrapie pathogenesis by transgenic expression of anti-prion antibodies. Science 294 : 178-182, 2001.
PubMed
P.251 掲載の参考文献
1) 厚生省 : クロイツフェルト・ヤコブ病等に関する緊急全国調査研究報告書 (班長 : 佐藤猛), 1997年3月.
 
2) Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts-Japan. MMWR Morb Mortal Wkly Rep 46 (45) : 1066-1069, 1997.
PubMed
3) 佐藤猛ほか : 感染性プリオン病 : 硬膜移植後CJDと変異型CJD. 神経研究の進歩 47 (1) : 100-108, 2003.
 
4) Brown P, et al : Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55 (8) : 1075-1081, 2000.
PubMed
5) Hoshi K, et al : Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 55 (5) : 718-721, 2000.
PubMed
6) Thadani V, et al : Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 69 (5) : 766-769, 1988.
 
7) Miyashita K, et al : Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology 41 (6) : 940-941, 1991.
 
8) Hannah EL, et al : Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 56 : 1080-1083, 2001.
PubMed
9) 厚生労働省遅発性ウィルス研究班 (班長 : 北本哲之) : クロイツフェルト・ヤコブ病診療マニュアル, p28-31, 2002.
 
10) 佐藤克也ほか : 硬膜移植後発症クロイッフェルト-ヤコブ病のサブタイプの確立. 臨床神経 42 (12) : 1353, 2002.
 
11) Lane KL, et al : Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 34 (4) : 737-739 ; discussion 739-740, 1994.
 
12) Kopp N, et al : Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques. Lancet 348 (9036) : 1239-1240, 1996.
 
13) Takashima S, et al : Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet 350 (9081) : 865-866, 1997.
 
14) Shimizu S, et al : Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 56 (3) : 357-362, 1999.
PubMed
15) Kimura K, et al : Atypical form of dural graft associated Creutzfeldt-Jakob disease : report of a postmortem case with review of the literature. J Neurol Neurosurg Psychiatry 70 (5) : 696-699, 2001.
PubMed
P.255 掲載の参考文献
1) Will RG, et al : A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 : 921-925, 1996.
PubMed
2) Collinge J, et al : Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 : 685-690, 1996.
PubMed
3) Bruce ME, et al : Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 : 498-501, 1997.
PubMed
4) Telling GC, et al : Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 91 : 9936-9940, 1994.
PubMed
5) Will RG, et al : Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 47 : 575-582, 2000.
PubMed
6) Spencer MD, et al : First hundred cases of variant Creutzfeldt-Jakob disease : retrospective case note review of early psychiatric and neurological features. BMJ 324 : 1479-1482.
PubMed
7) Zeidler M, et al : The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355 : 1412-1418, 2000.
PubMed
8) Collie DA, et al : MRI of Creutzfeldt-Jakob disease ; imaging features and recommended MRI protocol. Clin Radiol 56 : 726-739, 2001.
PubMed
9) WHO : www.who.int, 2001 (The National CJD Surveillance Unit. Creutzfeldt-Jakob disease surveillance in the UK. Ninth Annual Report 2000. Dept of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, 2001).
 
10) 厚生労働省遅発性ウイルス感染調査研究班 : クロイツフェルト・ヤコブ病診療マニュアル [改訂版].
 
11) 厚生労働省科学研究費補助金特定疾患対策研究事業 遅発性ウイルス感染に関する調査研究 平成13年度研究報告書 英国における変異型クロイツフェルト・ヤコブ病診療に関する報告会, 平成14年3月, 班長 : 北本哲之.
 
12) 厚生労働省科学研究費補助金特定疾患対策研究事業 プリオン病及び遅発性ウイルス感染に関する調査研究 平成14年度研究報告書 変異型Creutzfeldt-Jakob病が疑われた問題症例および若年発症例の特徴, 平成15年3月, 班長 : 水澤英洋.
 
13) Hill AF, et al : Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349 : 99-100, 1997.
PubMed
14) Hilton DA, et al : Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 252 : 703-704, 1998.
 
15) Hachiya SN, et al : Therapeutic approaches in prion disease [minireview]. Journal of Health Science 2003. (in print)
 
P.260 掲載の参考文献
1) Gajdusek DC, Zigas V : Kuru : clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. Am J Med 26 : 442-469, 1959.
PubMed
2) Gajdusek DC : Slow-virus infections of the nervous system. N Engl J Med 276 : 392-400, 1967.
PubMed
3) 森茂 : クールー. 日本臨牀 55 : 987-992, 1997.
Medical*Online
4) 山内一也 : プリオン病の謎に迫る, p41-55, NHKブックス, 2002.
 
5) Gajdusek DC, Zigas V : Degenerative disease of the central nervous system in New Guinea : The endemic occurrence of "kuru" in the native population. N Engl J Med 257 : 974-978, 1957.
PubMed
6) Gajdusek DC : Unconventional viruses causing subacute spongiform encephalopathies. In : Virology (ed by Fields BN, et al), p 1519-1557, Raven Press, New York, 1985.
 
7) Zigas V, Gajdusek DC : Kuru : clinical study of a new syndrome resembling paralysis agitans in natives of the Eastern Highlands of Australian New Guinea. Med J Aust 2 : 745-754, 1957.
 
8) Collins S, McLean CA, Masters CL : Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru : a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 8 : 387-397, 2001.
 
9) MatZo I, et al : Pathology of kuru. Lab Invest 8 : 799-847, 1959.
 
10) Hainfellner JA, et al : Pathology and immunocytochemistry of a kuru brain. Brain Pathol 7 : 547-553, 1997.
PubMed
11) Hadlow WJ : Scrapie and kuru. Lancet ii : 289, 1959.
 
12) Gajdusek DC, et al : Experimental transmission of a kuru-like syndrome in chimpanzees. Nature 209 : 794-796, 1966.
PubMed
13) Gibbs CJ Jr, et al : Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J Infect Dis 142 : 205-208, 1980.
PubMed
14) Gajdusek DC : Unconventional viruses and the origin and disappearance of kuru. Science 197 : 943-960, 1977.
PubMed
15) Prusiner SB : Novel proteinaceous infectious particles cause scrapie. Science 216 : 136-144, 1982.
PubMed
16) Mead S, et al : Balancing selection at prion protein gene consistent with prehistoric kuru like epidemics. Science 300 : 640-643, 2003.
 
P.264 掲載の参考文献
1) World Health Organization : Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies : Report of a WHO consultation. World Health Organization Web site, 1998 : available at http://www.who.int/health-topics/tse.htm
 
2) 戸田宏幸ほか : プリオン病の感染対策. 神経研究の進歩 47 (1) : 119-125, 2003.
 
3) 佐藤猛ほか : クロイツフェルト・ヤコブ病の疫学と臨床像. Annual Review神経 (後藤文男ほか編), p309-317, 中外医学社, 1998.
 
4) Doh-ura K, et al : Pro to Leu change at position 102 of prion proteins is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 163 (2) : 974-979, 1989.
 
5) Kitamoto T, et al : Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 191 (2) : 709-714, 1993.
PubMed
6) Kitamoto T, et al : An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192 (2) : 525-531, 1993.
 
7) Hitoshi S, et al : Double mutations at codon 180 and codon 232 of the PRNP gene in an apparently sporadic case of Creutzfeldt-Jakob disease. J Neurol Sci 120 (2) : 208-212, 1993.
 
8) 赤井淳一郎ほか : Creutzfeldt-Jakob病の従兄弟例. 神経研究の進歩 23 : 472-483, 1979.
 
9) Miyakawa T, et al : Japanese Creutzfeldt-Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. Neurol Res 20 (8) : 684-688, 1998.
PubMed
10) 戸田宏幸ほか : 富士川流域におけるCreutzfeldt-Jakob病の疫学的検討. 臨床神経 40 : 1403, 2000.
 
11) Furukawa H, et al : A Japanese case of Creutzfeldt-Jakob disease with a point mutation in the prion protein gene at codon 210. J Neurol Sci 141 (1-2) : 120-122, 1996.
 
12) 清水利彦ほか : プリオン蛋白232番コドンに点変異を認めたCreutzfeldt-Jakob病の1例. 臨床神経 34 : 590-592, 1994.
 
13) Nagayama M, et al : Fatal familial insomnia with a mutation at codon 178 of the prion protein gene : first report from Japan. Neurology 47 : 1313-1316, 1996.
PubMed
14) Parchi P, et al : Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46 (2) : 224-233, 1999.
 
15) Shibuya S, et al : Protective prion protein polymorphism against sporadic Creutzfeldt-Jakob disease (Letter). Lancet 351 (9100) : 419, 1998.
PubMed
P.270 掲載の参考文献
1) Prusiner SB : Novel proteinaceous infectious particles cause scrapie. Science 216 : 136-144, 1982.
PubMed
2) Oesch B, et al : A cellular gene encodes scrapie PrP 27-30 protein. Cell 40 : 735-746, 1985.
PubMed
3) Hsiao K, et al : Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338 : 342-345, 1989.
PubMed
4) Liberski PP, et al : A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Straussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol (Berl) 96 : 425-430, 1998.
PubMed
5) Goldfarb LG, et al : An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Straussler-Scheinker family. J Neurol Sci 111 : 189-194, 1992.
 
6) Hainfellner JA, et al : The original Gerstmann-Straussler-Scheinker family of Austria : divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5 : 201-211, 1995.
PubMed
7) 立石潤 : プリオンとプリオン病, 共立出版, 1998.
 
8) クロイツフェルト・ヤコブ病診療マニュアル (改訂版), 厚生労働省特定疾患対策研究事業 厚生労働省遅発性ウイルス感染調査研究班, 2002.
 
9) van Gool WA, et al : Hypokinesia and presenile dementia in a Dutch family with a novel insertion in the prion protein gene. Brain 118 (Pt 6) : 1565-1571, 1995.
 
10) Kitamoto T, et al : An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192 : 525-531, 1993.
 
11) Piccardo P, et al : Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57 : 979-988, 1998.
PubMed
12) Bugiani O, et al : Neuropathology of Gerstmann-Straussler-Scheinker disease. Microsc Res Tech 50 : 10-15, 2000.
PubMed
P.273 掲載の参考文献
1) Medori R, et al : Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion proteln gene. N Engl J Med 326 : 444-449, 1992.
 
2) Goldfarb LG, et al : Fatal familial insomnia and familial Creutzfeldt-Jakob disease : disease phenotype determined by a DNA polymorphism. Science 258 : 806-808, 1992.
PubMed
3) Gambetti P, et al : Fatal familial insomnia and familial Creutzfeldt-Jakob disease : clinical, pathological and molecular features. Brain Pathol 5 : 43-51, 1995.
PubMed
4) Chapman J, et al : Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200 (Lys) mutation. Neurology 46 : 758-761, 1996.
 
5) Lugaresi E, et al : Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315 : 997-1003, 1986.
PubMed
6) Reder AT, et al : Clinical and genetic studies of fatal familial insomnia. Neurology 45 : 1068-1075, 1995.
PubMed
7) Nagayama M, et al : Fatal familial insomnia with a mutation at codon 1780f the prion protein gene : first report from Japan. Neurology 47 : 1313-1316, 1996.
PubMed
8) Silburn P, et al : Fatal familial insomnia : aseventh family. Neurology 47 : 1326-1328, 1996.
PubMed
9) Taniwaki Y, et al : Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia. J Neurol Neurosurg Psychiatry 68 : 388, 2000.
PubMed
10) McLean CA, et al : The D178N (cis-129M) "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology 49 : 552-558, 1997.
 
11) Zerr I, et al : Phenotypic variability in fatal familial insomnia (D178N-129M) genotype. Neurology 51 : 1398-1405, 1998.
PubMed
12) Montagna P, et al : Fatal familial insomnia : sleep, neuroendocrine and vegetative alterations. Adv Neuroimmunol 5 : 13-21, 1995.
PubMed
13) Cortelli P, et al : Cerebral metabolism in fatal familial insomnia : relation to duration, neuropathology, and distribution of protease-resistant prion protein. Neurology 49 : 126-133, 1997.
PubMed
14) Perani D, et al : [18F] FDG PET in fatal familial insomnia : the functional effects of thalamic lesions. Neurology 43 : 2565-2569, 1993.
PubMed
15) Manetto V, et al : Fatal familial insomnia : clinical and pathologic study of five new cases. Neurology 42 : 312-319, 1992.
PubMed
P.277 掲載の参考文献
1) Stendel R, et al : Spontaneous bilateral chronic subdural haematoma of the posterior fossa. Case report and review of the literature. Acta Neurochir (Wien) 144 (5) : 497-500, 2002.
PubMed
2) 松澤源志ほか : 慢性硬膜下血腫内腔の内視鏡所見-その出血源について-. 神経外傷 20 : 115-120, 1997.
 
3) 塩見直人ほか : 内視鏡観察による慢性硬膜下血腫内腔所見の検討. 脳神経外科 30 (7) : 717-722, 2002.
 
4) Williams GR, et al : Burr-hole versus twist-drill drainage for the evacuation of chronic subdural haematoma : a comparison of clinical results. J Clin Neurosci 8 (6) : 551-554, 2001.
PubMed
5) Ishikawa E, et al : Reversible dementia in patients with chronic subdural hematomas. J Neurosurg 96 (4) : 680-683, 2002.
PubMed
6) Mori K, Maeda M : Surgical treatment of chronic subdural hematoma in 500 consecutive cases : clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41 (8) : 371-381, 2001.
PubMed
7) Missori P, et al : Intraparenchymal haemorrhage after evacuation of chronic subdural haematoma. Report of three cases and review of the literature. Br J Neurosurg 16 (1) : 63-66, 2002.
PubMed
8) Okada Y, et al : A comparative study of the treatment of chronic subdural hematoma-burr hole drainage versus burr hole irrigation. Surg Neurol 57 (6) : 405-409, 2002.
PubMed
9) Kuroki T, et al : Strict closed-system drainage for treating chronic subdural haematoma. Acta Neurochir (Wien) 143 (10) : 1041-1044, 2001.
PubMed
10) 塩見直人ほか : 慢性硬膜下血腫におけるドレナージ挿入方向と再発の関係. 脳神経外科 30 (8) : 823-827, 2002.
 
P.284 掲載の参考文献
1) Paterniti S, et al : Is the size of an epidural haematoma related to outcome? Acta Neurochir (Wien) 140 (9) : 953-955, 1998.
PubMed
2) 周籐高ほか : Air in epidural hematoma例の検討. 脳と神経 49 (11) : 977-981, 1997.
 
3) Lee EJ, et al : Factors influencing the functional outcome of patients with acute epidural hematomas : analysis of 200 patients undergoing surgery. J Trauma 45 (5) : 946-952, 1998.
PubMed
4) 中村弘 : 成人急性硬膜下血腫1手術例の転帰に深く関係する因子は何か. 神経外傷 25 : 189-199, 2002.
 
5) 本橋蔵ほか : 後頭部打撲により対側損傷にて生じた前頭部急性硬膜外血腫の一例. 脳と神経 52 (9) : 833 -836, 2000.
 
6) 宮崎芳彰ほか : 後頭部打撲による反衝損傷型前頭部急性硬膜下血腫の1例. 脳神経外科 23 (10) : 917-920, 1995.
 
7) 高里良男ほか : 重症頭部外傷の予後-転帰不良例を中心に-. 神経外傷 25 : 147-152, 2002.
 
8) 亀山元信ほか : 頭部外傷データバンクにおける重症頭部外傷の年齢分布. 神経外傷 25 : 153-158, 2002.
 
9) Cifu DX, et al : Functional outcomes of older adults with traumatic brain injury : aprospective, multicenter analysis. Arch Phys Med Rehabil 77 (9) : 883-888, 1996.
 
P.289 掲載の参考文献
1) Leon-Carrion J : Dementia due to head trauma : an obscure name for a clear neurocognitive syndrome. NeuroRehabilitation 17 : 115-122, 2002.
PubMed
2) 高村政志ほか : 熊本県頭部外傷データバンクーこれまでの経過とこれからの課題. 神経外傷Neurotraumatology 21 : 118-124, 1998.
 
3) 川又達朗ほか : 頭部外傷データバンク1998年上半期報告-多地域9施設における重傷頭部外傷例の分析-. 神経外傷Neurotraumatology 22 : 73-79, 1999.
 
4) Meythaler JM, et al : Current concepts : diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil 82 : 1461-1471, 2001.
PubMed
5) Greenwald BD, et al : Congenital and acquired brain injury. 1. Brain injury : epidemiology and pathophysiology. Arch Phys Med Rehabil 84 (Suppl 1) : S3-7, 2003.
PubMed
6) Watanabe TK, et al : Congenhal and acquired brain injury. 5. Outcomes after acquired brain injury. Arch Phys Med Rehabil 84 (Suppl 1) : S23-27, 2003.
 
7) 池田修一 : ボクサー脳症. 神経研究の進歩 43 : 858-861, 1999.
 
8) Mehta KM, et al : Head trauma and risk of dementia and Alzheimer's disease : The Rotterdam Study. Neurology 53 : 1959-1962, 1999.
PubMed
9) American Psychiatric Association (高橋三郎ほか訳) : DSM-IV-TR 精神疾患の診断・統計マニュアル, 医学書院, 2002.
 
10) 下田正代 : びまん性脳損傷の認知障害評価. 総合リハビリテーション 30 : 1187-1194, 2002.
 
11) NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain lnjury : Rehabilitation of Persons With Traumatic Brain Injury (道免和久訳 : 脳外傷患者のリハビリテーション). JAMA <日本語版> (3) : 79-90, 2001.
 
12) 大橋正洋 : 脳外傷のリハビリテーション-社会復帰を阻害する高次脳機能障害への対応-. 医学のあゆみ 203 : 637-641, 2002.
 
13) 大橋正洋 : 脳外傷による高次脳機能障害のリハビリテーション. 脳の科学 24 : 665-670, 2002.
 
P.294 掲載の参考文献
1) Stolze H, et al : Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry 70 : 289-297, 2001.
PubMed
2) Black PM : Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients. J Neurosurg 52 : 371-377, 1980.
PubMed
3) Iddon JL et al : Spechic patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease : a pilot study. J Neurol Neurosurg Psychiatry 67 : 723-732, 1999.
PubMed
4) Boon AJW, et al : Dutch normal-pressure hydrocephalus study : baseline characteristics with emphasis on clinical findings. Eur J Neurol 4 : 39-47, 1997.
 
5) Ahlberg J, et al : Outcome of shunt operation on urinary incontinence in normal pressure hydrocephalus predicted by lumbar puncture. J Neurol Neurosurg Psychiatry 51 : 105-108, 1988.
PubMed
6) Mori K : Management of idiopathic normal pressure hydrocephalus : A multiinstitutional study conducted in Japan. J Neurosurg 95 : 970-973, 2001.
PubMed
7) Kitagaki H, et al : CSF spaces in idiopathic normal pressure hydrocephalus : morphology and volumetry. AJNR Am J Neuroradiol 19 : 1277-1284, 1998.
 
8) Krauss JK : White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group : a comparative study. Neurosurgery 40 : 491-495, 1997.
 
9) Benzel EC, et al : Communicating hydrocephalus in adults : Prediction of outcome after ventricular shunting procedures. Neurosurgery 26 : 655-660, 1990.
PubMed
10) Kristensen B, et al : Regional cerebral blood flow, white matter abnornlalities, and cerebrospinal fluid hydrodynamics in patients with idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry 60 : 282-288, 1996.
PubMed
11) Kahlon B, et al : Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 73 : 721-726, 2002.
PubMed
12) Walchenbach R, et al : The value of temporary external CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 72 : 503-506, 2002.
PubMed
13) Anderson RC, et al : Volumetric measurements in the detection of reduced ventricular volume in patients with normal-pressure hydrocephalus whose clinical condition improved after ventriculoperitoneal shunt placement. J Neurosurg 97 : 73-79, 2002.
PubMed
14) Savolainen S, et al : Five-year outcome of normal pressure hydrocephalus with or without a shunt : predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir 144 : 515-523, 2002.
PubMed
15) Raftopoulos C, et al : Prospective analysis by computed tomography and long-term outcome of 23 adult patients with chronic idiopathic hydrocephalus. Neurosurgery 38 : 51-59, 1996.
PubMed
P.297 掲載の参考文献
1) 設楽信行ほか : Treatable dementia I 脳腫瘍. 老年期痴呆 2 : 25-32, 1998.
 
2) 半田肇, 花北順哉 : 神経局在診断, p340-343, 文光堂, 1995.
 
3) 半田肇, 花北順哉 : 神経局在診断, p246-259, 文光堂, 1995.
 
4) 石郷岡純ほか : 合併症対策 化学療法剤による副作用 精神障害. 日本臨牀 47 (増刊 : 癌治療学 (下)) : 1041-1046, 1989.
 
5) 吉澤佳子, 笠原敏彦 : 抗がん剤治療中に生じる精神神経症状. 精神科治療学 11 : 133-139, 1996.
 
P.301 掲載の参考文献
1) 柴崎浩ほか : 厚生省特定疾患免疫性神経疾患調査研究班-平成2年度研究報告書, p93-99, 1991.
 
2) Rao SM, et al : Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41 : 685-691, 1991.
PubMed
3) Rao SM, et al : Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39 : 161-166, 1989.
PubMed
4) Swirsky-Sacchetti T, et al : Neuropshychological and structural brain lesion in multiple sclerosis : a regional analysis. Neurology 42 : 1291-1295, 1992.
 
5) Miki Y, et al : Isolated U-fiber involvement in MS preliminary observations. Neurology 50 : 1301-1306, 1998.
PubMed
6) Feinstein A, et al : A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 116 : 569-602, 1993.
 
7) 秋山尚子, 岩田誠 : Clinical Neuroscience 15 (2) : 66-67, 1997.
 
8) Foong J, et al : Correlates of executive function in multiple sclerosis : use of MRS as an index of focal pathology. J Neuropsychiatry Clin Neurosci 11 : 45-50, 1999.
PubMed
9) Paulesu E, et al : Functional basis of memory impairment in multiple sclerosis : A [18F] FDG PET study. Neuroimage 4 : 87-96, 1996.
PubMed
P.307 掲載の参考文献
1) Balo J : Encephalitis periaxialis concentrica. Arch Neurol Psychiat 19 : 242-264, 1928.
 
2) Marburg O : Die sogenannte "akute Multiple Sklerose" (Encephalomyelitis periaxialis scleroticans). Jb Psychiat 27 : 217-312, 1906.
 
3) Lucchinetti C, et al : Heterogeneity of multiple sclerosis lesions : implications for the pathogenesis of demyelination. Ann Neurol 47 : 707-717, 2000.
PubMed
4) 泉徹ほか : 急性白質脳症を来たしたフィリピン人女性の2症例. 臨床神経 24 : 1217-1220, 1984.
 
5) 関島良樹ほか : Balo病の臨床. 神経内科 40 : 233-241, 1994.
 
6) Morioka C, et al : The evolution of the concentric lesions of atypical multiple sclerosis on MRL Radiat Med 12 : 129-133, 1994.
 
7) 田平武ほか : 日本のBalo病全国調査. 神経免疫学 6 : 35-38, 1998.
 
P.311 掲載の参考文献
1) Yogo Y, et al : Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64 : 3139-3143, 1990.
PubMed
2) Sugimoto C, et al : Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid ; diagnostic value for progressive multifocal leukoencephalopathy. Arch Virol 143 : 249-262, 1998.
PubMed
3) Matsushima T, et al : Unusual MRI and pathologic findings of progressive multifocal leukoencephalopathy complicating adult Wiskott-Aldrich syndrome. Neurology 48 : 279-282, 1997.
PubMed
4) Newton HB, et al : Progressive multifocal leukoencephalopathy presenting as multiple enhancing lesions on MRI : case report and literature review. J Neuroimaging 5 : 125-128, 1995.
PubMed
5) 余郷嘉明, 杉本千恵 : JCウイルスの遺伝的変化と潜伏感染-進行性多巣性白質脳症との関連. Annual Review神経 2001, p 137-144, 中外医学社, 2001.
 
6) Wakutani Y, et al : A case of brain biopsy proven progressive multifocal leukoencephalopathy ; Pathological findings and analysis of JC virus regulatory region. Neuropathology 18 : 347-351, 1998.
 
7) 越智博文ほか : PETにてmethionine集積を認めた進行性多巣性白質脳症の1例. 臨床神経学 36 : 853-863, 1996.
 
8) Okada Y, et al : Transcriptional activation of JC virus by human T-lymphotropic virus type I Tax protein in human neuronal cell lines. J Biol Chem 275 : 17016-17023, 2000.
PubMed
9) Tashiro K, et al : Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 234 : 427-429, 1987.
PubMed
10) Steiger MJ, et al : Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33 : 407-411, 1993.
PubMed
11) Hall CD, et al : Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338 : 1345-1351, 1998.
 
12) Albrecht H, et al : Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12 : 1149-1154, 1998.
PubMed
13) 清水優子ほか : 高活性抗レトロウイルス療法が有効であった後天性免疫不全症候群にともなう進行性多巣性白質脳症の1例. 臨床神経学 40 : 821-826, 2000.
 
14) De Luca A, et al : Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 14 : 117-121, 2000.
 
15) 中野俊也ほか : 高度な壊死性変化を示した進行性多巣性白質脳症 (PML) の1剖検例. Neuropathology 18 (S) : 181, 1998.
 
P.313 掲載の参考文献
1) Rubinstein LJ, et al : Disseminated necrotizing leukoencephalopathy : acomplication of treated central nervous system leukemia and lymphoma. Cancer 35 : 291-305, 1975.
 
2) Nakazato Y, et al : Disseminated necrotizing leukoencephalopathy. Acta Pathol Jpn 30 : 659-670, 1980.
PubMed
3) 中島明彦ほか : Methotrexate髄注を受けた急性リンパ性白血病に見られた汎発性壊死性白質脳症の1例. 癌の臨床 29 : 138-142, 1983.
 
4) 大坂顕道ほか : 髄膜白血病で再発し散在性壊死性白質脳症で死亡した急性前骨髄球性白血病の1例. 臨床血液 24 : 1386-1391, 1983.
 
5) Laxmi SN, et al : Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter. Radiat Med 14 : 303-307, 1996.
PubMed
6) Suzuki K, et al : Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy. Acta Neuropathol (Berl) 65 : 145-149, 1984.
PubMed
7) McGuire D, et al : JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients : predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37 : 395-399, 1995.
PubMed
8) Price RA, Jamierson PA : The central nervous system in childhood leukemia 2. Subacute leukoencephalopathy. Cancer 35 : 306-318, 1975.
PubMed
9) Budka H : Pathology of Encephalopathies, Treatment of Neoplastic Lesions of the Nervous System, p45-50, Pergamon Press, Oxford and New York, 1982.
 
10) Shibutani M, Okeda R : Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 78 : 291-300, 1989.
 
11) Shibutani M, et al : Methotrexate-related multifocal axonopathy. Report of an autopsy case. Acta Neuropathol 79 : 333-335, 1989.
PubMed
12) Mei LH, et al : Methotrexate encephalopathy. Hum Pathol 9 : 635-648, 1978.
 
13) 平井博子ほか : 壊死性白質脳症を合併した多発性骨髄腫の1剖検例. 臨床血液 22 : 1565-1571, 1981.
 
14) Kay HE, et al : Encephalopathy in acute leukemia associated with methotrexate therapy. Arch Dis Child 47 : 344-354, 1972.
PubMed
15) Sakamaki H, et al : Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma. Radiat Med 11 : 146-153, 1993.
PubMed
P.317 掲載の参考文献
1) Valk PE, Dillon WP : Radiation injury of the brain. AJNR Am J Neuroradiol 12 : 45-62, 1991.
PubMed
2) DeAngelis LM, et al : Radiation-induced dementia in patients cured of brain metastases. Neurology 39 : 789-796, 1989.
PubMed
3) Peterson K, Rottenberg DA : Radiation damage to the brain. In : Handbook of Clinical Neurology (ed by Vinken PJ, Bruyn GW), Vol 67 (revised series 23, neuro-oncology Part 1, Brain tumors : Principles of biology, diagnosis and therapy, ed by Vecht CJ), p325-351, Elsevier Science BV, Amsterdam, 1997.
 
4) Asai A, et al : Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63 : 1962-1974, 1989.
PubMed
5) Schlemmer HP, et al : Differentiation of radiation necrosis from tUmor progression using proton magnetic resonance spectroscopy. Neuroradiology 44 : 216-222, 2002.
PubMed
P.322 掲載の参考文献
1) 古谷博和, 三好甫 : 急性散在性脳脊髄炎. 別冊医学のあゆみ 神経疾患 (中村重信編), p444-447, 医歯薬出版, 1999.
 
2) 中島誠 : コルサコフ症候群を呈し急性散在性脳脊髄炎が考えられた一例. 香川労災病院雑誌 7 : 157-159, 2001.
 
3) 井澤正博, 高倉公朋 : 中枢神経疾患の感染症. 救急医学 20 : 725-730, 1996.
 
4) 星野晴彦, 高木誠 : 高次神経機能障害をきたす疾患. Modern Physician 21 : 241-245, 2001.
 
5) 庄司絋史 : 脳炎・髄膜炎と痴呆. Dementia Japan 11 : 317-319, 2001.
 
6) 荒賀茂, 中島健二 : ウイルス関連神経疾患の症候論-中枢神経, 髄膜, 末梢神経疾患-. 日本臨牀 55 : 805-808, 1995.
 
7) Cohen O, et al : Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol 58 : 797-801, 2001.
PubMed
8) Gamboa ET, et al : Delayed onset of post-rabies vaccination encephalitis. Ann Neurol 13 : 676-678, 1983.
PubMed
9) Dale RC, et al : Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 50 : 588-595, 2001.
PubMed
10) 松井真 : 急性脳炎・脳症とADEMの境界-ステロイド反応性脳炎-. 21世紀の神経免疫学 (田中正美, 湯浅龍彦編), p45-48, 医歯薬出版, 2001.
 
11) 山嵜正志, 高昌星 : 急性散在性脳脊髄炎. 内科 85 : 627-631, 2000.
 
12) 榮樂信隆, 納光弘 : 急性散在性脳脊髄炎. 別冊日本臨牀 神経症候群 II, p442-446, 日本臨牀社, 1999.
 
P.326 掲載の参考文献
1) Adams RD, et al : Central pontine myelinolysis : ahitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol Psychiatry 81 : 154-172, 1959.
PubMed
2) Messert B, et al : Central pontine myelinolysis. Neurology 29 : 147-160, 1979.
PubMed
3) Norenberg MD, et al : Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol 11 : 128-135, 1982.
PubMed
4) Kleinschmidt-De Masters BK, Norenberg MD : Rapid correction of severe hyponatremia causes demyelination : Relation to central pontine myelinolysis. Science 211 : 1068-1070, 1981.
 
5) Goebel HH, Zur PH : Central pontine myelinolysis. In : Handbook of Clinical Neurology, Vol 28, Metabolic and Deficiency Disease of the Nervous System, Part II (ed by Vinken PJ, Bruyn GW), p 285 -316, Elsevier/North-Holland Biomedical Press, Amsterdam, 1976.
 
6) Lampl C, Yazdi K : Central pontine myelinolysis. Eur Neurol 47 : 3-10, 2002.
PubMed
7) McKee A, et al : Central pontine myelinolysis in severely burned patients : Relationship to serum hyperosmolality. Neurology 38 : 1211-1217, 1988.
PubMed
8) Wright DG, et al : Pontine and extrapontine myelinolysis. Brain 102 : 361-385, 1979.
PubMed
9) Price BH, Mesulam MM : Behavioral manifestations of central pontine myelinolysis. Arch Neurol 44 : 671-673, 1987.
PubMed
10) Goebel HH, Zur PH : Central pontine myelinolysis : A clinical and pathological study of ten cases. Brain 95 : 495-504, 1972.
 
11) Menger H, Jorg J : Outcome of central pontine and extrapontine myelinolysis (n=44). J Neurol 246 : 700-705, 1999.
PubMed
12) Chu K, et al : Diffusion-weighted MR findings of central pontine and extrapontine myelinolysis. Acta Neurol Scand 104 : 385-388, 2001.
PubMed
13) Ingram DA, et al : Brain-stem auditory evoked responses in diagnosis of central pontine myelinolysis. J Neurol 233 : 23-24, 1986.
PubMed
14) Sterns RH, et al : Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314 : 1523-1542, 1986.
 
15) Harris CP, et al : Symptomatic hyponatraemia : can myelinolysis be prevented by treatment? J Neurol Neurosurg Psychiatry 56 : 626-632, 1993.
PubMed
16) Rojiani AM, et al : Protective effect of・steroids in erectrolyte induced demyelination. J Neuropathol Exp Neurol 46 : 495-504, 1987.
 
17) Bibl D, et al : Treatment of central pontine myelinolysis with therapeutic plasmapheresis. Lancet 353 : 1155, 1999.
PubMed
18) Finstere J, et al : Immunoglobulins are effective in pontine myelinolysis. Clin Neuropharmacol 23 : 110-113, 2000.
 
19) Rojiani AM, et al : Electrolyte-induced demyelination in rats 2. Ultrastructural evolution. Acta Neurol 88 : 293-299, 1994.
 
20) Sugimoto T, et al : Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa. J Neurol Neurosurg Psychiatry 74 : 353-355, 2003.
PubMed
P.330 掲載の参考文献
1) Binswanger O : Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 31 : 1103-1105, 1137-1139, 1180-1186, 1894.
 
2) Jellinger K, Neumayer E : Progressive subcorticale vasculare encephalopathie Binswanger. Eine klinisch-neuropathologische studie. Arch Psychiatr Nervenkr 250 : 523-554, 1964.
 
3) National Institute of Neurological Disorders and Stroke (Ad Hoc Committee) : Classification of cerebrovascular disease III. Stroke 21 : 637-676, 1990.
 
4) de Leeuw FE, et al : Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125 : 765-772, 2002.
 
5) Yamanouchi H, et al : Decrease in nerve fibers in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type ; An electron microscopic study. J Neurol 236 : 382-387, 1989.
PubMed
6) Gerard G, Weisberg IA : MRI periventricular lesions in adults. Neurology 36 : 998-1001, 1986.
 
7) 赫彰郎 : 脳血管障害と白質病変. 脳卒中 17 : 481-488, 1995.
 
8) Fazekas F, et al : MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR 8 : 421-426, 1987.
 
9) McQuinn BA, O'Leary DH : White matter lucencies on computed tomography, subacute arteriosclerotic encephalopathy (Binswanger's disease), and blood pressure. Stroke 18 : 900-905, 1987.
 
10) 津金澤俊和ほか : 広汎なleuko-araiosisをみる非痴呆症例の白質における拡散係数と拡散異方性に関する検討. 日医大誌 65 : 167-172, 1998.
 
11) Yao H, et al : Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 21 : 1694-1699, 1990.
PubMed
12) Bennett DA, et al : Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 53 : 961-965, 1990.
PubMed
13) Bennett DA, et al : Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol 239 : 186-190, 1992.
 
14) 山之内博 : Binswanger型白質脳症. Clinical Neuroscience 21 : 54-56, 2003.
 
15) Tournier-Lasserve E, et al : Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3 : 256-259, 1993.
PubMed
P.334 掲載の参考文献
1) Stevens DL, et al : Chronic familial vascular encephalopathy. Lancet 1 : 1364-1365, 1977.
 
2) Tournier-Lasserve E, et al : Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3 : 256-259, 1993.
PubMed
3) 西尾健資ほか : Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) の1剖検例. 臨床神経 37 : 910, 1997.
 
4) 内野誠 : 脳血管障害の遺伝的背景 A. CADASIL. 神経内科 58 (Suppl 3) : 28-34, 2003.
 
5) Ducros A, et al : Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cm interval. Am J Hum Genet 58 : 171-181, 1996.
PubMed
6) Joutel A, et al : Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 : 707-710, 1996.
PubMed
7) Joutel A, et al : Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350 (9090) : 1511-1515, 1997.
PubMed
8) Ruchoux MM, Maurage CA : CADASIL : cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 56 : 947-964, 1997.
PubMed
9) Joutel A, et al : Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358 : 2049-2051, 2001.
PubMed
10) Bowler JV, Hachinski V : Progress in the genetics of cerebrovascular disease : inherited subcortical arteriopathies. Stroke 25 : 1696-1698, 1994.
PubMed
11) 福武敏夫 : 禿頭と腰痛を伴い, 高血圧を伴わない家族性若年発症の血管性白質脳症- "CADASIL plusと呼ぶか?". 脳卒中 18 : 457-461, 1996.
 
12) 河村清治ほか : ビンスワンガー型脳症を合併したウェルナー症候群の1例. 第460回内科学会関東地方会抄録集, 1997.
 
13) Auer DP, et al : Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy : MR imaging study with statistical parametric group comparison. Radiology 218 : 443-451, 2001.
PubMed
14) Ruchoux MM, et al : Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J pathol 162 (1) : 329-342, 2003.
PubMed
15) Mayer M, et al : Erbliche zerebrale Arteriopathie CADASIL. Nervenarzt 66 : 927-932, 1995.
 
16) Weller M : Acetazolamide-responsive migraine in CADASIL. Neurology 50 : 1505, 1998.
PubMed
17) 村瀬永子ほか : Sneddon症候群を伴った家族性若年性ビンスワンガー型脳症. 臨床神経 36 : 336-340, 1996.
 
18) 足立芳樹ほか : 精神症状にフルボキサミンが有効であった1例. 分子精神医学 1 : 208-209, 2001.
 
19) 片山泰朗ほか : 若年性遺伝性Binswanger型脳血管性痴呆. 別冊日本臨牀 神経症候群 II, p454-456, 日本臨牀社, 1999.
 
P.339 掲載の参考文献
1) Newman NJ, et al : Paraneoplastic limbic encephalitis : Neuropsychiatric presentation. Biol Psychiatry 27 : 529-542, 1990.
PubMed
2) 廣瀬源二郎, 吉岡 亮 : Paraneoplastic limbic encephalitis. 神経内科 37 : 344-349, 1992.
 
3) Bekheit AMO, et al : Paraneoplastic limbic encephalitis : clinical-pathological correlations. J Neurol Neurosurg Psychiatry 53 : 1084-1088, 1990.
 
4) Gultekin SH, et al : Paraneoplastic limbic encephalitis : neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123 : 1481-1494, 2000.
PubMed
5) Alamowitch S, et al : Limbic encephalitis and small cell lung cancer : Clinical and immunological features. Brain 120 : 923-928, 1997.
PubMed
6) Almeras C, et al : Paraneoplastic limbic encephalitis, a complication of the testicular cancer. Urology 58 : 105, 2001.
PubMed
7) 楠原智彦ほか : 非ヘルペス性急性辺縁系脳炎の存在について. 臨床神経 34 : 1083-1088, 1994.
 
9) Mori M, et al : Successful immune treatment for non-paraneoplastic limbic encephalitis. J Neurol Sci 201 : 85-88, 2002.
PubMed
10) 酒井宏一郎 : 傍腫瘍性神経症候群の神経抗原. 神経内科 53 : 183-190, 2000.
 
P.343 掲載の参考文献
1) Vance ML : Hypopituitarism. N Engl J Med 330 : 1651-1662, 1994.
PubMed
2) Abbound CF : Anterior pituitary failure. In : The Pituitary (ed by Melmed S), p 341-410, Blackwell Science, Massachusetts, 1995.
 
3) Lamberts SWJ, et al : Pituitary insufficiency. Lancet 352 : 127-134, 1998.
 
4) 平山恵三 (編) : 他臓器疾患における神経障害. 臨床神経内科学, p557-586, 南山堂, 1996.
 
5) 宮井潔, 清水直容 : 間脳下垂体疾患診断の手引き (1990). 日内分泌会誌 67 : 250-262, 1991.
Medical*Online
P.348 掲載の参考文献
1) 小澤安則 : 甲状腺機能低下症. 内分泌疾患診療マニュアル (関原久彦ほか監編), pS186-189, 日本医師会, 2002.
 
2) Ewins DL, et al : Association between autoimmune thyroid disease and familial Alzheimer's disease. Clin Endocrinol 35 : 93-96, 1991.
 
3) Ganguli M, et al : Association between dementia and elevated TSH : a community-based study. Biol Psychiatry 40 : 714-725, 1996.
PubMed
4) Smith JS, Kiloh LG : The investigation of dementia : results of 200 consecutive admissions. Lancet i : 824-827, 1991.
 
5) Freemon FR : Evaluation of patients with progressive intellectual deterioration. Arch Neurol 37 : 658-659, 1976.
 
6) Haupt M, Kurz A : Dementia in hypothyroidism. Fortschr Neurol Psychiatr 58 (5) : 175-177, 1990.
PubMed
7) Hofmann M, et al : Reversible dementia. Schweiz Rundsch Med Prax 87 (22) : 773-777, 1998.
 
8) 田尻淳一 : 甲状腺の病気 http://www.j-tajiri.or.jp/index.html
 
9) Clarfield AM : The reversible dementias : do they reverse? Ann Intern Med 109 (6) : 476-486, 1998.
 
10) 三隅俊吾ほか : 痴呆様症状で発症した甲状腺機能低下症の1例. 山口医学 (0513-1731) 50 (3) : 684, 2001.
 
11) Fylkesnes SI, Nygaard HA : Dementia and hypothyroidism. Tidsskr Nor Laegeforen 120 (8) : 905-907, 2000.
PubMed
P.352 掲載の参考文献
1) 奥田諭吉, 山下亀次郎 : 原発性副甲状腺機能亢進症・二次性副甲状腺機能亢進症. 内科学 (杉本恒明, 小俣政男編), p1418-1424, 朝倉書店, 1999.
 
2) Abrams GM, Cheryl J : Neurological disorders of mineral metabolism and parathyroid disease. In : Handbook of Clinical Neurology ; Systemic Diseases, Part II (ed by Goetz CG, Aminoff MJ), p 111-129, Elsevier Science BV, Amsterdam, 1998.
 
3) Petersen P : Psychiatric disorders in primary hyperparathyroidism. J Clin Endocrinol 28 : 1491-1495, 1968.
 
4) Palmer FJ : The clinical manifestations of primary hyperparathyroidism. Compr Ther 9 : 56-64, 1983.
PubMed
5) Pfitzenmeyer P, et al : Primary hyperparathyroidism in very old patients. Eur J Med 2 : 453-456, 1993.
PubMed
6) Joborn C, et al : Primary hyperparathyroidism in patients with organic brain syndrome. Acta Med Scand 219 : 91-98, 1986.
PubMed
7) Heath DA, et al : Surgical treatment of hyperparathyroidism in the elderly. BMJ 280 : 1406-1408, 1980.
PubMed
8) Luxenberg J, et al : Reversible long-standing dementia with normocalcemic hyperparathyroidism. J Am Geriatr Soc 32 : 546-547, 1984.
PubMed
9) Dennis M, et al : Hyperthyroidism and dementia. Postgrad Med J 73 : 755-757, 1997.
PubMed
10) Cogan MG, et al : Central nervous system manifestations of hyperparathyroidism. Am J Med 65 : 963-970, 1978.
PubMed
11) 池田恭治 : 副甲状腺機能低下症. 内科学 (杉本恒明, 小俣政男編), p1425-1427, 朝倉書店, 1999.
 
12) Hyldstrup L, et al : Reversible dementia in idiopathic hypoparathyroidism. Dan Med Bull 28 : 74-75, 1981.
PubMed
13) Mateo D, et al : Dementia in idiopathic hypoparathyroidism. Rapid efficacy of alfacalcidol. Arch Neurol 39 : 424-425, 1982.
PubMed
14) Illum F, et al : Prevalences of CT-detected calcification in the basal ganglia in idiopathic hypoparathyroidism and pseudohypoparathyroidism. Neuroradiology 27 : 32-37, 1985.
PubMed
15) Nicolai A, et al : Dementia syndrome in patients with postsurgical hypoparathyroidism and extensive brain calci血cations. Eur Neurol 34 : 230-235, 1994.
 
16) Slager UT, et al : The incidence, composition and pathological significance of intracerebral vascular deposits in the basal ganglia. J Neuropathol Exp Neurol 15 : 417-431, 1956.
PubMed
P.355 掲載の参考文献
1) Johnstone PAS, et al : Mental status changes of Addison's disease. Psychosomatics 31 : 103-107,
 
2) Engel GL, Margolin SG : Neuropsychiatric disturbances in internal disease. Arch Intern Med 70 : 236-259, 1942.
 
3) Sorkin SZ : Addison's disease. Medicine 28 : 371-425, 1949.
 
4) Smith KC, et al : Psychiatric disturbance in endocrinologic disease. Psychosom Med 34 : 69-86, 1972.
 
5) Cleghorn RA : Adrenal cortical insufficiency. Can Med Assoc J 65 : 449-454, 1951.
PubMed
6) Michael RP, Gibbons JL : Interrelationships between the endocrine system and neuropsychiatry. Int Rev Neurobiol 5 : 243-302, 1963.
PubMed
7) Timiras PS, et al : Effect of adrenalectomy, hydrocortisone acetate, and deoxycorticosterone acetate on brain excitability and electrolyte distribution in mice. J Pharmacol Exp Ther 112 : 80-93, 1954.
PubMed
8) Thom GW, et al : Carbohydrate metabolism in Addison's disease. J Clin Invest 19 : 813-832, 1940.
 
9) Gillin JC, et al : Effects of decreased adrenal corticosteroids : changes in sleep in normal subjects and patients with adrenal cortical insufficiency. Electroencephalogr Clin Neurophysiol 36 : 283-289, 1974.
PubMed
10) Van der Sande JJ, Van Seters AP : The adrenal gland : its relationship to neurology. In : Handbook of Clinical Neurology, Vol 39 (ed by Vinken PJ, Bruyn GW), p469-515, North-Holland, Amsterdam, 1980.
 
11) Yasuda Y, et al : Serial electroencephalograms and somatosensory evoked potentials in a patient with isolated adrenocorticotropic hormone deficiency. Intern Med 35 : 227-230, 1996.
 
12) Sternberg A, et al : True pituitary Addison's disease : A pituitary unitrophic deficiency. J Clin Endocrinol Metab 14 : 1519-1529, 1954.
 
13) Endo M, et al : Mental status in a patient with isolated ACTH deficiency. Biol Psychiatry 18 : 375-383, 1983.
 
14) 深田倍行ほか : ACTH単独欠損症の脳波学的検討. 神経内科 17 : 144-149, 1982.
 
15) 永井洋子ほか : 副腎皮質ホルモン補充により痴呆状態の改善を認めたACTH単独欠損症の一例. 日内分泌会誌 70 : 989-994, 1994.
Medical*Online
P.359 掲載の参考文献
1) Nicholls AG : Simple adenoma of the pancreas from an island of Langerhans. J Med Res 3 : 385, 1902.
 
2) Proye CA : Endocrine tumors of the pancreas : an update. Aust N Z J Surg 68 : 90-100, 1998.
PubMed
3) Harris S : Hyperinsulinism and dysinsulinism. JAMA 83 : 729-733, 1924.
 
4) Stefanini P, et al : Beta-islet cell tumors of the pancreas : Results of a study on 1067 cases. Surgery 75 : 597-609, 1974.
 
5) 石井裕正ほか : インスリノーマ. 胆と膵 17 : 21-25, 1996.
Medical*Online
6) 石井裕正ほか : インスリノーマー本邦の1976-1990年における443例の臨床統計的観察. 日本臨牀 51 : 199-209, 1993.
 
7) 荒井正夫ほか : 膵内分泌腫瘍の臨床症状診断ならびに治療 (1) インスリノーマ. 臨床消化器内科 12 : 1285-1291, 1997.
 
8) Whipple AO, et al : Adenoma of islet cells with hyperinsulinism : A review. Ann Surg 101 : 1299-1335, 1935.
PubMed
9) Fajans SS, et al : Fasting hypoglycemia in adults. N Engl J Med 294 : 766-772, 1976.
PubMed
10) Grunt JA, et al : Blood sugar, serum insulin and free fatty acid interrelationships during intravenous tolbutamide testing in normal young adults and patients with insulinoma. Diabetes 19 : 122-126, 1970.
 
11) Turner RC, et al : Control of basal insulin secretion, with special reference to diagnosis of insulinomas. BMJ 11 : 132-137, 1971.
 
12) Grant CS : Insulinoma. Surg Oncol Clin N Am 7 : 819-844, 1998.
PubMed
13) Dizon AM, et al : Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med 106 : 307-310, 1999.
PubMed
14) Tintore M, et al : Peripheral neuropathy in association with insulinoma : clinical features and neuropathology of a new case. J Neurol Neurosurg Psychiatry 57 : 1009-1010, 1994.
 
15) Jaspan JB, et al : Hypoglycemic peripheral neuropathy in association with insulinoma : implication of glucopenia rather than hyperinsulinism. Case report and literature review. Medicine 61 : 33-44, 1982.
PubMed
P.364 掲載の参考文献
1) Rodriguez-Martin JL, et al : Thiamine for Alzheimer's disease. Cochrane Database Syst Rev (2) : CD001498, 2001.
 
2) Kopelman MD : The Korsakoff syndrome. Br J Psychiatry 166 (2) : 154-173, 1995.
PubMed
3) Cutting J : Korsakoff's syndrome. In : Handbook of Clinical Neurology (ed by Vinken P, et al), p 193-204, Elsevier Science, Amsterdam, 1985.
 
4) Victor M : The Wernicke-Korsakoff syndrome. In : Handbook of Clinical Neurology (ed by Vinken P, Bruyn G), p 243-270, Elsevier/North-Holland Publishing Company, Amsterdam, 1976.
 
5) Shikata E, et al : 'Iatrogenic' Wernicke's encephalopathy in Japan. Eur Neurol 44 (3) : 156-161, 2000.
 
6) 山鳥重 : 記憶の神経心理学, 1ed, 医学書院, 2002.
 
7) Talwar D, et al : Vitamin B (1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC : comparison with erythrocyte transketolase activation assay. Clin Chem 46 (5) : 704-710, 2000.
 
8) Antunez E, et al : Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 171 (4) : 1131-1137, 1998.
 
9) Doraiswamy P, et al : Wernicke-Korsakoff syndrome caused by psychogenic food refusal : MR findings. AJNR Am J Neuroradiol 15 : 594-596, 1994.
PubMed
10) Harding A, et al : Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 123 (Pt 1) : 141-154, 2000.
 
11) 駒ヶ嶺正純, 篠原幸人 : Wernicke脳症の治療. 神経内科治療 4 (3) : 283-288, 1987.
Medical*Online
12) Iwamoto Y, et al : Beneficial effect of steroid pulse therapy on Wernicke-Korsakoff syndrome due to hyperemesis gravidarum. Rinsho Shinkeigaku 34 (6) : 599-601, 1994.
 
13) Iga JI, et al : A case of Korsakoff's syndrome improved by high doses of donepezil. Alcohol Alcohol 36 (6) : 553-555, 2001.
 
P.367 掲載の参考文献
1) Baior BM, Bunn HF : Megaloblastic anemias. In : Harrison's Principles of Internal Medicine, 15th ed, p 674 -680, McGraw Hill, New York, 2001.
 
2) Harper C, Butterworth R : Nutritional and metabolic disorders. In : Greenfield's Neuropathology, 7th ed, p 607-652, Edwald Arnold, London, 2002.
 
3) Lindenbaum J, et al : Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318 : 1720-1728, 1988.
 
4) Healton EB, et al : Neurologic aspects of cobalamin deficiency. Medicine 70 : 229-245, 1991.
PubMed
5) 河西竜太ほか : 脊髄・末梢神経の障害を示さず脳症状のみを呈したビタミンB1, 欠乏症. 神経治療 16 : 753-757, 1999.
 
6) Hemmer B, et al : Subacute combined degeneration : clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 65 : 822-827, 1998.
PubMed
7) Snow CF : Laboratory diagnosis of vitamin B12 and folate deficiency. A guide for the primary care physician. Arch Intern Med 159 : 1289-1298, 1999.
PubMed
8) Chatterjee A, et al : Leukoencephalopathy associated with cobalamin deficiency. Neurology 46 : 832-834, 1996.
PubMed
9) Garry PJ, et al : Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc 32 : 719-726, 1984.
 
10) Clarfield AM : The reversible dementia : do they reverse? Ann Intern Med 15 : 476-486, 1988.
PubMed
11) Eastley R, et al : Vitamin B12 deficiency in dementia and cognitive impairment : the effects of treatment on neuropsychological function. Int J Geriatr Psychiatry 15 : 226-233, 2000.
PubMed
12) Kwok T, et al : Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriatr Psychiatry 13 : 611-616, 1998.
PubMed
13) Wang HX, et al : Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56 : 1188-1194, 2001.
 
14) Lopez OL, et al : Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades : II. Neurology 55 : 1863-1869, 2000.
PubMed
15) McCaddon A, et al : Functional vitamin B12 deficiency and Alzheimer disease. Neurology 58 : 1395-1399, 2002.
PubMed
P.372 掲載の参考文献
1) 中村重信 : 葉酸欠乏症, 先天性葉酸吸収不全症. 別冊日本臨牀 神経症候群 IV, p 98-101, 日本臨牀社, 2000.
 
2) Pincus H-J, et al : Subacute combined system degeneration with folate deficiency. JAMA 221 : 496-497, 1972.
 
3) Hassing L, et al : Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning : a population-based study of healthy very old adults. Biol Psychiatry 45 : 1472-1480, 1999.
PubMed
4) Yukawa M, et al : Characteristic features of folate-deficient neurological disease in the elderly. Geriatrics and Gerontology International 2 : 97-104, 2002.
 
5) American Psychiatric Association (APA) : Diagnostic and Statistical Manual of Mental Disorders, 4th ed, p 113-155, APA, Washington, D C, 1994.
 
6) Arnold S-E, et al : Reversible dementias. Med Clin North Am 77 : 215-230, 1993.
PubMed
7) Melamed E, et al : Reversible central nervous system dysfunction in folate deficiency. J Neurol Sci 25 : 93-98, 1975.
PubMed
8) Nilsson K, et al : Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 16 : 609-614, 2001.
PubMed
9) Mattson P-M, et al : Folic acid and homocysteine in age-related disease. Ageing Research Reviews 1 : 95-111, 2002.
 
10) Morris S-M : Folate, homocysteine, and neurological function. Nutr Clin Care 5 : 124-132, 2002.
 
11) Kruman I-I, et al : Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22 : 1752-1762, 2002.
 
12) Wang H-X, et al : Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56 : 1188-1194, 2001.
 
13) Seshadri S, et al : Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 : 476-483, 2002.
PubMed
14) Reynolds H-E : Folic acid, ageing, depression, and dementia. BMJ 324 : 1512-1515, 2002.
 
P.375 掲載の参考文献
1) Still CN : Nicotinic acid and nicotinamide deficiency : pellagra and related disorders of the nervous system. In : Handbook of Clinical Neurology (ed by Vinken PJ, Bruyn GW), Vol 28, p 59, North Holland, Amsterdam, 1975.
 
2) Brooks-Hill RW, Vellend H : Pellagra-like encephalopathy complicating a multiple drug regimen for the treatment of pulmonary infection due to mycobacterium avium-intracellulare. Am Rev Respir Dis 131 : 476, 1985.
PubMed
3) Ishii N, Nishihara Y : Pellagra encephalopathy among tuberculous patients : its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry 48 : 628-634, 1985.
PubMed
4) Jarrett P, et al : Pellagra, azathioprine and inflammatory bowel disease. Clin Exp Dermatol 22 : 44-45, 1997.
PubMed
5) Stevens HP, et al : Pellagra secondary to 5-fluorouracil. Br J Dermatol 128 : 578-580, 1993.
PubMed
6) Judo LE, Poskitt BL : Pellagra in a patient with an eating disorder. Br J Dermatol 125 : 71-72, 1991.
 
7) Malfait P, et al : An outbreak of pellagra related to changes in dietary niacin among Mozambican refugees in Malawi. Int J Epidemiol 22 : 504-511, 1993.
PubMed
8) Moren A, et al : Pellagra in Mozambican refugees. Lancet 335 : 1403-1404, 1990.
PubMed
9) 田代邦雄, 森若文雄 : ペラグラ. Clin Neurosci 6 : 1018-1019, 1988.
 
10) 古和久典, 中島健二 : ペラグラ, porphyriaと痴呆. Dementia (Japan) 11 : 245-248, 1997.
 
11) 石井惟友 : ペラグラ脳症. Clin Neurosci 3 : 1092-1093, 1985.
 
12) Serdaru M, et al : The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically. Brain 111 : 829-842, 1988.
PubMed
P.378 掲載の参考文献
1) Takahashi H, et al : α-Tocopherol protects PC12 cells from hyperoxia-induced apoptosis. J Neurosci Res 52 : 184-191, 1998.
 
2) Tagami M, et al : Vitamin E prevents apoptosis in cortical neurons during hypoxia and oxygen reperfusion. Lab Invest 78 : 1415-1429, 1998.
PubMed
3) Mark R, et al : Characterization of 8-epiprostaglandin F2α as a marker of amyloid β-peptide-induced oxidative damage. J Neurochem 72 : 1146-1153, 1999.
 
4) Yamada K, et al : Protective effects of idebenone and alpha-tocopherol on beta-amyloid- (1-42) -induced learning and memory deficits in rats : implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11 (1) : 83-90, 1999.
PubMed
5) Tohgi H, et al : Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci Lett 174 (1) : 73-76, 1994.
PubMed
6) Jimenez-Jimenez FJ, et al : Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J Neural Transm 104 (6-7) : 703-710, 1997.
 
7) Schmidt R, et al : Plasma antioXidants and cognitive performance in middle-aged and older adults : results of the Austrian Stroke Prevention Study. J Am Geriatr Soc 46 (11) : 1407-1410, 1998.
PubMed
8) Sano M, et al : A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336 (17) : 1216-1222, 1997.
 
9) Pincus MM : Alpha-tocopherol and Alzheimer's disease. N Engl J Med 337 (8) : 572, 1997.
 
10) Kilander L, Ohrvall M : Alpha-tocopherol and Alzheimer's disease. N Engl J Med 337 (8) 1572-573, 1997.
 
11) Tabet N, et al : Vitamin E for Alzheimer's disease. Cochrane Database Syst Rev (4) : 2000.
PubMed
12) Kontush A, et al : Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-beta content. Free Radic Res 35 (5) : 507-517, 2001.
PubMed
13) Laurin D, et al : Vitamin E and C supplements and risk of dementia. JAMA 288 : 2266-2268, 2002.
 
14) Engelhart MJ, et al : Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 (24) : 3223-3229, 2002.
PubMed
15) Morris MC, et al : Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287 (24) : 3230-3237, 2002.
 
P.383 掲載の参考文献
1) Ott A, et al : Diabetes mellitus and the risk of dementia : The Rotterdam Study. Neurology 53 : 1937-1942, 1999.
PubMed
2) Yoshitake T, et al : Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population : the Hisayama Study. Neurology 45 : 1161-1168, 1995.
 
3) Peila R, et al : Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies : The Honolulu-Asia Aging Study. Diabetes 51 : 1256-1262, 2002.
PubMed
4) Reaven GM, et al : Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13 : 16-21, 1990.
PubMed
5) Kuusisto J, et al : Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype : cross sectional population based study. BMJ 315 : 1045-1049, 1997.
PubMed
6) Kern W, et al : Role of insuline in Alzheimer's disease : Approaches emerging from basic animal research and neurocognitive studies in humans. Drug Dev Res 56 : 511-525, 2002.
 
7) Craft S, et al : Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease : Relationship to severity of dementia and apolipoprotein E genotype. Neurology 50 : 164-168, 1998.
PubMed
8) Frolich L, et al : Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105 : 423-438, 1998.
PubMed
9) Frolich L, et al : Adisturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann NY Acad Sci 893 : 290-293, 1999.
 
10) Strachan MW, et al : Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20 (3) : 438-445, 1997.
PubMed
11) 玉谷典華, 井口昭久 : 老化とインスリン. 肥満研究 7 (3) : 228-232, 2001.
Medical*Online
12) 三浦久幸, 遠藤英俊 : 高齢者糖尿病と痴呆. Geriatric Medicine 38 (7) : 946-950, 2000.
Medical*Online
P.387 掲載の参考文献
1) Meldrum B, Garthwaite J : Excitatory amino acid toxicity and neurodegenerative disease. Trends Pharmacol Sci 11 : 379-387, 1990.
PubMed
2) Young GB : 無酸素および虚血による脳障害. 昏睡と意識障害 (井上聖啓ほか監訳), 第1版, p377-421, メディカル・サイエンス・インターナショナル, 2001.
 
3) Wisniewski HM, Maslinska D : Beta-protein immunoreactivity in the human brain after cardiac arrest. Folia Neuropathol 34 (2) : 65-71, 1996.
PubMed
4) Adams RD, Victor M : The acquired metabolic disorders of the nervous system. In : Principles of Neurology, 5th ed, p 877-902, McGraw-Hill, New York, 1993.
 
5) Ginsberg MD : Delayed neurological deterioration following hypoxia. Adv Neurol 26 : 21-44, 1979.
PubMed
6) 小濱啓次 : プレホスピタルケアからみた心停止後脳蘇生の限界. 集中治療 11 : 23-29, 1999.
 
7) Zeiner A, et al : Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome. Arch Intern Med 161 : 2007-2012, 2001.
PubMed
8) Zandbergen EGJ, et al : Systemic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet 352 : 1808-1812, 1998.
 
9) Wijdicks EF, et al : Prognostic value of myoclonic status in comatose survivors of cardiac arrest. Ann Neurol 35 : 239-243, 1994.
 
10) Caine D, Watson JD : Neuropsychological and neuropathological sequelae of cerebral anoxia : a critical review. J Int Neuropsychol Soc 6 (1) : 86-99, 2000.
PubMed
11) Gadian DG, et al : Developmental amnesia associated with early hypoxic-ischaemic injury. Brain 123 (Pt 3) : 499-507, 2000.
 
12) Decker MJ, Rye DB : Neonatal intermittent hypoxia impairs dopamine signaling and executive functioning. Sleep Breath 6 (4) : 205-210, 2002.
PubMed
13) Rietveld S, Colland VT : The impact of severe asthma on schoolchildren. J Asthma 36 (5) : 409-417, 1999.
PubMed
14) Hopkins RO, et al : Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 160 (1) : 50-56, 1999.
PubMed
15) Incalzi RA, et al : Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 148 (2) : 418-424, 1993.
PubMed
16) Stuss DT, et al : Chronic obstructive pulmonary disease : effects of hypoxia on neurological and neuropsychological measures. J Clin Neuropsychol 19 (4) : 515-524, 1997.
 
17) Kozora E, et al : Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol 12 (3) : 178-183, 1999.
PubMed
18) Rosen H, et al : Serum levels of the brain-derived potentials S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49 : 183-191, 2001.
 
19) Sherman AL, et al : Somatosensory potentials, CSF creatine kinase BB activity, and awakening after cardiac arrest. Neurology 54 : 889-894, 2000.
PubMed
20) 今西正巳 : 脳蘇生 ; 蘇生後脳症の病態-頭部CT所見から-. 救急医学 23 : 1849-1853, 1999.
 
21) Wijdicks EF, et al : MR imaging in comatose survivors of cardiac resuscitation. Am J Neuroradiol 22 : 1561-1565, 2001.
PubMed
22) Brunko E, Zeger de Beyl D : Prognostic value of early cortical somatosensory evoked potentials after resuscitation from cardiac arrest. Electroencephalogr Clin Neurophysiol 66 : 15-24, 1987.
 
23) Jorgensen EO, Malchow-Moller A : Natural history of global and critical brain ischemia. Resuscitation 9 : 133-174, 1981.
PubMed
24) Madl C, et al : Early prediction of individual outcome after cardiopulmonary resuscitation. Lancet 341 : 855-858, 1993.
PubMed
25) Mecklinger A, et al : Event-related potential evidence for a specific recognition memory deficit in adult survivors of cerebral hypoxia. Brain 121 (Pt 10) : 1919-1935, 1998.
 
26) Kesner RP, Hopkins RO : Short-term memory for duration and distance in humans : role of the hip pocampus. Neuropsychology 15 (1) : 58-68, 2001.
 
27) Safar P, Bircher NG : Cardiopulmonary cerebral resuscitation. In : Basic and Advanced Cardiac and Trauma Life Support, 3rd ed, WB Saunders, London, 1988.
 
28) 中村敏弘ほか : 蘇生後脳症に対する脳低体温療法の現況. 救急医学 23 : 1856-1860, 1999.
 
29) Debette S, et al : Levodopa and bromocriptine in hypoxic brain injury. J Neurol 249 (12) : 1678-1682, 2002.
PubMed
30) 林成之 : 脳低体温療法 (脳温, 脳冷却法, 補助療法, 治療成績). 脳蘇生治療と脳死判定の再検討 (高須敏明, 林成之編), p48-62, 近代出版, 2001.
 
31) 神野哲夫 : 意識障害への脳刺激法. 脳神経 47 : 643-649, 1995.
 
P.391 掲載の参考文献
1) Moser HW, et al : X-linked adrenoleukodystrophy. In : The Metabolic and Molecular Bases of Inherited Disease, 8th ed (ed by Scriver CR, et al), p 3257-3301, McGraw-Hill, New York, 2001.
 
2) Percy AK, Rutledge SL : Adrenoleukodystrophy and related disorders. Ment Retard Dev Disabil Res Rev 7 : 179-189, 2001.
PubMed
3) Takemoto Y, et al : Epidemiology of X-linked adrenoleukodystrophy in Japan. J Hum Genet 47 : 590-593, 2002.
PubMed
4) 榊原洋一 : 副腎白質ジストロフィー. 小児中枢神経疾患の画像診断 (小児内科, 小児外科編集委員会共編), p471-473, 東京医学社, 1995.
 
5) Loes DJ, et al : Adrenoleukodystrophy : a scoring method for brain MR observations. AJNR Am J Neuroradiol 15 : 1761-1766, 1994.
PubMed
6) Mosser J, et al : Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361 : 726-730, 1993.
PubMed
7) Uchiyama A, et al : Identification of a nonsense mutation in ALD protein cDNA from a patient with adrenoleukodystrophy. Biochem Biophys Res Commun 198 : 632-636, 1994.
PubMed
8) McGuinness MC, et al : Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy. J Neuroimmunol 61 : 161-169, 1995.
 
9) Kamijo K, et al : The 70kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein) -related ATP-binding protein superfamily. J Biol Chem 265 : 4534-4540, 1990.
 
10) Lombard-Platet G, et al : A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci USA 93 : 1265-1269, 1996.
PubMed
11) Moser HW, et al : Therapy of X-linked adrenoleukodystrophy : prognosis based upon age and MRI abnormality and plans for placebo-control trials. J Inherit Metab Dis 23 : 273-277, 2000.
 
12) Restuccia D, et al : Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy. Neurology 52 : 810-816, 1999.
PubMed
13) Oka A, et al : Temporary improvement of neurological symptoms with gammaglobulin therapy in a boy with adrenoleukodystrophy. Brain Dev 18 : 119-121, 1996.
 
14) Miike T, et al : Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy. Brain Dev 11 : 134-137, 1989.
PubMed
15) Shapiro E, et al : Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356 : 713-718, 2000.
PubMed
16) Suzuki Y, et al : Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis 23 : 453 -458, 2000.
 
17) Kemp S, et al : Gene redundancy and pharmacological gene therapy : implications for X-linked adrenoleukodystrophy. Nat Med 4 : 1261-1268, 1998.
PubMed
18) McGuinness MC, et al : Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. Mol Genet Metab 74 : 256 -263, 2001.
 
19) Pai GS, et al : Lovastatin therapy for X-linked adrenoleukodystrophy : clinical and biochemical observations on 12 patients. Mol Genet Metab 69 : 312-322, 2000.
PubMed
20) Singh I, et al : Lovastatin for X-1inked adrenoleukodystrophy. N Engl J Med 339 : 702-703, 1998.
 
21) Pahan K, et al : Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100 : 2671-2679, 1997.
PubMed
P.398 掲載の参考文献
1) von Figura K, et al : Metachromatic leukodystroph. In : The Metabolic and Molecular Bases of Inherited Disease, 8th ed (ed by Scriver CR, et al), p 3695-3724, McGraw-Hill, New York, 2001.
 
2) Austin JH, et al : A controlled study of enzymatic activities in three human disorders of glycolipid metabolism. J Neurochem 10 : 805, 1965.
 
3) Mehl E, Jatzkewitz H : Evidence for the genetic block in metachromatic leukodystrophy (MLD). Biochem Biophys Res Commun 19 : 407, 1965.
 
4) Stevens RL, et al : Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet 33 : 900, 1981.
PubMed
5) Stein C, et al : Cloning and expression of human arylsulfatase A. J Biol Chem 264 : 1252, 1989.
PubMed
6) Wenger DA, et al : Galactosylceramide lipidosis : Globoid cell leukodystrophy (Krabbe disease). In : The Metabolic and Molecular Bases of lnherited Disease, 8th ed (ed by Scriver CR, et al), p 3669-3694, McGraw-Hill, New York, 2001.
 
7) Suzuki K, Suzuki Y : Globoid cell leukodystrophy (Krabbe's disease) : Deficiency of galactocerebroside β-galactosidase. Proc Natl Acad Sci USA 66 : 302-309, 1970.
 
8) Svennerholm L, et al : Krabbe disease : A galactosylsphingosine (psychosine) lipidosis. J Lipid Res 21 : 53, 1980.
PubMed
9) Zlotogora J, et al : Krabbe disease locus mapped to chromosome 14 by genetic linkage. Am J Hum Genet 47 : 37, 1990.
PubMed
10) Chen YQ, et al : Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum Mol Genet 2 : 184, 1993.
 
P.402 掲載の参考文献
1) 青木継稔ほか : Wilson病の全国調査成績. 小児内科 23 : 1893-1898, 1991.
 
2) Culotta VC, Gitlin JD : Disorder of copper transport. In : The Metabolic Basis of Inherited Disease, Vol 2, 8th ed (ed by Scriver CR, et al), p 3105-3126, McGraw-Hill, New York, 2001.
 
3) Butler P, et al : Molecular diagnosis of Wilson disease. Mol Genet Metab 72 : 223-230, 2001.
PubMed
4) Shimizu N, et al : Molecular analysis and diagnosis in Japanese patients with Wilson's disease. Pediatr Int 41 : 419-422, 1999.
 
5) Aoki T, et al : Nationwide survey of clinical feature of Wilson's disease in Japan. In : Neonatal and Perinatal Screening, the Asian Pacific Perspective (ed by Lam STS, Pang CCP), p 25-28, The Chinese University Press, Hong Kong, 1996.
 
6) 清水教一ほか : 全国調査からみた神経型・肝神経型Wilson病の臨床像および肝銅含量に関する検討. 脳と発達 28 : 391-397, 1996.
 
7) 青木継稔, 清水教一 : Wilson病 (肝レンズ核変性症), 神経症状を中心として. 神経研究の進歩 39 : 479-486, 1995.
 
8) 清水教一 : Wilson病. 日本臨牀 59 (増刊号8) : 383-392, 2001.
Medical*Online
9) Shimizu N, et al : Molecular diagnosis of Wilson's disease. Lancet 349 : 1811-1812, 1997.
 
10) 藤井秀樹 : 発症前Wilson病のセルロプラスミン及び銅代謝に関する研究, 診断基準作成の試み. Biomed Res Trace Elements 8 : 75-83, 1997.
 
11) 須田真津子ほか : 塩酸トリエンチンが著効した神経型Wilson病3症例の検討. 脳と発達 25 : 429-434, 1993.
 
P.407 掲載の参考文献
1) 折茂肇 : 新老年学, p960-992, 東京大学出版会, 1999.
 
2) Misra SC, Mansharamani GG : Hyponatremia in elderly hospital in-patients. Br J Clin Pract 43 : 295-296, 1989.
PubMed
3) 猿田享男 : 水・電解質代謝. 臨牀と研究 72 : 1576-1577, 1995.
 
4) Ito H, et al : Disorders of fluid and electrolyte metabolism in elderly diabetics. Nippon Ronen Igakkai Zasshi 26 : 233-239, 1989.
PubMed
5) Friedman E, et al : Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 110 : 24-30, 1989.
 
6) 森井浩世 : 老年者のCa, Mg代謝異常. 老化と疾患 6 : 1245-1249, 1993.
 
7) Guillemant S, et al : Effect of Vitamin D3 administration on serum 25-hydroxyvitamin D3, 1, 25-dihydroxyvitamin D3 and osteocalcin in vitamin D-deficient elderly people. J Steroid Biochem 33 : 1155-1159, 1989.
 
8) Toba K, et al : Fluid therapy for elderly patients. Nippon Ronen Igakkai Zasshi 25 : 225-230, 1988.
PubMed
9) Shiraki M, et al : The clinical study of hyponatremia in the elderly. The incidence and the characterization of hyponatremia with unknown etiology (author's transl). Nippon Ronen Igakkai Zasshi 16 : 245-252, 1979.
 
P.412 掲載の参考文献
1) Ferenci P, et al : Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification : final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 : 716-721, 2002.
PubMed
2) Michael M, et al : Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 53 : 758-7631996.
 
3) Hazell AS, Butterworth RF : Hepatic encephalopathy : An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 222 (2) : 99-112, 1999.
PubMed
4) Jones EA : Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab Brain Dis 17 (4) : 275-281, 2002.
PubMed
5) Butterworth RF : Pathophysiology of hepatic encephalopathy. Metab Brain Dis 17 (4) : 221-227, 2002.
PubMed
6) Norenberg MD : The Role of astrocytes in hepatic encephalopathy. Neurochem Pathol 6 : 13-26, 1987.
PubMed
7) 高橋善彌太ほか : 劇症肝炎の全国集計 ; 初発症状から意識障害発現までの日数と予後および定義の検討 第12回犬山シンポジウム : A型肝炎, 劇症肝炎, p116-225, 中外医学社, 1982.
 
8) 河本正好ほか : 老年期痴呆が疑われた猪瀬型肝脳疾患の一例. 臨床精神医学 21 (6) : 1057-1064, 1992.
 
9) Foley JM, et al : Significance of the electroencephalographic changes in hepatic coma. Trans Am Neurol Assoc 75 : 161-164, 1950.
 
10) Bickford RG, Butt HR : Hepatic coma : The electroencephalographic pattem. J Clin Invest 34 : 790-799, 1955.
 
11) 小林義昭 : 肝性脳症にみられる三相波に関する研究. 精神経誌 65 : 502-513, 1963.
 
12) Inoue E, et al : Portal-systemic encephalopathy : presence of basal ganglia lesions with high signal intensity on MR images. Radiology 179 : 551-555, 1991.
PubMed
13) Derk K, et al : Manganese and chronic hepatic encephalopathy. Lancet 346 : 270-273, 1995.
 
14) 飯島昌一ほか : 肝疾患における頭部MRI所見の検討-臨床症状および血液生化学データとの関連-. 臨床神経 33 (10) : 1047-1054, 1993.
 
15) Goulenok C, et al : Flumazenil vs. placebo in hepatic patients with cirrhosis : a meta-analysis. Aliment Pharmacol Ther 16 : 361-372, 2002.
PubMed
P.417 掲載の参考文献
1) 猪瀬正 : 肝脳変性疾患の一特殊型. 精神経誌 51 : 245-269, 1950.
 
2) Sherlock S, et al : Portal-systemic encephalopathy, neurological complications of liver disease. Lancet ii : 453-457, 1954.
 
3) Ferenci P, et al : Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification : final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 35 : 716-721, 2002.
PubMed
4) Watanabe A : Portal-systemic encephalopathy in non-cirrhotic patients : classification of clinical types, diagnosis and treatment. J Gastroenterol Hepatol 15 : 969-979, 2000.
PubMed
5) 浜崎啓介, 折田薫三 : 門脈大循環短絡症. 別冊日本臨牀 肝・胆道系症候群 肝臓編 (下巻), p243-247, 日本臨牀社, 1995.
 
6) Butterworth RF : Neurotransmitter dysfunction in hepatic encephalopathy : new approaches and new findings. Metab Brain Dis 16 : 55-65, 2001.
PubMed
7) Rao KV, Norenberg MD : Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 16 : 67-78, 2001.
PubMed
8) Wiltfang J, et al : Psychiatric aspects of portal-systemic encephalopathy. Metab Brain Dis 13 : 379-389, 1998.
PubMed
9) Burkhard PR, et al : Chronic parkinsonism associated with cirrhosis. Arch Neurol 60 : 521-528, 2003.
PubMed
10) Rose C, et al : Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117 : 640-644, 1999.
PubMed
P.422 掲載の参考文献
1) van Woerkom W : La cirrhose hepatique avec alterations dan les centres nerveux evoluant chz des sujets d'age moyen. Nouvelle Iconographie de la Salpetriere, Clnique des Maladies du Systeme Nerveux 7 : 41-51, 1914.
 
2) Victor M, et al : The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44 (5) : 345-396, 1965.
PubMed
3) Finlayson MH, Superville B : Distribution of cerebral lesions in acquired hepatocerebral degenera-tion. Brain 104 (Pt 1) : 79-95, 1981.
 
4) Jog MS, Lang AE : Chronic acquired hepatocerebral degeneration : case reports and new insights. Mov Disord 10 (6) : 714-722, 1995.
PubMed
5) Rossor MN : Other causes of dementia. In : Neurology in Clinical Practice (ed by Bradly WG, et al), p1621, Butterworth-Heinemann, Boston, 1996.
 
6) Thobois S, et al : Orofacial dyskinesias in a patient with primary biliary cirrhosis : a clinicopathological case report and review. Mov Disord 17 (2) : 415-419, 2002.
 
7) Salam-Adams M, Adams RD : Acquired hepatocerebral syndromes. In : Handbook of Clinical Neurology, Vol 5 (49) : Extrapyramidal Disorders (ed by Vinken PJ, et al), Elsevier Science Publishers BV, Amsterdarn, 1986.
 
8) Inoue E, et al : Portal-systemic encephalopathy : presence of basal ganglia lesions with high signal intensity on MR images. Radiology 179 (2) : 551-555, 1991.
PubMed
9) Kulisevsky J, et al : MR imaging of acquired hepatocerebral degeneration. AJNR Am J Neuroradiol 12 (3) : 527-528, 1991.
PubMed
10) 竹内博明ほか : 肝性脳症. 日ア精医誌 4 : 113-121, 1997.
 
11) Pujol A, et al : Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI : a possible marker of advanced liver disease. Neurology 41 (9) : 1526-1527, 1991.
PubMed
12) Ueki Y, et al : Clinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapy. Acta Neurol Scand 106 (2) : 113-116, 2002.
PubMed
13) Devenyi AG, et al : Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 106 (4) : 1068-1071, 1994.
PubMed
14) Powell EE, et al : Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 98 (4) : 1079-1082, 1990.
PubMed
P.427 掲載の参考文献
1) Alfrey AC, et al : Syndrome of dialysis dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Organs 18 : 257-261, 1972.
PubMed
2) Alfrey AC, et al : The dialysis encephalopathy syndrome : possible aluminum intoxication. N Engl J Med 294 : 184-188, 1974.
 
3) Biasioli S : Neurological aspects of dialysis. In : Clinical Dialysis (ed by Nissensson AR, et al), p 777-785, Appeleton & Lange, Stamford, 1995.
 
4) Wills MR, Savory J : Aluminum poisoning ; Dialysis encephalopathy, osteomalacia, and anaemia. Lancet i : 29-34, 1983.
PubMed
5) Pickett JL, et al : Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 33 : 1122-1130, 1999.
PubMed
6) Block GA, et al : Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients ; a national study. Am J Kidney Dis 31 : 607-617, 1998.
PubMed
7) Goodman WG, et al : Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 : 1478-1483, 2000.
PubMed
8) Blacher J, et al : Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38 : 938-942, 2001.
PubMed
9) Slatopolsky E, et al : RenaGel, a nonabsorbed calcium-and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 55 : 299-307, 1999.
PubMed
10) Cases A, et al : Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine. Clin Nephrol 29 : 176-178, 1988.
PubMed
11) Veis JH, et al : Mucormycosis in deferoxamine-treated patients on dialysis. Ann Intern Med 107 : 258, 1987.
PubMed
P.434 掲載の参考文献
1) Harris EN, Hughes GRV : Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 8 : 251-266, 1985.
 
2) ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature : The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42 : 599-608, 1999.
 
3) Hirohata S, et al : A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis. J Rheumatol 15 : 706-710, 1988.
PubMed
4) Hirohata S, et al : Cerebrospinal fluid IgM, IgA and IgG indexes in systemic lupus erythematosus. Arch Intern Med 145 : 1843-1846, 1985.
PubMed
5) Hirohata S, Miyamoto T : Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 33 : 644-649, 1990.
PubMed
6) Shiozawa S, et al : Interferon-alpha in lupus psychosis. Arthritis Rhuem 35 : 417-422, 1992.
PubMed
7) Isshi K, Hirohata S : Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 39 : 1483-1490, 1996.
PubMed
8) Bluestein HG, et al : Cerebrospinal fluid antibodies to neuronal cells-association with neuropsychiatric manifestations of systemic lupus erythematosus-. Am J Med 70 : 240-246, 1981.
PubMed
9) Isshi K, Hirohata S : Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41 : 1819-1827, 1998.
PubMed
10) Herranz MT, et al : Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 37 : 568-571, 1994.
PubMed
11) Hirohata S, Hayakawa K : Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42 : 2729-2730, 1999.
 
12) DeGiorgio LA, et al : A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7 : 1189-1193, 2001.
PubMed
P.439 掲載の参考文献
1) Hughes JT, Brownell B : Granulomatous giant-cell angiitis of the central nervous system. Neurology 16 : 293-298, 1966.
PubMed
2) Moore PM : Diagnosis and management of isolated angiitis of the central nervous system. Neurology 39 : 167-173, 1989.
PubMed
3) Younger DS, et al : Granulomatous angiitis of the nervous system. Neurol Clin 15 : 821-834, 1997.
PubMed
4) Calabrese LH : Vasculitis of the central nervous system. Rheum Dis Clin North Am 21 : 1059-1076, 1995.
PubMed
5) Burger PC, et al : Granulomatous angiitis : An unusual etiology of stroke. Stroke 8 : 29-35, 1977.
PubMed
6) Koo EH, Massey EW : Granulomatous angiitis of the central nervous system : Protein manifestations and response to treatment. J Neurol Neurosurg Psychiatry 51 : 1126-1133, 1988.
PubMed
7) 難治性血管炎調査研究班 : 結節性多発動脈炎 (古典的PN). 厚生省特定疾患免疫疾患調査研究班難治性血管炎分科会平成10年度研究報告書, p241-242, 1999.
 
8) Moore PM, Fauci AS : Neurologic manifestations of systemic vasculitis : a retrospective and prospective study of the clinico-pathologic features and responses to therapy in 25 patients. Am J Med 71 : 517-524, 1981.
 
9) Moore PM, Cupps TR : Neurologic complications of vasculitis. Ann Neurol 14 : 155-167, 1983.
PubMed
10) Moore PM : Neurological manifestation of vasculitis : Update on immunopathogenic mechanisms and clinical features. Ann Neurol 37 (Suppl) : S131-S141, 1995.
PubMed
11) 長沢俊彦 : 結節性多発動脈炎 (PN) の診断基準と治療方針検討小委員会報告. 厚生省特定疾患・系統的脈管障害調査研究班1989年度報告書, p11-13, 1990.
 
12) 橋本博史ほか : 結節性多発動脈炎, ウエゲナー肉芽腫症, アレルギー性肉芽腫性血管炎, 悪性関節リウマチの臨床像と経過・予後の比較. リウマチ 28 : 145-155, 1988.
 
13) Drachman DD : Neurological complications of Wegener's granulomatosis. Arch Neurol 8 : 145-155, 1963.
 
14) Nishino H, et al : Neurological involvement in Wegener's granulomatosis : An analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33 : 4-9, 1993.
 
15) van der Woude FJ, et al : Autoantibodies against neutrophils and monocyte : Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet i : 425-429, 1985.
 
16) Hunder GG, et al : The American College of Rheumatology 1990 Criteria for the Classification of Giant Cell Arteritis. Arthritis Rheum 33 : 1122-1128, 1990.
PubMed
17) Bogousslavsky J, et al : Bilateral obstruction of internal carotid artery from giant-cell arteritis and massive infarction limited to the vertebrobasilar area. Eur Neurol 24 : 57-61, 1985.
 
18) Caselli RJ : Giant cell (temporal) arteritis : Atreatable cause of multi-infarct dementia. Neurology 40 : 753-755, 1990.
PubMed
19) Alexander EL, et al : Neurologic complications of primary Sjogren's syndrome. Medicine 61 : 247-257, 1982.
 
20) Caselli RJ, et al : The treatable dementia of Sjogren's syndrome. Ann Neurol 30 : 98-101, 1991.
 
21) Caplan L : Nonatherosclerotic vasculopathy. In : Caplan's Stroke : AClinical Approach, 3rd ed, p 295-342, Butterworth Heinemann, Boston, 2000.
 
22) Porta-Etessam J, et al : Thalamic dementia due to infarct of the left thalamus and genum of the right internal capsule. Rev Neurol 33 : 1043-1046, 2001.
PubMed
P.444 掲載の参考文献
1) Stern BJ, et al : Sarcoidosis and its neurological manifestations. Arch Neurol 42 : 909-917, 1985.
PubMed
2) Cordingley G, et al : Sarcoidosis presenting as senile dementia. Neurology 31 (9) : 1148-1151, 1981.
PubMed
3) Hier DB, et al : A case of subconical dementia due to sarcoidosis of the hypothalamus and fornices. Brain Cogn 2 (2) : 189-198, 1983.
 
4) Schielke E, et al : Sarcoidosis presenting as rapidly progressive dementia : clinical and neuropathological evaluation. J Neurol 248 (6) : 522-524, 2001.
PubMed
5) Sanson M, et al : Sarcoidosis presenting as late-onset dementia. J Neurol 243 (6) : 484-487, 1996.
PubMed
6) Silberberg DH : Sarcoidosis of the nervous system. In : Neurology and General Medicine, 2nd ed (ed by Aminoff MJ), p 847-858, Churchill Livingstone, New York, 1995.
 
7) Mendez MF, et al : Frontal lobe dysfunction from meningeal sarcoidosis. Psychosomatics 33 (2) : 215-217, 1992.
PubMed
8) Bona JR, et al : Neurosarcoidosis as a cause of refractory psychosis : a complicated case report. Am J Psychiatry 155 (8) : 1106-1108, 1998.
PubMed
9) Sabaawi M, et al : Neurosarcoidosis presenting as schizophreniform disorder. Int J Psychiatry Med 22 (3) : 269-274, 1992.
PubMed
10) McLoughlin D, et al : Bipolar disorder and cerebral sarcoidosis. Br J Psychiatry 158 : 410-413, 1991.
PubMed
11) Walbridge DG : Rapid-cycling disorder in association with cerebral sarcoidosis. Br J Psychiatry 157 : 611-613, 1990.
PubMed
12) Stiller J, et al : Neurosarcoidosis presenting as major depression. J Neurol Neurosurg Psychiatry 47 (9) : 1050-1051, 1984.
PubMed
13) Vanhoof J, et al : Hypothalamic hypopituitarism with hyperphagia and subacute dementia due to neurosarcoidosis : case report and literature review. Acta Clin Belg 47 (5) : 319-328, 1992.
PubMed
14) 林健ほか : 精神症状にて発症し生検によって診断しえたサルコイド髄膜脳炎の1例. 臨床神経 35 (9) : 1008 -1011, 1995.
 
15) Miller DH, et al : Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 38 : 378-383, 1988.
PubMed
16) Oksanen V, et al : Angiotensin converting enzyme in cerebrospinal fluid : a new assay. Neurology 35 : 1220-1223, 1985.
PubMed
17) Nakamura A, et al : Systemic sarcoidosis : a case with a focal hydrocephalus and elevated lysozyme and angiotensin-converting enzyme in the cerebrospinal fluid. J Neurol 246 : 320-322, 1999.
PubMed
18) Scott TF, et al : Shunt-responsive dementia in sarcoid meningitis : role of magnetic resonance imaging and cisternography. J Neuroimaging 10 (3) : 185-186, 2000.
PubMed
P.448 掲載の参考文献
1) Behcet H : Uber residivierende, aphtose, durch ein virus verraschte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wbchenschr 105 : 1152-1157, 1937.
 
2) 坂根剛 : ベーチェット病は血管炎か. リウマチ科 17 : 599-608, 1997.
 
3) Mizukami K, et al : CNS changes in neuro-Behget's disease : CT, MR, and SPECT findings. Comput Med Imaging Graph 16 : 401-406, 1992.
 
4) 若山吉弘ほか : Neuro-Behget症候群患者末梢神経生検所見. 臨床神経 14 : 519-525, 1974.
 
5) Worthmann F, et al : Muscular involvement in Behget's disease : case report and review of the literature. Neuromuscul Disord 6 : 247-253, 1996.
 
6) Bogdanova D, et al : Parkinsonian syndrome as a neurological manifestation of Behget's disease. Can J Neurol Sci 25 : 82-85, 1998.
 
7) Bayramlar H, et al : Autonomic nervous system involvement in Behget's disease. J Neuroophthalmol 18 : 182-186, 1998.
 
8) Inaba G : Behcet's disease. In : Handbook of Clinical Neurology (ed by Vinken PJ, et al), p 593-610, Elsevier Science, Amsterdam, 1989.
 
9) 友竹正人ほか : 精神症状が前景に立った神経ベーチェット病の4症例. 九州精神医 42 : 137-149, 1996.
 
10) 稲葉午朗, 岸いずみ : 神経ベーチェット病. 最新医学 43 : 321-328, 1988.
Medical*Online
11) 坂根剛, 岳野光洋 : 神経Behget病の臨床像と病態. 医学のあゆみ 173 : 47-52, 1995.
 
12) 橋本喬史 : 神経ベーチェット病の病態と診断. 炎症と免疫 4 : 311-316, 1996.
Medical*Online
13) Hamzaoui K, et al : CD11/CD18 bearing lymphocytes in cerebrospinal fluid from patients with active Behget's disease. Clin Exp Rheumatol 12 : 575-576, 1994.
PubMed
14) Kocer N, et al : CNS involvement in neuro-Behcet syndrome : an MR study. AJNR Am J Neuroradiol 20 : 1015-1024, 1999.
 
15) Al Kawi MZ, et al : MRI findings in neuro-Behget's disease. Neurology 41 : 405-408, 1991.
 
16) Nakamura Y, et al : Magnetic resonance imaging in neuro-Behget's disease. Acta Med Kinki Univ 19 : 1-7, 1994.
 
17) Wechsler B, et al : Cerebral venous thrombosis in Behget's disease : clinical study and long-term follow-up of 25 cases. Neurology 42 : 614-618, 1992.
 
18) 菊池善郎ほか : 99mTc-HMPAO脳SPECTによる神経ベーチェット病の評価-MR画像との比較-. 日本医放会誌 57 : 515-519, 1997.
 
19) 橋本喬史ほか : シクロスポリンの作用機序と副作用. 最新医学 43 : 361-365, 1988.
Medical*Online
P.455 掲載の参考文献
1) Trier JS : Celiac sprue. N Engl J Med 325 : 1709-1719, 1991.
PubMed
2) Fasano A, Catassi C : Current approaches to diagnosis and treatment of celiac disease : an evolving spectrum. Gastroenterology 120 : 636-651, 2001.
PubMed
3) Farrell R, Kelly CP : Celiac sprue. N Engl J Med 346 : 180-188, 2002.
PubMed
4) Dieterich W, et al : Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 : 797-801, 1997.
PubMed
5) Reunala T : Dermatitis herpetiformis : coeliac disease of the skin. Ann Med 30 : 416-418, 1998.
PubMed
6) Finelli PF, et al : Adult celiac disease presenting as cerebellar syndrome. Neurology 30 : 245-249, 1980.
PubMed
7) Cooke WT, Smith WT : Neurological disorders associated with adult coeliac disease. Brain 89 : 683-722, 1966.
PubMed
8) Kinney HC, et al : Degeneration of the central nervous system associated with celiac disease. J Neurol Sci 53 : 9-22, 1982.
PubMed
9) Hadjivassiliou M, et al : Gluten ataxia in perspective : epidemiology, genetic susceptibility and clinical characteristics. Brain 126 : 685-691, 2003.
PubMed
10) Hadjivassiliou M, et al : The humoral response in the pathogenesis of gluten ataxia. Neurology 58 : 1221-1226, 2002.
PubMed
11) Pellecchia MT, et al : Cerebellar ataxia associated With subclinical coeliac disease responding to gluten-free diet. Neurology 53 : 1606-1608, 1999.
PubMed
12) Mauro A, et al : Cerebellar syndrome in adult celiac disease with Vitamin E deficiency. Acta Neurol Scand 84 : 167-170, 1991.
PubMed
13) Bhatia KP, et al : Progressive myoclonic ataxia associated with celiac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 118 : 1087-1093, 1995.
PubMed
14) Holmes GKr : Neurological and psychiatric complications in coeliac disease. In : Epilepsy and Other Neurological Disorders in Coeliac Disease (ed by Gobbi G, et al), p 251-264, John Libbey, London, 1997.
 
15) Chapman RWG, et al : Increased prevalence of epilepsy in coeliac disease. BMJ 2 : 250-251, 1978.
 
16) Lea ME, et al : Bilateral occipital calcification associated with coeliac disease, folate deficiency, and epilepsy. Am J Neuroradiol 16 : 1498-1500, 1995.
PubMed
17) Bardella MT, et al : Need for follow up in coeliac disease. Arch Dis Child 70 : 211-213, 1994.
PubMed
18) Kaplan JG, et al : Distal axonopathy associated with chronic gluten enteropathy : a treatable disorder. Neurology 38 : 642-645, 1988.
PubMed
19) Collin P, et al : Celiac disease, brain atrophy, and dementia. Neurology 41 : 372-375, 1991.
PubMed
20) Wills AJ, et al : Dermatitis herpetiformis and neurological dysfunction. J Neurol Neurosurg Psychiatry 72 : 259-261, 2002.
PubMed
P.460 掲載の参考文献
1) Thierry AM, et al : Selective activation of the mesocortical DA system by stress. Nature 263 : 242-244, 1976.
PubMed
2) Santiago M, et al : Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists. Brain Res 630 : 28-31, 1993.
PubMed
3) Rothschild AI : Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam : A review of the literature. J Clin Psychiatry 53 (Suppl) : 69-79, 1992.
 
4) Gray SL, et al : Drug-induced cognition disorders in the elderly. Incidence, prevention and management. Drug Saf 21 : 101-122, 1999.
PubMed
5) Lipowski ZJ : Delirium (acute confusional states). JAMA 258 : 1789-1792, 1987.
PubMed
6) Inouye SK : The dilemma of delirium : Clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 97 : 278-288, 1994.
PubMed
7) Marcantonio ER, et al : The relationship of postoperative delirium with psychoactive medications. JAMLA. 272 : 1518-1522, 1994.
 
8) Starr JM, Whalley U : Drug-induced dementia. Incidence, management and prevention. Drug Saf 11 : 310-317, 1994.
 
9) Larson EB, et al : Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 107 : 169-173, 1987.
PubMed
10) 高橋三郎ほか (編) : せん妄, 痴呆, 健忘性障害, および他の認知障害. DSM-IV-TR 精神疾患の診断・統計マニュアル, p141-180, 医学書院, 2002.
 
11) Weytingh MD, et al : Reversible dementia : more than 10% or less than 1%? A quantitative review. J Neurol 242 : 466-471, 1995.
PubMed
12) Moore AR, O'Keeffe ST : Drug-induced cognitive impairment in the elderly. Drugs Aging 15 : 15-28, 1999.
 
13) Meador KJ : Cognitive side effects of medications. Neurol Clin North Am 16 : 141-155, 1998.
 
14) Schaufele M, et al : Which factors influence cognitive decline in older adults suffering from dementing disorders? Int J Geriatr Psychiatry 17 : 1055-1063, 2002.
PubMed
15) Golombok S, et al : Cognitive impairment in long-term benzodiazepine users. Psychol Med 18 : 365-374, 1988.
PubMed
16) Shulman KI : Clock-drawing : Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15 : 548-561, 2000.
PubMed
17) Lopez OL, et al : Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol 56 : 1266-1272, 1999.
PubMed
18) Jenicke MA, Cremens C : Geriatric psychopharmacology. In : Annual of Drug Therapy (ed by Jefferson JW, Griest JH), p 125-155, WB Saunders, Philadelphia, 1994.
 
P.464 掲載の参考文献
1) 村崎光邦 : 抗不安薬, 睡眠薬と記憶障害. Clinical Neuroscience 16 (2) : 181-185, 1998.
 
2) Haslett WH, Dundee JW : Studies of drugs given before anaesthesia. XIV. Two benzodiazepine derivatives-chlordiazepoXide and diazepam. Br J Anaesth 40 : 250-258, 1968.
PubMed
3) 石郷岡純 : ベンゾジアゼピン系睡眠薬の副作用と処方上の留意点. 臨床精神医学講座 (松下正明編), 13 睡眠障害, p148-158, 中山書店, 1999.
 
4) Hinrichs JV, Ghoneim MM : Diazepam, behavior, and aging : increased sensitivity or lower baseline performance? Psychopharmacology (Berl) 92 : 100-105, 1987.
PubMed
5) 石郷岡純 : 睡眠薬と記憶障害. 日獨医報 37 : 10-21, 1992.
 
6) Hanlon JT, et al : Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 64 : 684-692, 1998.
PubMed
7) Fastbom J, et al : Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord 12 : 14-17, 1998.
PubMed
8) Dealberto MJ, et al : Psychotropic drug use and cognitive decline among older men and women. Int J Geriatr Psychiatry 12 : 567-574, 1997.
PubMed
9) Lagnaoui R, et al : Benzodiazepine use and risk of dementia : a nested case-control study. J Clin Epidemiol 55 : 314-318, 2002.
PubMed
10) Tune LE, Bylsma FW : Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr 3 : 397-408, 1991.
PubMed
11) Guo Z, et al : Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old : a community-based prospective study. Am J Epidemiol 148 : 887-892, 1998.
 
12) 村崎光邦 : Tandospironeの基礎と臨床. 臨床精神薬理 1 : 81-92, 1998.
 
13) Suzuki M, et al : Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on daytime sleepi-ness and psychomotor functions : a comparative double-blind study with diazepam. Yakubutsu Seishin Kodo 13 : 213-224, 1993.
 
14) 稲田健ほか : ベンゾジアゼピン受容体. KEY WORD 精神第三版 (樋口輝彦編), p 224-225, 先進医学社, 2003.
 
15) 村崎光邦ほか : ベンゾジアゼピン系薬物の常用量依存について-その3 ; ベンゾジアゼピン系薬物長期服用者の精神運動機能の研究. 厚生省「精神・神経疾患研究委託費」, 薬物依存の発生機序と臨床および治療に関する研究, 平成4年度研究成果報告書, p155-162, 1993.
 
P.469 掲載の参考文献
1) 青葉安里 : 薬物療法. 老年期精神疾患治療のためのストラテジー, p188-196, ワールドプランニング社, 1994.
 
2) King DJ : The effects of neuroleptics on cognitive and psychomotor function. Br J psychiatry 157 : 799-811, 1990.
PubMed
3) 渡部廣行 : 初期アルツハイマー型痴呆の認知機能障害に関する研究-抗コリン薬 (ビペリデン) 誘発性認知機能障害との類似性について-. 老年精神医学雑誌 7 : 1025-1034, 1996.
 
4) Keefe RSE, et al : The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia : A review and meta-analysis. Schizophr Bull 25 : 201-222, 1999.
 
5) 太田共夫, 山口登 : 新世代型および従来型抗精神病薬と認知機能. 臨床精神薬理 5 : 1249-1256, 2002.
 
6) 高橋三郎ほか (訳) : DSM-IV 精神疾患の診断・統計マニュアル, p 166-167, 医学書院, 1996.
 
7) 葛原茂樹 : 薬物による知的機能低下. 老年期痴呆 8 : 83-91, 1994.
 
8) 山田通夫ほか : 向精神薬による痴呆症状. 老年期痴呆 4 : 47-57, 1990.
 
9) David T, et al : Drug-induced dementia. South Med J 84 : 24 -31, 1991.
 
10) Evans L : Psychological effects caused by drugs in overdose. Drugs 19 : 220-240, 1980.
 
P.473 掲載の参考文献
1) Aarsland D, et al : Prevalence and characteristics of dementia in Parkinson's disease. Arch Neurol 60 : 387-392, 2003.
PubMed
2) 田丸冬彦 : パーキンソン病における痴呆・精神障害とその病態生理. 日内会誌 83 : 555-558, 1994.
 
3) Levy G, et al : Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 51 : 722-729, 2002.
PubMed
4) 葛原茂樹 : 老年者の退行性神経疾患. パーキンソン病. 日老会誌 23 : 17-22, 1986.
 
5) 葛原茂樹 : パーキンソン病の自然経過-高齢者の特徴-. Gerontology New Horizon 13 (Suppl) : 39-44, 2001.
 
6) Dubois B, et al : A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 288 : 213-218, 1983.
PubMed
7) Ruberg M, et al : Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia. Brain Res 232 : 129-139, 1982.
PubMed
8) 村田美穂 : Evidence based medicineに基づく治療 : 抗コリン薬・塩酸アマンタジン. 神経研究の進歩 44 : 611-615, 2000.
 
9) 日本神経学会 (編) : パーキンソン病治療ガイドライン2002-II. 各抗パーキンソン病薬および治療法の有効性と安全性. 臨床神経 42 : 432-459, 2002.
 
10) Dubois B, et al : Cholinergic dependent cognitive deficits in Parkinson's disease. Ann Neurol 22 : 26-30, 1987.
PubMed
11) Smet YD, et al : Confusion, dementia and anticholinergics in Parkinson's disease. J Neurol Neurosurg Psychiatry 45 : 1161-1164, 1982.
 
12) Meco G, et al : Mental impairment in Parkinson's disease. The role of anticholinergic drugs. Acta Psychiatr Belg 84 : 325-335, 1984.
PubMed
13) Kurlan R, Como P : Drug-induced alzheimerism. Arch Neurol 45 : 356-357, 1988.
PubMed
14) Nishiyama K, et al : Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination. Adv Neurol 60 : 479-483, 1993.
PubMed
15) Pondal M, et al : Anticholinergic therapy and dementia in patients with Parkinson's disease. J Neurol 243 : 543-546, 1996.
PubMed
16) Rinne UK : Problems associated with long-term levodopa treatment of Parkinson's disease. Acta Neurol Scand 95 (Suppl) : 19-26, 1983.
 
17) Sweet RD, et al : Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 26 : 305-310, 1976.
PubMed
18) Markham CH, Diamond SG : Long-term follow-up of early dopa treatment in Parkinson's disease. Ann Neurol 19 : 365-372, 1986.
 
19) Hietanen M, Teravainen H : Dementia and treatment with L-dopa in Parkinson's disease. Mov Disord 3 : 263-270, 1988.
 
20) Joyce JN, et al : Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia : role of D3 and not D2 receptors. Brain Res 955 : 138-152, 2002.
 
P.478 掲載の参考文献
1) 荒木善洋ほか : てんかん者の記憶障害について-事象関連電位と心理測定による検討. 第24回日本てんかん学会 (沖縄) 抄録集, p177, 1990.
 
2) 久郷敏明 : 合併症としての精神症状. 抗てんかん薬の影響, p133, 星和書店, 1996.
 
3) 守田嘉男 : てんかん脳波におけるシータ律動の臨床的意義. 兵庫医科大学雑誌 1 : 35 -45, 1976.
 
4) 守田嘉男, 三好功峰 : 側頭葉病変と精神症状. 神経精神薬理 9 : 413-420, 1987.
 
5) 守田嘉男 : マイナートランキライザー. 認知の科学と臨床 (武田雅俊編), p173-178, 中山書店, 2003.
 
6) 大沢武志 : てんかん患者にみられる精神症状と治療. てんかん薬剤治療の実際 (和田豊治編), p230-242, 大日本製薬株式会社, 1986.
 
7) Reynolds EH : Chronic antiepileptic toxicity : A review. Epilepsia 16 : 319-352, 1975.
PubMed
P.483 掲載の参考文献
1) 高島明彦 神経細胞死のメカニズム. 脳の科学 (2000年増刊号) 19 : 128-132, 2000.
 
2) Yankner BA, et al : Neurotrophic and neurotoxic effects of amyloid β protein : reversal by tachyldnin neuropeptides. Science 250 : 279-282, 1990.
 
3) McGeer PL, et al : Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility of glycoprotein HLA-DR. Neurosci Lett 79 : 195-200, 1987.
PubMed
4) Yasojima K, et al : Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J pathol 154 : 927-936, 1999.
 
5) Akiyama H, et al : Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neurosci Lett 206 : 169-172, 1996.
PubMed
6) Frautschy SA, et al : Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol 140 : 1389-1399, 1992.
PubMed
7) in t'Veld BA, et al : Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345 (21) : 1515-1521, 2001.
 
8) McGeer PL, et al : Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease : a review of 17 epidemiologic studies. Neurology 47 : 425-432, 1996.
PubMed
9) 高木淑江ほか : Aβ産生・代謝・蓄積のメカニズム. 脳の科学 (2000年増刊号) 19 : 111-116, 2000.
 
10) Weggen S, et al : A subset of NSAIDs lower amyloidgenic Aβ42 independently of cyclooxygenase activity. Nature 414 : 212-216, 2001.
 
11) 森原剛史, Greg MC : 抗炎症剤の抗アルツハイマー病効果. 臨床精神医学 31 : 1171-1176, 2002.
 
P.488 掲載の参考文献
1) Norrby SR : NeurotoXicity of carbapenem antibiotics : consequences for their use in bacterial meningitis. J Antimicrob Chemother 45 : 5-7, 2000.
PubMed
2) Hikida M, et al : Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic : inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats. Antimicrob Agents Chemother 37 : 199-202, 1993.
PubMed
3) Mermelstein HT : Clarithromycin-induced delirium in a general hospital. Psycosomatics 39 : 540-542, 1998.
 
4) Snavely SR, Hodges GR : The neurotoxicity of antibacterial agents. Ann Intern Med 101 : 92-104, 1984.
PubMed
5) Mandell LA, et al : Antimicrobial safety and tolerability : differences and dilemmas. Clin Infect Dis 32 : S72-79, 2001.
PubMed
6) 野田正勝 : 処方時にチェックの必要な組み合わせの実際例 ニューキノロン薬と非ステロイド系抗炎症薬の併用によるけいれん. 治療 76 : 2265-2271, 1994.
 
7) Ernst ME, Franey RI : Acyclovir-and gancyclovir-induced neurotoxicity. Ann Pharmacother 32 : 111-113, 1998.
 
8) Haefeli WE, et al : Acyclovir-induced neurotoxicity : concentration-side effect relationship in acyclovir overdose. Am J Med 94 : 212-215, 1993.
PubMed
9) 谷川原祐介 : 第44回日本老年医学会学術集会記録 : 高齢者の薬物動態-最近の進歩-. 日老医誌 40 : 109-119, 2003.
 
10) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会 : 高齢者における抗菌薬の使用法. 呼吸器感染症に関するガイドライン-成人院内肺炎診療の基本的考え方-, p65-68, 2002.
 
P.492 掲載の参考文献
1) Page KA, et al : Intracerebra1 (parenchymal) infusion of methotrexate : report of a case. J Neuroon-col 12 : 181-186, 1992.
 
2) Asato R, et al : Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 70 : 1997-2004, 1992.
PubMed
3) 森松光紀ほか : Methotrexate髄注に伴うdisseminated necrotizing leukoencephalopathyの1例. 神経内科 9 : 54-62, 1978.
 
4) 加納康彦 : 葉酸・プリン拮抗物質. 治療薬ガイド 2001-2002 (Medical Practice編集委員会編), p 909-914, 文光堂, 2001.
 
5) Boogerd W : Neurological complications of chemotherapy. In : Handbook of Clinical Neurology, Vol 65 (ed by de Wolff FA), p 527-546, Elsevier, Amsterdam, 1995.
 
6) Packer RJ, et al : Focal encephalopathy following methotrexate therapy. Administration via a misplaced intraventricular catheter. Arch Neurol 38 : 450-452, 1981.
 
7) Kuzuhara S, et al : Subacute leucoencephalopathy induced by carmofur, a 5-fiuorouracil derivative. J Neurol 234 : 365-370, 1987.
 
8) Ohara S, et al : Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative. Acta Neuropathol 96 : 527-531, 1998.
PubMed
9) Siegal T, et al : Early and delayed neurotoxicity of mitoxantrone and doxonlbicin following subarachnoid injection. J Neurooncol 6 : 135-140, 1988.
PubMed
10) Marx G, et al : Phase 1 study of docetaxel plus ifosfamide in patients with advanced cancer. Br J Cancer 87 : 846-849, 2002.
 
11) Bessell EM, et al : CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 50 : 457-464, 2001.
PubMed
12) Meyers CA, et al : Persistent neurotoXicity of systemically administered interferon-alpha. Neurology 41 : 672-676, 1991.
PubMed
13) Cairncross G, et al : Myeloablative chemotherapy for recurrent aggressive oligodendroglioma. Neurooncology 2 : 114-119, 2000.
 
14) Kingma A, et al : Cerebrovascular complications of L-asparaginase therapy in children with leukemia : aphasia and other neuropsychological deficits. Pediatr Hematol Oncol 10 : 303-309, 1993.
PubMed
15) Mullenix PJ, et al : Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia. Pediatr Res 35 : 171-178, 1994.
 
P.497 掲載の参考文献
1) Larson EB, et al : Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 107 : 169-173, 1987.
PubMed
2) 石郷岡純 : 薬物による中毒性脳症. 老年期痴呆 2 : 83-89, 1988.
 
3) 佐々木良元, 葛原茂樹 : 薬物と痴呆. Dementia Japan 11 : 270-274, 1997.
 
P.501 掲載の参考文献
1) 北林百合之介ほか : 薬物によるせん妄. 老年精神医学雑誌 9 : 1316-1323, 1998.
Medical*Online
2) 澤田康文ほか : 薬剤予測学入門 用法・用量の科学的設定は可能か? (13) ヒスタミンH2レセプター遮断薬による中枢神経系副作用を予測する (上). 月刊薬事 35 : 97-108, 1993.
 
3) Vial T, et al : Side effects of ranitidine. Drug Saf 6 : 94-117, 1991.
PubMed
4) 下川昌文ほか : H2受容体遮断薬による中枢性副作用の薬物動態論的評価 : 危険因子としての肝, 腎疾患. 薬物動態 8 : 295-305, 1993.
Medical*Online
5) 吉岡恵子ほか : Famotidine過剰投与により意識障害を来たしたと考えられる血液透析患者の2例-硬膜下血腫手術後のfamotidine髄液中濃度について-. 透析会誌 24 : 727-729, 1991.
 
6) 山岡功一, 山内惟光 : Cimetidine長期投与中に発症し, 投与中止により軽快した治療抵抗性うつ病の1例. 臨床精神医学 20 : 795-799, 1991.
 
7) Knodell RG, et al : Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101 : 1680-1691, 1991.
PubMed
8) Montastruc JL, et al : Drug-induced parkinsonism : a review. Fundam Clin Pharmacol 8 : 293 -306, 1994.
 
9) Morikawa O, et al : Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 349 : 317-324, 1998.
 
10) Malek-Ahmadi P : Mood disorders associated with interferon treatment : theoretical and practical considerations. Ann Pharmacother 35 : 489-495, 2001.
PubMed
P.506 掲載の参考文献
1) Goyer RA, Clarkson TW : Toxic effects of metals. In : Casarett and Doull's Toxicology ; The Basic Science of Poisons, 6th ed (ed by Klaassen CD), p 811-867, McGraw-Hill, New York, 2001.
 
2) Spencer PS : Aluminum and its compounds. In : Experimental and Clinical NeurotoXicology, 2nd ed (ed by Spencer PS, Schaumburg HH), p 142-151, Oxford University Press, New York, 2000.
 
3) Letzel S, et al : Longitudinal study of neurotoxicity with occupational exposure to aluminum dust. Neurology 54 : 997-1000, 2000.
PubMed
4) Bishop NJ, et al : Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 336 : 1557-1561, 1997.
PubMed
5) 荒記俊一ほか : 鉛. 中毒学-基礎・臨床・社会医学- (荒記俊一編), p82-88, 朝倉書店, 2002.
 
6) Lidsky TI, Schneider JS : Lead neurotoxicity in children : basic mechanisms and clinical correlates. Brain 126 : 5-19, 2003.
PubMed
7) Cory-Schlecta DA, Schaumburg HH : Lead, inorganic. In : Experimental and Clinical Neurotoxicology, 2nd ed (ed by Spencer PS, Schaumburg HH), p708-720, Oxford University Press, New York, 2000.
 
8) Schaumburg HH : Lead, organic. In : Experimental and Clinical Neurotoxicology, 2nd ed (ed by Spencer PS, Schaumburg HH), p 720-721, Oxfbrd University Press, New York, 2000.
 
9) Stewart WF, et al : Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 52 : 1610-1617, 1999.
PubMed
10) Schwartz BS, et al : Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 55 : 1144-1150, 2000.
PubMed
11) Verity MA, Sarafian TA : Mercury and mercury compounds. In : Experimental and Clinical Neurotoxicology, 2nd ed (ed by Spencer PS, Schaumburg HH), p 763-770, Oxford University Press, New York, 2000.
 
12) Chu N-S, et al : Manganese. In : Experimental and Clinical Neurotoxicology, 2nd ed (ed by Spencer PS, Schaumburg HH), p 752-755, Oxford University Press, New York, 2000.
 
13) Normandin L, Hazell AS : Manganese neurotoxicity : an update of pathophysiologic mechanisms. Metab Brain Dis 17 : 375-387, 2002.
PubMed
14) 加地浩 : マンガン. 中毒学-基礎・臨床・社会医学- (荒記俊一編), p101-104, 朝倉書店, 2002.
 
P.510 掲載の参考文献
1) 長谷川弘道, 河合清之 : 一酸化炭素. 中毒症-基礎と臨床- (池田良雄ほか編), p281-291, 朝倉書店, 1975.
 
2) 内藤裕史 : 一酸化炭素. 中毒百科-事例・病態・治療-, p116-122, 南江堂, 1991.
 
3) Sayers RR, et al : US Bur Mines Rept Invest, No. 2476, 1923.
 
4) 立津政順ほか : 急性一酸化炭素中毒-三井三池炭塵爆発の長期予後-, p1-163, 星和書店, 1994.
 
5) Goldaum CLR, et al : What is the mechanism of carbon monoxide toxicity. Aviat Space Environ Med 46 : 1289-1291, 1975.
 
P.513 掲載の参考文献
1) Marchiafava E, Bignami A : Sopra un alterazione del corpo calloso osservata in soggetti alcoolisti. Riv Patol Nerv 8 : 544, 1903.
 
2) Morel F : Une forme anatomo-clinique particuliere de l'alcoolisme chronique : Sclerose corticale laminaire alcoolique. Rev Neurol 71 : 280-288, 1939.
 
3) 加藤伸勝 : アルコール痴呆の臨床概念. アルコール研究と薬物依存 26 : 119-133, 1991.
 
4) Victor M, et al : The Wernicke-Korsakoff Syndrome, FA Davis, Philadelphia, 1989.
 
5) 小阪憲司 : アルコールによる痴呆. 臨床精神医学 14 : 1165-1173, 1985.
 
6) 加藤元一郎 : アルコール性痴呆. 日本アルコール精神医学雑誌 5 : 15-24, 1998.
 
7) 森山泰ほか : アルコール関連痴呆. 日本アルコール精神医学雑誌 9 : 33-41, 2002.
 
8) 安藤蒸, 沼倉泰二 : 中毒性脳症を中心としたアルコール症に伴う痴呆. 老年期痴呆 2 : 63-71, 1988.
 
9) 桶田理喜, 中野隆史 : アルコール性層状皮質硬化症 (Morel) といわゆるペラグラ脳症とを合併した慢性アルコール中毒の1剖検例. 神経研究の進歩 20 : 37-51, 1976.
 
10) 三ツ汐洋ほか : アルコール依存症者の前頭葉機能障害. 日本アルコール精神医学雑誌 3 : 41-48, 1996.
 
11) 鹿島晴雄, 加藤元一郎 : アルコール痴呆. 神経心理学 7 : 54-65, 1991.
 
12) 山崎茂樹ほか : 頭部CT所見から見たアルコール症者の脳萎縮像の研究. 臨床精神医学 12 : 995-1007, 1983.
 
13) 苗村育郎 : 前頭葉萎縮を巡って. 日本アルコール精神医学雑誌 4 : 123-132, 1997.
 
14) Parsons O, Leber WR : The relationship between cognitive dysfunction and brain damage in alcoholics. Clin Exp Res 5 : 326-343, 1981.
PubMed

書評

最近チェックした商品履歴

Loading...